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Abstract
Generally, all bilaterans examined have similar conservation of HOX protein structure,
function, expression, and requirement. However, at the level of being the same, it is
unknown whether the HOX protein, Antennapedia, is required for tarsus determination in
Drosophila melanogaster as in Tribolium casteneum, or whether the requirement of HOX
proteins in determination of body parts diverges in insects. I proposed to use a heat
shock-inducible nanobody (UAS- NSlmb-vhhGFP4 driven by hsp-GAL4) activated during
the third larval stage in all cells to degrade thoracically expressed HOX proteins (Sex
combs reduced, Antennapedia, and Ultrabithorax) tagged with green fluorescence protein
(GFP) derivatives; GFP, YFP, CFP, or 17 amino acid epitope of GFP. Due to difficulties
in establishing CRISPR mediated homologous recombination, only the initial steps have
been completed, but the system is now established to determine whether HOX
requirement for tarsus determination is conserved in insects.

Keywords
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Introduction

1.1 Advantages of Drosophila as a Model Organism
Drosophila melanogaster, the common fruit fly, was first documented as being used in
1901 by William Castle’s laboratory at Harvard. However, Thomas Hunt Morgan is
considered to be the “father” of Drosophila research (Kohler, 1994). Morgan began using
Drosophila for the experimental study of evolution around 1906 and shortly thereafter he
discovered the white gene (flies with this mutation have white eyes instead of red). This
led to fruit flies making important contributions to the fields of medical and scientific
research, including molecular biology, cell biology, developmental biology, and
population biology (Stephenson & Metcalfe, 2013). Morgan won the Nobel Prize in
Physiology or Medicine in 1933 “for his discoveries concerning the role played by the
chromosome in heredity” and his students also went on to make key advances in genetics
and helped to expand Drosophila as the leading genetic system. One of whom, Muller,
won a Nobel Prize in Physiology or Medicine in 1946 “for the discovery of the
production of mutations by means of x-ray irradiation” and is also credited with the
development of balancer chromosomes. The past few decades has seen Drosophila
become a predominant model used to understand how genes direct the development of an
embryo from a single cell to a mature multicellular organism (Edward B. Lewis,
Christiane Nüsslein-Volhard, and Eric F. Wieschaus won a Nobel Prize in Physiology or
Medicine 1995 “for their discoveries concerning the genetic control of early embryonic
development”). Many of the processes that direct development within the fly have been
conserved through evolution and are strikingly similar to the processes that direct
development in all organisms. The Drosophila genome sequence was first released in
March 2000 and is freely available, along with annotations, via “Flybase”, an online
database dedicated to Drosophila (dos Santos et al., 2014). Currently, it is estimated that
there are ~14,000 genes in Drosophila (Adams et al., 2000). The past century has seen a
huge range of genetic tools become available for Drosophila that match or surpass those
for any other multicellular organisms. There are vast assortments of strains containing
endogenous mutations available from stock centres or the labs that generated them which
are collated in Flybase.
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Drosophila have a relatively short life cycle and are inexpensive and easy to keep. This
means that genetic experiments that would take months or even years in vertebrate
models, such as mice, Xenopus, or zebrafish, can be completed in a matter of weeks.
Female flies can lay up to ~100 eggs per day for up to 20 days and it takes approximately
10 days at 25ºC for an embryo to develop into a fertile adult fly (Dahmann, 2008). Thus,
it is relatively easy to generate large numbers of embryos (only ~500 µm in size) or flies
for an experiment (Jennings, 2011). Furthermore, unlike other vertebrate models,
Drosophila is not subject to animal licensing laws and there are generally very few
restrictions on their use in the laboratory as there are minimal ethical and safety issues
(Jennings, 2011). Additionally, individual flies are easily manipulated if necessary
through safe anaesthetisation with carbon dioxide. Fly strains are maintained through
living stocks (Jennings, 2011).

1.2 Genetic Tools Available in Drosophila
Prior to the 1940s, Drosophila was used as a major model organism in the field of
genetics (Hartwell et al., 2004). However, after the establishment of recombinant
technology with bacteria and virus models, Drosophila again became a prominent model
organism for the study of developmental genetics (Hartwell et al., 2004). The renewed
interest in Drosophila was because genes previously identified by mutant alleles that had
been shown to be important in development or behavior could now be isolated and
analyzed using recombinant technology (Hartwell et al., 2004). The isolation of
Drosophila genes led to the discovery that similar genes were found in higher organisms
(Hartwell et al., 2004).

1.2.1

Balancer Chromosomes

In Drosophila, crossing-over only occurs in females. The absence of crossing-over in
males allows linkage relationships to be maintained by ensuring strict male inheritance
(Hartwell et al., 2004). In females, only one or two crossing-over events typically occur
on each major chromosome arm per meiosis. To help maintain linkage, “balancer
chromosomes”, which contain multiple, overlapping inversions, are used. Balancer
chromosomes normally carry a dominant marker to allow researchers to follow the
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balancer through crosses, as well as a recessive lethal mutation, such that flies
homozygous for the balancer chromosome don’t survive (Herman et al., 1976). This
allows no recombinant chromosomes to be passed to the next generation, and therefore,
balancer chromosomes and their homologs are inherited as intact single mendelian units
(“An Introduction to Balancers,” Bloomington Drosophila Stock Center website).
Balancer chromosomes are essential in maintaining stocks of flies carrying lethal
mutations and in many genetic manipulations.

1.2.2

Transgenesis: P Element

“Transgenesis” is a general term referring to a group of technologies that allows the
reintroduction of DNA into the genome of an organism. P element mediated
transformation was the first of these methods to be developed. Originally identified as a
tool for mutagenesis, Rubin & Spradling (1982) recognized the ability to use P elements
for transgenesis. The transposase enzyme causes the excision of a P element from its
initial position in the host genome and the reinsertion of the element randomly at another
position in the genome. To prevent uncontrolled transposition, the two parts of the P
element, the transposase enzyme and the recognition sequences for transposase action,
are separated on two separate plasmids, the P element plasmid and a helper plasmid
(Karess & Rubin, 1984). This method has a wide variety of applications, including
enhancer trapping, gene-tagging, targeted misexpression, RNA interference (RNAi)
delivery, and homologous recombination/gene replacement.

1.2.3

LoxP/Cre

Advances in the field of transgenesis have improved fly transgenic methods. The P
element method is limited by the small size of the DNA that can be integrated, and that
the insertion site cannot be controlled. Methods using recombinases and integrases are
integration site specific (Venken & Bellen, 2007). In one such method, the loxP/Cre
system is composed of the recombinase, Cre, which recognizes the target site, loxP.
When the genome has a single loxP site, Cre can target a transgene to this site that also
has a loxP site. When a transgene is integrated in DNA and contains two flanking loxP
sites, the Cre recombinase removes the transgene. However, when the Cre recombinase
excises DNA, one of the loxP sites remains in the genome, referred to as a “scar”. When
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multiple, sequential recombination events are required, as is the case for this project, the
loxP scar will interact with other loxP sequences in the genome causing chromosomal
deletions and inversions (Delneri et al., 2000, 2003). A mutant loxP, lox2272, does not
recombine with the standard loxP site but is still recognized by Cre recombinase to allow
multiple, sequential recombination events (Lee & Saito, 1998; Missirlis et al., 2006).

1.2.4

GAL4/UAS

Transgenesis can also be used to induce ectopic misexpression of genes, that is, abnormal
temporal expression or expression in cells or tissues outside where the gene is normally
expressed. For example, fusing a heat-shock promoter (hsp) to a gene renders the
expression of the gene to be temperature-dependent and ubiquitous (Bonner et al., 1984).
An improved technique allows gene expression to be controlled both temporally and
spatially using a yeast transcriptional activator GAL4 (Brand & Perrimon, 1993). In the
GAL4/UAS system, GAL4 expression induces a GAL4 responsive promotor, or upstream
activation sequence (UAS). Depending on the promoter used, GAL4 can be expressed in
a specific pattern, at a specific time, (example using a hsp), or ubiquitously (example
using the armadillo promoter). Genes that are downstream of a UAS sequence can only
be activated by GAL4, and therefore, control of the expression of a gene of interest at
almost any stage of development and in any tissue is possible (Ryder & Russell, 2003).
To further refine the temporal expression of GAL4 activity, a temperature-sensitive (ts)
GAL80ts is often used (Matsumoto et al., 1978). GAL80 protein binds to GAL4,
repressing the activation of gene expression (Brand & Perrimon, 1993). Therefore, only
at high temperatures does GAL80ts dissociate from GAL4 allowing gene expression.

1.2.5

RNAi

Contrary to ectopically expressing genes, is to silence gene expression. One method to
accomplish this is with inducible RNA interference (RNAi). RNAi allows silencing of a
gene without having to mutate the endogenous copy by injecting double-stranded RNA
into an embryo which then acts as a degradation template for the host mRNA (Fire et al.,
1998; Yang et al., 2000). However, induction of RNAi in Drosophila by injection has
problems associated with it, including that the effect is not stably inherited and that
silencing a gene early in development can hinder the analysis of its effects later in
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development (Kennerdell & Carthew, 1998). In addition, RNAi is not very efficient and
results in off-target effects (Qiu et al., 2005).

1.2.6

Transgenesis: Zinc-finger and Transcription Activator-like
Effector Nucleases

The big disadvantage of P element or any transposon-mediated system of transgenesis, is
that the DNA is incorporated randomly in the genome. The expression of the transgene is
then susceptible to the chromatin environment around the insertion site, referred to as
position effect. The use of site-specific recombinases allows the insertion of all constructs
at the same position in the genome (Venken & Bellen, 2007). But perhaps the best
approach in transgenesis is the ability to modify the endogenous locus through
homologous recombination (HR). HR is a powerful tool for genome editing in which a
double stranded break (DSB) in the endogenous DNA is repaired by an exogenous repair
template resulting in an exchange of nucleotide (nt) sequence (Capecchi, 1989). DSBs
stimulate cellular DNA repair mechanisms, including either HR when a repair template is
supplied, or error-prone non-homologous end joining (NHEJ; Lieber, et al., 2003; West,
2003). The first method of creating DSBs in the Drosophila genome was purely genetic,
using a yeast I-SceI endonuclease (Bellaiche et al., 1999; Rong & Golic, 2000). However,
this method is very labour intensive and inefficient. Some improvements for creation of
site-specific, targeted DSBs have since been discovered using nucleases like Zinc-finger
nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). ZFNs are
protein fusions between the FokI nuclease and three zinc-finger DNA-binding domains
that introduce sequence specificity (Bibikova et al., 2003). TALENs are a protein fusion
between the FokI nuclease and a transcription activator-like effector (TALE; Christian et
al., 2010). These two methods, although useful, are labour-intensive and time-consuming.

1.2.7

Transgenesis: CRISPR

A simple and more efficient alternative has recently emerged to induce targeted DSBs:
CRISPR (clustered regularly interspaced short palindromic repeats). In type II CRISPR
systems, short sequences complementary to foreign DNA, CRISPR RNA (crRNA), and
trans-activating CRISPR RNA (tracrRNA), direct sequence-specific cleavage of
exogenous DNA through interaction with a CRISPR-associated nuclease (Cas9; Gaj et
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al., 2013; Gratz et al., 2013; Figure 1.A). The Cas9 protein requires a 20 nt guide
sequence complementary to the target site within the crRNA and a conserved
dinucleotide-containing protospacer adjacent motif (PAM) sequence, NGG, upstream of
the crRNA binding region (Jinek et al., 2012). On average, this sequence (NGG) occurs
every 8 bases in the DNA and recent reports suggest that this requirement may be relaxed
to include NAG sequences, increasing the number of potential target sites (Mali et al.,
2013a). Additionally, Cas9 nucleases may be engineered with altered PAM specificities
(Kleinstiver et al., 2015). This allows the system to be used to target virtually any
sequence for cleavage simply by redesigning the crRNA. The system has been simplified
into a minimal two-component system – Cas9 and a chimeric RNA (chiRNA) that
includes both the crRNA and the tracrRNA from Streptococcus pyogenes (Jinek et al.,
2012; Figure 1.B). The CRISPR system has been used to accomplish efficient genome
engineering in many organisms, including but not limited to Drosophila (Chang et al.,
2013; Cho et al., 2013; Cong et al., 2013; DiCarlo et al., 2013; Ding et al., 2013;
Friedland et al., 2013; Gratz et al., 2013; Guo & Li, 2015; Hwang et al., 2013; Jiang et
al., 2013; Jinek et al., 2012; Mali et al., 2013b; Wang et al., 2013). Optimization to
improve specificity and efficiency has seen development of transgenic flies expressing
Cas9 and/or chiRNA. The germline-specific nanos (nos) promoter and the ubiquitous
actin5C (act) promoter are two commonly used promoters to drive Cas9 expression in
Drosophila (Kondo & Ueda, 2013; Port et al., 2014; Ren et al., 2013).

1.3 CRISPR: A History
CRISPRs are the most efficient method of genome editing to date. A series of repeats
were first discovered in the Escherichia coli genome in 1987 (Ishino et al., 1987). They
were originally termed Short Regularly Spaced Repeats (SRSRs) and in 2000, these
repeats were found to exist in the genomes of other archaea and bacteria (Mojica & DíezVillaseñor, 2000). CRISPR loci have been found in 80% archaeal genomes and about
40% of bacterial genomes sequenced to date (“CRISPRs Database,” 2014). In 2002,
SRSRs were renamed CRISPRs when it was established that the three major components
of a CRISPR locus are: cas genes (encode a nuclease), a leader sequence, and a repeatspacer array (Jansen et al., 2002). In 2005, three independent research groups indicated
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Figure 1. CRISPR System.
(A) In the type II CRISPR system, transcripts from the CRISPR repeat arrays are
processed into crRNAs, each harboring a variable sequence homologous to that of the
invading DNA, known as the “protospacer” sequence, and part of the CRISPR repeat.
Each crRNA hybridizes with a second RNA, known as the tracrRNA, and these two
RNAs complex with the Cas9 nuclease. The crRNA directs Cas9 to cleave
complementary target-DNA sequences, if they are adjacent to short sequences known as
protospacer adjacent motifs (PAMs). (B) The system was further simplified to a twocomponent system that utilizes a chiRNA, or guide RNA, which is a fusion of the crRNA
and tracrRNA, and Cas9. The chiRNA uses 20 nt of sequence that corresponds to the
target DNA sequence (Jinek et al., 2012. Reprinted with permission from AAAS). N.B.
Copyright image permissions are provided in Appendix C for all figures/images.
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that the CRISPR/Cas system has a role in bacterial adaptive immunity and worked
analogously to the eukaryotic system of RNAi, with the spacers serving as a template for
RNA molecules (Bolotin et al., 2005; Makarova et al., 2006; Mojica et al., 2005; Pourcel
et al., 2005). Barrangou et al. (2007) showed that the resistance specificity was due to the
spacer DNA sequence coinciding to phage DNA sequence. The study of CRISPR/Cas
relationships identified 3 major systems, Type I, Type II, and Type III, which all have
three stages: adaptation, expression and interference (Figure 2; Makarova et al., 2011).
The adaptation stage involves the recognition of invading DNA and then incorporation of
some of the invading DNA sequence, called spacers, into the CRISPR array by Cas
proteins (Makarova et al., 2011). The CRISPR array is then transcribed in the expression
stage to form a long pre-CRISPR RNA (pre-crRNA) that is processed and assembled into
one of three crRNA/Cas riboproteins (Makarova et al., 2011). The Type I, Type II, or
Type III crRNA/Cas riboproteins interfere with invading DNA, cleaving it at the target
sites (Makarova et al., 2011). The Type II system, which uses the nuclease, Cas9, was
used by researchers in 2012 to edit the genome of human tissue culture cells (Jinek et al.,
2012). In type II CRISPR systems, short sequences complementary to foreign DNA,
crRNA, and tracrRNA, direct sequence-specific cleavage of exogenous DNA through
interaction with a Cas9 nuclease (Jinek et al., 2012; Figure 1.A). Jinek et al. (2012) then
further simplified the type II system to be a minimal two-component system – Cas9 and a
chimeric RNA (chiRNA) that is a fusion of the crRNA with the tracrRNA from
Streptococcus pyogenes (Figure 1.B). Since then, the CRISPR system has been exploited
and used efficiently in many organisms and cells, including, yeast (DiCarlo et al., 2013),
zebrafish (Chang et al., 2013; Hwang et al., 2013), mice (Wang et al., 2013), nematodes
(Friedland et al., 2013), plants (Jiang et al., 2013), monkey embryos (Guo & Li, 2015),
human stem cells (Cho et al., 2013; Cong et al., 2013; Ding et al., 2013; Jinek et al.,
2012; Mali et al., 2013b) and Drosophila (Gratz et al., 2013). More importantly,
CRISPR has interesting applications in medicine, for example curing genetic disease.
Mice were cured of a liver disorder (Yin et al., 2014). Libraries of tens of thousands of
guide RNA (chiRNA) are already available for human genes (Pennisi, 2013) and the
CRISPR systems have continued to be optimized.
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Figure 2. The Three Stages of CRISPR–Cas Action.
CRISPR–Cas systems act in three stages: adaptation, expression and interference.
Adaptation begins by recognition of invading DNA by Cas1 and Cas2 and integration of
short sequences in a CRISPR array. Expression involves transcription of the CRISPR
array into a long pre-crRNA. CrRNA processing and interference (nucleic acid cleavage)
is different in each of the three CRISPR systems, Type I, II, and III (Makarova et al.,
2011)
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1.4 Development of Drosophila
Fruit flies like to lay their eggs near the surface of fermenting (ripening) foods or other
organic materials. Drosophila, like butterflies and moths, are holometabolous insects,
which mean that they undergo a four stage life cycle; egg, larva, pupa, and adult fly
(Figure 3). At 25ºC, the fertilized embryo develops in the egg for around one day before
hatching as a larva. The initiation of Drosophila embryogenesis is characterized by a
syncytial blastoderm, where nuclei divide in a multinucleate common cytoplasm for
around 2 hours. During this syncytial blastoderm stage, a subset of nuclei cellularizes
gaining a plasma membrane. These cells are the pole cells and are the progenitors of the
germ line, the sperm and ova (Campos-Ortega & Hartenstein, 1997). After a few more
nuclear divisions, the rest of the nuclei cellularize to form the cellular blastoderm. The
cellular blastoderm then undergoes gastrulation, giving rise to the three germ layers. For
the next 6 hours, germ band elongation takes place, in which the ventral epidermis
lengthens and mitotic divisions begin to occur. The neuroblasts are determined, the
embryo becomes segmented, and the cephalic furrow begins formation. Subsequently, the
head features start to develop and the neuroblast complete their formation. Germ band
retraction begins at ~9.5 hours post-fertilization which involves ventral closure and
segment formation within the embryo. The central and peripheral nervous systems
become differentiated, followed by dorsal closure of the midgut and epidermis. Head
involution begins, and dorsal closure is completed. Next, the ventral nerve cord shortens
and air fills the tracheal tree. Embryogenesis concludes with the hatching of a first instar
larva at 21-22 hours after fertilization. Over the next five days, the larva eats and grows,
going through two molts, to become a second and third instar larva, until it pupates.
While a pupa, it undergoes metamorphosis into the adult fly over the course of four days.
Most of the embryonic and larval tissue is destroyed during metamorphosis, and the adult
tissues (e.g. wing, leg, eye) develop from groups of cells known as imaginal discs.
Imaginal discs are derived from cells set aside during embryogenesis that form the adultspecific structures. During the larval stages and metamorphosis, the imaginal cells
proliferate to form differentiated discs of cells. When metamorphosis is complete, the
adult-specific identities are formed and a mature adult fly ecloses.
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Figure 3. Schematic of the Stages of the Drosophila Life Cycle.
After fertilization and the initiation of embryogenesis, an embryo hatches as a first instar
larva before it molts twice to form a second and third instar larva. The third instar larva
pupariates into a pupa and then ecloses as a mature adult fly. This figure was adapted
from Hartwell et al. (2004).
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1.5 The Drosophila Genome
The Drosophila genome has been well characterized and was one of the first eukaryotic
genomes to be sequenced, closely following yeast (Saccharomyces cerevisiae) and the
nematode (Caenorhabditis elegans) (Adams et al., 2000; The C. elegans Sequencing
Consortium, 1998; Goffeau et al., 1996). The DNA of Drosophila is broken up into six
units: three autosomes (chromosome 2, 3, and 4), two sex chromosomes (X and Y; Figure
4) as well as the mitochondrial genome. Out of ~180 Mb, 120 Mb is euchromatin, which
is mainly located on the two large autosomes (2 and 3) and the X chromosome (Adams et
al., 2000). The small fourth chromosome contains only ~1 Mb of euchromatin (Adams et
al., 2000). The genomic DNA sequence of Drosophila is combined with all the known
knowledge of Drosophila genetics and function in a publicly available database, called
FlyBase (dos Santos et al., 2014). Although “Drosophila” is typically used to refer to
Drosophila melanogaster, and indeed this is the case throughout this work, there are
actually over 1500 different species in the Drosophila genus of the Drosophilidae family,
of which 12 have been sequenced (Bächli, TaxoDros website; Drosophila 12 Genomes
Consortium, 2007).

1.6 Gene Expression in Drosophila
The development of the larval anterior to posterior (A-P), or head to tail, axis has been
the subject of intensive research. The process of the segmentation and organization of the
body plan resulting in the formation of distinct developmental identities is proposed to be
controlled by a regulatory hierarchy of five sets of genes: maternal effect genes, gap
genes, pair rule genes, segment polarity genes, and homeotic genes (Figure 5). Most of
these genes encode transcription factors. Segmentation begins before the egg is laid
during oogenesis of the mother. In the ovary of the mother, specific genes are transcribed
and their transcripts are transported to the egg and function after fertilization to pattern
the embryo and specify cell states (St Johnston & Nüsslein-Volhard, 1992). For example,
Bicoid RNA is localized in the cytoplasm at the anterior pole of the egg and is translated
after fertilization to produce an A-P concentration gradient of Bicoid protein. A mother
homozygous for a bicoid mutation produces embryos in which the head and thoracic

13
segments are missing (Driever & Nüsslein-Volhard, 1988). Maternal effect proteins

Figure 4. Mitotic Chromosomes of Drosophila, Showing Euchromatic Regions,
Heterochromatic Regions, and Centromeres.
Arms of the autosomes are designated 2L, 2R, 3L, 3R, and 4. Length is in megabases
(Mb). The heterochromatic block of the X chromosome is polymorphic among stocks and
varies from one-third to one-half of the length of the mitotic chromosome. The Y
chromosome is nearly entirely heterochromatic (Adams et al., 2000. Reprinted with
permission from AAAS).
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Figure 5. Segmentation Genes are Expressed as a Hierarchy to Regulate the Pattern
of Development Along the A-P axis of a Developing Drosophila Embryo.
These are in situ hybridizations to mRNA of representative genes from each class of
segmentation gene in the segmental hierarchy. The protein products of genes expressed
earlier in the hierarchy regulate the expression of genes further down in the hierarchy to
segment the developing embryo and determine segmental identities. The expression
patterns of the Maternal coordinate gene, bicoid (bcd), Gap gene, Krüppel (Kr), Pair rule
gene, runt (run), Segmental polarity gene, engrailed (en), and Homeotic selector genes,
Deformed (Dfd) and Abdominal-B (Abd-B) are shown (Tomancak et al., 2002, 2007).
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regulate the expression of the second class of segmentation genes, the gap genes. Gap
genes are amongst the first zygotically expressed genes and are transcribed in spatially
restricted expression domains along the A-P axis of the embryo and include: huckebein,
tailless, giant, hunchback, Krüppel, and knirps (St Johnston & Nüsslein-Volhard, 1992).
Gap loss-of-function (lf) mutations result in the loss of multiple, contiguous segments.
The gap proteins regulate the expression of the third class of segmentation genes, the pair
rule genes. Pair rule genes are expressed in a pattern of seven repetitive stripes (RiveraPomar & Jãckle, 1996). In homozygous pair rule mutants, every other segment is deleted
(Jürgens et al., 1984; Wakimoto & Kaufman, 1981). The expression pattern of pair rule
genes establishes 14 parasegments. Subsequently, the pair rule proteins regulate the
expression of segment polarity genes. Segment polarity genes establish the polarity
within a segment. Segment polarity mutations cause posterior cells to form anterior
structures, often producing a mirror image of the anterior region (Nüsslein-Volhard &
Wieschaus, 1980). The expression of the segment polarity genes, wingless and engrailed,
define the parasegmental boundaries.
After the body is segmented by the first four classes of genes, the expression of the fifth
class, Hox genes, determines the unique structure of individual body segments, referred
to as segmental identity. Hox genes are important regulatory genes that are expressed in
spatially restricted domains along the A-P axis of the embryo by the segmentation genes
(Ingham & Martinez Arias, 1992). For example, the Hox gene, Dfd is expressed in the
maxillary segment near the anterior end of the embryo, while the Hox gene, Abd-B is
expressed in the most posterior end of the embryo in abdominal segments 8 and 9 (Figure
5). The phenotype of lf and gain-of-function alleles in Hox genes are the homeotic
transformations of one segment into the likeness of another (Bateson, 1894; Bridges,
1915).

1.7 The Homeotic Selector (or Hox) Genes
The order of the Homeotic, or Hox genes along the chromosome coincides with the
relative position of their expression pattern along the A-P axis of a developing embryo.
For example, in Drosophila, the left most gene in the complex is the labial (lab) gene,
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which is expressed most anteriorly in the embryo, and the right most gene, AbdB, is
expressed most posteriorly in the embryo. All of the intervening genes along the
complex, proboscipedia (pb), Dfd, Sex combs reduced (Scr), Antennapedia (Antp),
Ultrabithorax (Ubx), and abdominal-A (abdA), are expressed appropriately along the A-P
pattern in the embryo according to their position in the complex (Figure 6). This pattern
of expression is referred to as collinearity. The collective composition of the Hox gene
complex is referred to as the homeotic complex (HOM-C). The HOM-C complex is
broken into two in Drosophila, the Antennapedia and the Bithorax complexes (ANT-C
and BX-C).
The Hox genes contain a homeobox that encodes a DNA-binding motif, called a
homeodomain. The HOX proteins are transcription factors and the homeodomain
recognizes and binds to specific sequences of DNA (Levine & Hoey, 1988). Hox mutant
alleles result in homeosis, in which the morphology of a body region is transformed to
that of a different region (Bateson, 1894). Therefore, Hox genes act as binary switches,
where loss of function produces one transformation in the region where the gene is active
and gain of function produces the opposite transformation where the gene is normally
inactive. For example, the antenna and leg are homologous appendages and mutations
can cause the transformation of one into the other (Postlethwait & Schneiderman, 1971;
Struhl, 1982). The appendages are homologous in that the different parts correlate to
similar positions along the proximal-distal axis (Figure 7). The first antennal segment is
homologous to the leg coxa, where they join to the body of the fly. The second antennal
segment is homologous to the trochanter of the leg. The third antennal segment is
homologous to the femur, tibia, and first tarsal segment of the leg and the arista and its
base are homologous to the distal tarsal segments including the tarsal claw (Postlethwait
& Schneiderman, 1971).
One of the major findings in developmental biology is that Hox genes are conserved at
four levels: structure, expression, requirement, and function. The structure of individual
Hox genes is conserved as well as the structure of the Hox gene complexes (Graham et
al., 1989). The collinear pattern of expression of Hox genes is conserved (Graham et al.,
1989). The products of the Hox genes are required in a similar manner for the
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Figure 6. Hox Genes in Drosophila.
The order in which the Hox genes appear A-P in the complex on the chromosome
correspond to the domain of expression along the A-P axis of the embryo and the
segmental identity of A-P body parts in the adult fly. Abbreviations: HOM-C, Homeotic
complex; ANT-C, Antennapedia complex; BX-C, Bithorax complex; lab, labial; pb,
proboscipedia; Dfd, Deformed; Scr, Sex combs reduced; Antp, Antennapedia; Ubx,
Ultrabithorax; abdA, abdominal-A; AbdB, Abdominal-B. This figure was adapted from
Sadava et al. (2008).
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Figure 7. Homologous Appendages: Insect Leg and Antenna.
The first antennal segment is homologous to the leg coxa, where they join to the body of
the fly. The second antennal segment is homologous to the trochanter of the leg. The
third antennal segment is homologous to the femur, tibia, and first tarsal segment of the
leg and the arista and its base are homologous to the distal tarsal segments including the
tarsal claw (Gilbert, 2013 modified from Postlethwait & Schneiderman, 1971).
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development of body plans of bilaterally symmetric organisms. Finally, a Hox gene of
one organism can functionally replace that of another organism. These levels of Hox
conservation are generally well established at a level of similarity; however, this work
examines conservation of requirement in insects at a more detailed level of whether they
are the same.

1.8 The Homeotic Transcription Factors, Scr, Antp, and Ubx
This project attempts to examine the requirement of a specific set of Hox genes
potentially involved in tarsus determination. These Hox genes are, Sex combs reduced
(Scr), Antennapedia (Antp), and Ultrabithorax (Ubx), which have an integral role in
thorax development (Struhl, 1982). Scr activity is required for the prothorax (the first
thoracic segment, T1) and Ubx activity is required for the metathorax (third thoracic
segment, T3; Struhl, 1982). When these two genes are absent, both segments develop like
the mesothorax (the second thoracic segment, T2; Struhl, 1982). If Ubx is lost early in
development, while Scr remains, then posterior portions of the mesothorax and the
metathorax develop as in the prothorax (Kerridge & Morata, 1982; Morata & Kerridge,
1981). All three thoracic segments require Antp activity and when it is absent, part of the
mesothorax is transformed into corresponding antennal structures (Figure 8; Struhl,
1981b, 1982). Similar transformations to antenna occur in the prothorax and metathorax
when Scr and Ubx are absent as well (Struhl, 1982). When examining normal HOX
protein expression patterns early on in development, both ANTP and SCR are expressed
in all leg imaginal discs. Specifically, ANTP is expressed in the ectoderm and by the late
3rd larval stage , ANTP is not expressed in the tarsus primordium (Wirz et al., 1986), but
is restricted to the proximal leg primordium to help determine proximal leg structures
(Abu-Shaar & Mann, 1998; Casares & Mann, 2001; Emerald & Cohen, 2004). SCR is
expressed in the mesoderm of all leg imaginal discs (Glicksman & Brower, 1988). UBX
is expressed strongly in the ectoderm of the third thoracic leg, and weakly in the second
thoracic leg (Brower, 1987).
The analysis of orthologs in other species that evolved from a common ancestor can be
used to compare how gene’s function and requirement has evolved. As well as being
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Figure 8. Phenotype of Somatic Clones Lacking the Antp Gene in the Drosophila
Second Leg.
(A) Wild-type, second leg. (B) A blastoderm Antp clone covering the entire anterior
compartment of the second leg, transforms it into corresponding portions of the antenna.
Note the presence of structures characteristic of the first (I), second (II) and third (III)
antennal segments. Note also that marked cells situated at the margins of the clone form
normal leg tissue (in this case, a claw (arrow) and bristles characteristic of the distal leg).
The untransformed posterior compartment lies beneath the transformed anterior
compartment and hence is out of the plane of focus (Struhl, 1981b).
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extensively studied in Drosophila, Hox genes have been studied at length in the closely
related insect, Tribolium casteneum, red flour beetle, which both diverged from a
common ancestor around 300 million years ago. In Tribolium, the Scr ortholog,
Cephalothorax, is required for normal development of the first thoracic segment (T1)
(Beeman et al., 1993), and the Ubx ortholog, Ultrathorax, is required for the normal
development of T3 (Beeman et al., 1989), as found in Drosophila (Figure 9.A). However,
the beetle Antp ortholog, prothoraxless (ptl) may not be required in the same manner as
in Drosophila. In Tribolium, lf ptl mutant alleles result in transformations of all three
thoracic legs to antennae (Figure 9.B&C; Beeman et al., 1993). In Drosophila, Antplf
alleles affect the development of the proximal leg only resulting in a leg to third antennal
segment transformation and do not result in a tarsus to arista transformation of the distal
leg as observed in Tribolium (Figure 8; Struhl, 1981). Unfortunately, this analysis of Antp
function in adult Drosophila was performed using mosaic analysis where only small
clones of Antplf tissue were generated and analyzed in an otherwise wild type leg
(Percival-Smith et al., 2005; Struhl, 1981b). In addition, tarsus determination is a non-cell
autonomous process, which would not allow the identification of a tarsus to arista
transformation in the leg of an Antp lf/+ mosaic, even if Antp is required for tarsus
determination (Percival-Smith et al., 2005; Struhl, 1981). Furthermore, when the HOX
proteins, SCR, ANTP, and UBX, as well as the other Drosophila HOX proteins
excluding PB, are ectopically expressed in the antenna, an arista to tarsus transformation
is induced, such that the HOX protein required for tarsus determination in Drosophila is
unknown (Abbott & Kaufman, 1986; Burgess & Duncan, 1990; Casares et al., 1996;
Emerald & Cohen, 2004; Gibson & Gehring, 1988; Gibson et al., 1990; Mann &
Hogness, 1990; Percival-Smith et al., 2005; Percival-Smith et al., 1997; Schneuwly et al.,
1987; Struhl, 1981b, 1982).

1.9 Nanobodies
A novel method has recently been developed to selectively target and knock down
proteins. In 1993, it was discovered that the immune systems of Camelidae (i.e. camels
and llamas) contain functional antibodies that are composed of heavy polypeptide chains
only (Hamers-Casterman et al., 1993). Conventional antibodies (or immunoglobulins,
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Figure 9. (Left) The Hox Genes in Drosophila and Tribolium. (Right) Terminal
Phenotype of Lethal ptl lf Mutation in Tribolium.
(A) The regions of the A-P axis affected by lf mutations in Drosophila and Tribolium
Hox genes are indicated by lines, with pb and extra urogomphi (eu) being dotted to
indicate that they do not affect embryos. Segment abbreviations: ant, antennal; int,
intercalary; mn, mandibular; mx, maxillary; la, labial; T, thoracic; A, abdominal. (B)
Lateral view of head (H) through T2 of wild-type first instar larva. (C) Lateral view of
head through A2 of a first instar ptlD6O homozygote. Note transformation of all three pairs
of thoracic legs into antennae. Abbreviations: lb, labial palps; an, antennae; mn,
mandible; lr, labrum; mx, maxillary palps (Beeman et al., 1993).
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IgG) are all comprised of a similar basic structural unit of two identical heavy
polypeptide chains and two identical light polypeptide chains which are linked together
by disulphide bridges to form two antigen-binding (Fab) regions that are linked to a
constant (Fc) region via a flexible hinge (Figure 10; Woof & Burton, 2004) . The amino
terminal variable domains of the two Fab regions of the antibody mediate the highly
specific recognition of the antigen target (epitope). IgG of Camelidae species differ from
conventional antibodies as antigen binding is achieved by a single heavy chain variable
domain (VHH; Figure 10). The VHH domain represents the smallest (only 15 kDa)
available intact antigen-binding fragment, referred to as a nanobody (Muyldermans,
2001). This is half the size of the smallest intact antigen-binding fragment that can be
generated from conventional antibodies, and has the potential to allow access to epitopes
that are not reached by conventional antibodies (Muyldermans, 2001). Interestingly, in
1995 a research team at the University of Miami found a similar type of heavy-chain only
antibody in sharks and other cartilaginous fish (termed VNAR; Greenberg et al., 1995).
The VHH is able to bind to targets with high affinity and specificity because of a long
complementarity determining region 3 (CDR3) loop, which enlarges the surface area of
the antigen binding site of the VHH (Arbabi Ghahroudi et al., 1997). Compared to
antigen-binding derivatives of conventional antibodies, the single domain nature of VHH
gives rise to several unique features and advantages. First, the antigen recognition is
encoded by a single polypeptide in a single gene, which allows easy design of systems for
the selection of antigens with a particular epitope. Second, VHHs are naturally robust,
highly soluble and stable. Their solubility is greatly improved over that of other
antibodies due to substitutions of hydrophobic by hydrophilic residues within the V HH
folded domains (Muyldermans, 2001). Finally, the close homology of the VHH fragment
to human VH fragments is of great diagnostic and therapeutic value (Muyldermans, 2001).
Presently, mouse therapeutic antibodies can elicit an immune response in the human
patient, whereas nanobodies are less likely to do so (Courtenay-Luck et al., 1986;
Muyldermans, 2001).
To isolate a specific VHH domain that recognizes GFP, an alpaca (Lama pacos) was
immunized with purified green fluorescence protein (GFP) and a highly specific GFP-

24

Figure 10. Conventional Immunoglobulins Versus Camelidae Species
Immunoglobulins.
Conventional antibodies (or immunoglobulins, IgG) are composed of two identical heavy
chains and two identical light chains, linked by disulphide bridges (Fab), which are
connected by a flexible hinge to constant (Fc) domains. Light chains fold into a variable
domain (VL) and a constant domain (CL), whereas heavy chains are composed of one
variable domain (VH) and multiple constant domains (CH). The variable domains of both
the heavy and light chains at the tip of the Fab form the antigen-binding sites. IgG of
Camelidae species differ in antigen binding is achieved by a single heavy chain variable
domain (VHH or nanobody; Rothbauer et al., 2006).
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binding antibody fragment, α-GFP VHH (GFP-nanobody), was identified (Rothbauer et
al., 2006). The GFP-nanobody has the ability to precipitate its antigen from cell extracts
more efficiently than mono- and polyclonal anti-GFP antibodies (Rothbauer et al., 2008).
Furthermore, GFP remains stably bound to the GFP-nanobody even under high salt
conditions, high temperature conditions, and between the range of pH 4 to pH 11
(Rothbauer et al., 2008). The structure of the GFP:GFP-nanobody complex formation
was determined using X-ray crystallography to determine the criteria of specificity for
recognition of fluorescent proteins (Figure 11; Kubala et al., 2010). The GFP-nanobody
can also bind to the yellow fluorescent protein (YFP), and a modified cyan fluorescent
protein (CFP; Kubala et al., 2010). Therefore, GFP, YFP, and a modified CFP can be
used in conjunction with the GFP-nanobody (Kubala et al., 2010). This is especially
useful since GFP, CFP, and YFP fluorescence can be visualized separately when they are
co-expressed. This technology has been used in vitro, in vivo, and in planta (Rothbauer
et al., 2008, 2006; Schornack et al., 2009). Additionally, the 17 amino acids
(ILGHKLEYNYNSHNVYI) spanning the epitope on GFP that is recognized by the GFPnanobody is a sufficient, small target for binding (Grallert et al., 2013).
Caussinus et al. (2012) engineered a method to knock out GFP fusion proteins in any
eukaryotic genetic system using the endogenous ubiquitin pathway. The ubiquitin
pathway is an integral component of selective protein degradation in eukaryotes. Target
proteins that acquire multiple ubiquitin molecules, which are covalently attached through
a complex cascade of enzymes, are subsequently degraded by the proteasome
(Ciechanover, 1998). Substrate specificity in the ubiquitin pathway is determined by Fbox proteins (FBP). FBPs are modular with two distinct domains: An F-box domain that
interacts with the ubiquitin pathway and a protein-protein interaction domain (such as
WD40 repeats) on the C-terminus which binds to a specific substrate (Zhang et al., 2003).
Supernumerary limbs (Slmb) is a Drosophila FBP involved in normal growth and
patterning during development (Jiang & Struhl, 1998). A new FBP, NSlmb-vhhGFP4,
was engineered by fusing the F-box domain contained in the N-terminal part of Slmb to
the GFP-nanobody (vhhGFP4), which permits target proteins fused to GFP (or relevant
derivatives) to be specifically degraded through the proteasome upon expression
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Figure 11. Structure of the Complex Formed When the GFP-nanobody is Bound to
GFP.
Ribbon diagram (based on X-ray crystallography) showing perpendicular views of the
GFP:GFP-nanobody complex. GFP is shown in green to gold and the GFP-nanobody
(VHH Fragment) is shown in red to pink (N- to C-terminal; Kubala et al., 2010).
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(Figure 12; Caussinus et al., 2012). Additionally, since the target protein is fused to a
fluorescence protein, the removal of the target protein can be easily monitored. To
determine the kinetics of target protein degradation by NSlmb-vhhGFP4, live imaging of
Drosophila embryos was used to monitor the decrease in nuclear fluorescence of a target
protein signal relative to the appearance of another nuclear fluorescence that served as the
NSlmb-vhhGFP4 expression reporter (Figure 13; Caussinus et al., 2012). The
accumulated target protein begins to disappear from the embryos less than 30 min after
expression of NSlmb-vhhGFP4 and is reduced to 10% of its maximum intensity in less
than 3 hours (Caussinus et al., 2012). Transgenic Drosophila lines in which targeted
NSlmb-vhhGFP4 expression can be achieved with the UAS-GAL4 system, have already
been generated (Caussinus et al., 2012). This technique allows the dissection of
morphogenetic forces in a cell- and tissue-specific manner and allows fast tissue-specific
knockouts which were previously not feasible in post-mitotic cells (Caussinus et al.,
2012).

1.10 Goal
My goal is to address the question of what HOX protein is required for tarsus
determination in Drosophila. To answer this question, a method is required that inhibits
HOX activity only during larval stages and not during embryogenesis as HOX activity is
essential for the development of viable larvae (Brown et al., 2002). Additionally, the
method needs to inhibit HOX activity in all cells of the larva such that no hypothetical
HOX-dependent cell signalling molecule is produced. I propose to use a heat shockinducible nanobody (UAS- NSlmb-vhhGFP4 driven by hsp-GAL4) activated during the
third larval stage in all cells to degrade thoracically expressed HOX proteins (SCR,
ANTP, and UBX) tagged with XFP (GFP derivatives; GFP, YFP, CFP, or 17 amino acid
(aa) epitope of GFP; Figure 14). I will use the GFP-nanobody degrader (nanobody) to
determine whether the requirement for ANTP matches that of the requirement for Ptl in
Tribolium. This would suggest that requirement is conserved in insects. If the
requirement is not conserved, then tarsi may be determined by SCR alone, or in
conjunction with other HOX proteins, suggesting that HOX requirement for tarsus
determination has diverged during insect evolution. Alternatively, if ANTP, SCR and
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Figure 12. Schematic Illustration of GFP-nanobody Degrader.
(A) Linear representation of Slmb, and NSlmb-vhhGFP4. Numbers refer to amino acid
positions from N terminus (N) to C terminus (C). (B) SKP1–CUL1–F-box protein ligase
complexes (SCFs) mediate the ubiquitin transfer from E2 enzymes to target substrates.
Ubiquitin-tagged substrates are then degraded by the proteasome. The specificity of the
SCFs depends on the FBPs, which are either endogenous like Slmb or engineered like
NSlmb-vhhGFP4 (left and right sides, respectively; Caussinus et al., 2012).
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Figure 13. Kinetics of Target Protein Degradation by GFP-nanobody Degrader in
Drosophila.
Live confocal imaging of embryos in stages 9 to 13 was used to show the degradation of
a target protein (His2Av::EYFP; green) compared to expression of an NSlmb-vhhGFP4
reporter (mCherry-NLS; purple). The data points measured in the embryo are represented
(crosses) and summarized by regression curves (continuous and dashed lines). The data is
normalized and aligned in time with respect to mCherry-NLS expression and maturation
(vertical dashed line is time t). On average, the His2Av::EYFP signal is reduced to 10%
of its maximum (horizontal dashed line) 151 min (arrow) after time t (Caussinus et al.,
2012).
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Figure 14. Model: Nanobody Expression to Target and Degrade XFP-tagged
Proteins.
A heat-shock promoter (hsp) activated at the third larval stage of Drosophila
development induces expression of the transcriptional activator, GAL4. This GAL4 driver
line induces the GAL4 responsive promoter, or upstream activation sequence (UAS). UAS
activation causes expression of the GFP-nanobody degrader (“nanobody”), which then
targets GFP derivatives (XFP; tag) for poly-ubiquitination. Consequently, HOX fusion
proteins with a XFP tag are degraded by the intrinsic proteasome through the endogenous
ubiquitin pathway.
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UBX are not required for tarsus determination in Drosophila, then the mechanism of
determination is HOX-independent.
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2

Materials and Methods

2.1 Plasmids
Table 1 documents the origin of the plasmids used in this study.

2.2 Drosophila Strains
Drosophila were maintained at 25ºC with 60-65 % relative humidity on standard
Drosophila media supplemented with baker’s yeast ("Media Recipes and Methods",
Bloomington Drosopila Stock Center website). Table 2 documents the genotype and
origin of the fly strains used in this study.

2.3 chiRNA for CRISPR-mediated HR
chiRNA specific for Scr, Antp, and Ubx coding regions were designed to target a DSB as
close to the stop codon as possible (“Protocols: U6-gRNA (chiRNA) cloning",
flyCRISPR website). Primers phosphorylated at the 5’ end were designed to encode the
20 nt corresponding to the target sequence (Appendix B.a). The forward and reverse
primers were annealed together, and the double stranded product was ligated (T4 DNA
Ligase – Invitrogen) into the pU6-BbsI-chiRNA vector that had been digested with BbsI.
The ligation reaction was used to transform Escherichia coli Subcloning Efficiency™
DH5™ Competent Cells (Invitrogen) and ampicillin resistance was selected for on LB
agar plates. The plasmid DNA was isolated (Geneaid miniplasmid prep kit) and digested
with the restriction enzyme BbsI. Selected plasmid clones that had lost the BbsI
recognition site (i.e. did not get cleaved) were sent for sequence analysis (Robarts
Research Institute DNA Sequencing Facility).

2.4 Repair Vectors for CRISPR-mediated HR
The donor templates for HR were designed to consist of: 5’Hox::(XFP or tag) loxP
y+loxP 3’Hox inserted in a pFUS_A plasmid (Figure 15.B). The following are the six
repair vectors constructed: 5’Scr::GFP loxP y+loxP 3’Scr, 5’Scr::tag loxP y+loxP 3’Scr,
5’Antp::CFP lox2272 y+lox2272 3’Antp, 5’Antp::tag lox2272 y+lox2272 3’Antp,
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Plasmid Name

Supplier

Reference

Purpose

Annotated in
Appendix

MiMIC
(GenBank:
GU370067)

Drosophila
Genomics
Resource Center

Venken et al.
(2011)

yellow+
sequence

N/A

pHsp70-Cas9

Addgene
(45945)

Gratz et al.
(2013)

Cas9 plasmid

A. a

pU6-BbsIchiRNA

Addgene
(45946)

Gratz et al.
(2013)

chiRNA
plasmid

A. b

pFUS_A

Addgene
(31028)

Cermak et al.
(2011)

repair vector
backbone

A. c

pEGFP

APS lab

N/A

GFP
sequence

N/A

pFA6a-EYFPnatMX6

APS lab

Van Driessche
et al. (2005)

YFP
sequence

N/A

pUBXTT

APS lab

N/A

3X FLAG
peptide

N/A

Table 1. Origin of Plasmids.
Plasmid names, supplier, reference, and purpose for use in this work, as well as indication
of whether an appendix exists are given. Legend: N/A, not applicable; APS, Dr. Anthony
Percival-Smith.
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Stock

Genotype

Origin

Reference

yw

Df(1)w[67c23.2]

APS lab

N/A

Short
Form
yw

496

y w ; L / CyO ; TM6B, Tb,
P{walLy} / Ki ftz[11]
y w ; P{arm-GAL4, w+} ;
TM6B, Tb, P{walLy} /
Scr[14] e
w ; P{GAL4-Hsp70.PB}2

APS lab

N/A

balancer

APS lab

Sivanantharajah,
L. & PercivalSmith, A. (2014)
Tenney, K. et al.
(2006)
McGuire, S. E.
et al. (2003)
McGuire, S. E.
et al. (2003)
Caussinus, E. et
al. (2012)
Port, F. et al.
(2014)
Port, F. et al.
(2014)

armGAL4

805

2077
7108
7019
38422
54590
54591

w ; P{tubP-GAL80[ts]}10 ;
TM2 / TM6B, Tb
w ; P{tubP-GAL80[ts]}20 ;
TM2 / TM6B, Tb
y w ; P{UAS-NslmbvhhGFP4}2
y M{Act5C-Cas9.P}ZH2A w
y M{nos-Cas9.P}ZH-2A w

Bloomington
Stock Centre
Bloomington
Stock Centre
Bloomington
Stock Centre
Bloomington
Stock Centre
Bloomington
Stock Centre
Bloomington
Stock Centre

GAL4(hs)
GAL80(ts)
GAL80(ts)
UAS-nano
act-Cas9
nos-Cas9

Table 2. Genotypes and Origins of Fly Stocks.
Abbreviations: Df, deficiency; y, yellow; w, white; P{}, P element transposon; arm,
armadillo; TM6b, balancer of chromosome 3; Tb, Tubby; walLy, fragment containing y+
gene; Ki, Kinked; ftz, fushi-tarazu; Hsp, heat-shock promoter; tubP, tubulin promoter; ts,
temperature sensitive; TM2, balancer of chromosome 3; UAS, upstream activation
sequence; Nslmb-vhhGFP4, GFP-nanobody degrader, L, Lobe; CyO, Curly; Scr, Sex
combs reduced; e, ebony; nos, nanos promoter; act5C, actin5C promoter; N/A, not
applicable; APS, Dr. Anthony Percival-Smith.
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Figure 15. General Design of Repair Vectors.
(A) The 5’Hox::XFP or 5’Hox::tag (DNA fragment 1), loxP y+ (DNA fragment 2) and
loxP 3’Hox (DNA fragment 3) fragments are all created by standard PCR with unique
cohesive ends when digested with the restriction endonuclease, BsaI. The pFUS_A vector
is digested with BsaI and dephosphorylated. (B) All four DNA fragments ligate together
in a single ligation reaction to form a circularized repair vector for use in injecting
CRISPR components for HR.
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5’Ubx::YFP loxP y+loxP 3’Ubx, and 5’Ubx::tag loxP y+loxP 3’Ubx (annotated sequence
in Appendix A.d). The pFUS_A vector was digested with BsaI and dephosphorylated.
For each of the six constructs, three DNA fragments were created using standard PCR
mutagenesis technique (McPherson & Møller, 2000) with a Platinum® Taq DNA
Polymerase High Fidelity (Invitrogen). The following thermocycling parameters were
generally used: 94ºC for 2 min; 30 cycles of 94ºC for 45 s, 58ºC for 45 s and 72ºC for 20
min; 72ºC for 10 min; and held at 4ºC. Primers used for amplification are included in
Appendix B.
DNA fragment 1 contains the 5’ portion of a Hox gene fused either to XFP (GFP, YFP,
or CFP) or a tag (Table 3) and was created in two steps (Figure 15.A). First, genomic
DNA was isolated from adult y w flies. The 5’Scr, 5’Antp, and 5’Ubx portions were
amplified with the reverse primers containing identical sequence to GFP or the tag (An
illustrative example is given in Figure 16)
Second, a series of products were created with identical sequence to 5’Scr, 5’Antp, and
5’Ubx.
A pEGFP plasmid was used to amplify GFP with a forward primer containing identical
sequence to 5’Scr (Figure 16).
The pEGFP plasmid was also used to amplify a modified CFP with a forward primer
containing identical sequence to 5’Antp. In addition, primers were used containing
sequence changes to alter aa positions 66, 153, and 163 to create a CFP from the GFP
sequence that is recognized by the nanobody. The GFP aa 66 position was changed from
Tyr (DNA sequence TAC) to Trp (TGG). The GFP aa 153 position was changed from
Met (ATG) to Thr (ACC). The GFP aa 163 position was changed from Val (GTG) to Ala
(GCA).
A pFA6a-EYFP-natMX6 plasmid was used to amplify YFP with a forward primer
containing identical sequence to 5’Ubx.
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Sequence of the "tag"
17 aa epitope of GFP (17aa) fused to a 3X FLAG peptide (3 DYKXXD repeats)
Protein ILGHKLEYNYNSHNVYIDYKDHDGDYKDHDIDYKDDDDK

DNA

ATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGT
CTATATCGACTACAAAGACCATGACGGTGATTATAAAGATCA
TGACATCGACTACAAGGATGACGATGACAAG

Table 3. Protein and DNA Sequence of the Tag Fused to 5’ Hox Genes.
The tag consists of a fusion of the 17 aa epitope on GFP (17aa) that is recognized by the
nanobody (normal) with a 3X FLAG peptide (bold).
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Figure 16. Schematic Example of Generating DNA Fragment 1.
DNA source is indicated above and arrows indicate position and orientation of primers
used to PCR each DNA fragment resulting in 5’Scr::GFP and 5’Scr::tag. “tag” refers to a
fusion of the 17 aa epitope of GFP (17aa) and a 3X FLAG peptide.

39
To fuse 5’ Scr to GFP; the isolated product, 5’Scr containing identical sequence to GFP,
was used in a reaction with the isolated product, GFP with identical sequence to 5’Scr
(Figure 16).
To fuse 5’ Antp to CFP; the isolated product, 5’Antp containing identical sequence to
GFP, was used in a reaction with the isolated product, CFP with identical sequence to
5’Antp.
To fuse 5’ Ubx to YFP; the isolated product, 5’Ubx containing identical sequence to
GFP, was used in a reaction with the isolated product, YFP with identical sequence to
5’Ubx.
The pEGFP plasmid was used to amplify the 17 aa epitope of GFP that is recognized by
the nanobody (ILGHKLEYNYNSHNVYI) with a forward primer containing identical
sequence to 5’Scr, 5’Antp, and 5’Ubx and a reverse primer containing identical sequence
to a 3X FLAG peptide. The product was used in a subsequent reaction with the
following: A pUBXTT plasmid was used to amplify a 3X FLAG peptide with a forward
primer containing identical sequence to the 17 aa epitope of GFP
(ILGHKLEYNYNSHNVYI). The resulting product was an amplified fragment of 17 aa
epitope of GFP (17aa) fused with the 3X FLAG peptide (collectively called “tag”) with a
forward primer containing identical sequence to 5’Scr, 5’Antp, and 5’Ubx (An illustrative
example is given in Figure 16)
To fuse 5’ Scr to tag; the isolated product, 5’Scr containing identical sequence to tag, was
used in a reaction with the isolated product, tag with identical sequence to 5’Scr (Figure
16).
To fuse 5’ Antp to tag; the isolated product, 5’Antp containing identical sequence to tag,
was used in a reaction with the isolated product, tag with identical sequence to 5’Antp.
To fuse 5’ Ubx to tag; the isolated product, 5’Ubx containing identical sequence to tag,
was used in a reaction with the isolated product, tag with identical sequence to 5’Ubx.
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DNA fragment 2 contains either the loxP or lox 2272 site fused to the y+ gene (Figure
15.A). A minos-mediated integration cassette (MiMIC; GenBank accession code
GU370067) vector was digested, and used as the template for amplification of yellow+
with forward primers that incorporated on the 5’ end a loxP site or a lox2272 site.
DNA fragment 3 contains a loxP fused to the 3’ of Scr and Ubx or a lox2272 site fused to
the 3’ of Antp (Figure 15.A). Genomic y w DNA was used to create 3’Antp, 3’Scr, and
3’Ubx portions with primers that incorporated on the 5’ end a loxP site for 3’Scr and
3’Ubx and a lox2272 site for 3’Antp.
The products were verified by 1% (w/v) agarose gel electrophoresis, which was stained
with RedSafe (FroggaBio), and visualized on a gel doc (FlourChem8900 - Alpha
Innotech). They were subsequently purified using a PCR Product purification kit
(BioBasic Inc). The primers used to create all three DNA fragments contained the
restriction endonuclease site, BsaI, which is a restriction enzyme that recognizes a six
base sequence but generates a 4 base 5’ overhang outside the recognition site (Figure
17.A). In the design, all eight 5’ overhangs of pFUS_A and the three DNA fragments had
unique but complementary sequences such that the fragments would assemble in order
during ligation (Figure 17.B). The three DNA fragments were digested with BsaI and
used in a ligation reaction (T4 DNA Ligase – Invitrogen) with the digested and
dephosphorylated pFUS_A. E. coli Subcloning Efficiency™ DH5™ Competent Cells
(Invitrogen) were transformed and spectinomycin/streptomycin resistance was selected
for on X-gal and IPTG containing LB agar plates. When the fragments insert into
pFUS_A , the lacZ gene is lost and therefore white colonies, but not blue colonies of
bacteria, were chosen for PCR screening. The first PCR screen amplified a product from
the 5’ end of pFUS_A to the 5’ end of the y+ marker gene. The second PCR screen
amplified a product from the 3’ end of y+ to the 5’ end of pFUS_A. Primers used for
screening are included in Appendix B. If a sample showed products for both screens, the
plasmid DNA was isolated (Geneaid miniplasmid prep kit). The DNA was digested with
selected restriction enzymes BamHI, BglII, HincII, Tth111, XbaI, XhoI, and XmnI. The
plasmid clones that gave the expected patterns of cleavage for all of the restriction

41

Figure 17. Schematic of Using BsaI Unique Ends for a Single Ligation Reaction of
the Repair Vectors.
(A) The primers used to create all three DNA fragments contained the restriction
endonuclease site, BsaI, which is a restriction enzyme that recognizes a six base sequence
but generates a 4 base 5’ overhang outside the recognition site. (B) After being digested
with BsaI, all eight 5’ overhangs of pFUS_A and the three DNA fragments had unique
but complementary sequences such that the fragments would assemble in order during
ligation.
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enzymes were isolated (QIAGEN QIAfilter midiprep kit). The six repair vectors were
given the short forms: Scr::GFP, Scr::tag, Antp::CFP, Antp::tag, Ubx::YFP, and Ubx::tag.

2.5 CRISPR Germline Transformant Flies
2.5.1

Injections

Drosophila embryos were injected using standard protocols (Murphy & Carter, 1993).
Drosophila eggs were collected on apple or grape juice agar plates smeared with yeast
paste. 3% bleach was used to dechorionate the embryos on the plates and the embryos
were collected in mesh covered baskets. Embryos were then transferred to agar strips and
lined up so they were all in the same orientation before getting transferred to doublesided tape on a microscope slide. The embryos were placed under a dryer for 4 min and
40 sec before covering the embryos with halocarbon oil. The slide was positioned on an
inverted microscope equipped with a micromanipulator, micropipette holder, and a
microinjector. Syncytial blastoderm embryos expressing or not expressing Cas9 were
injected with DNA (in a 10% Glycerol and 1X PBS solution) at the posterior end with a
glass capillary injection needle (Table 4). The injected embryos on the tape were
transferred to apple juice agar plates and kept at 18ºC for 48 hours before being allowed
to hatch into larva and then eclose as adults in vials.
To assess germline transmission of targeted genome modifications, G0 adults that
developed from injected embryos were individually crossed to y w flies. The G1 offspring
of crosses were screened for the phenotype of the marker used, w+ or y+. The number of
vials that produced no offspring (i.e. were sterile) were recorded along with the total.

2.5.2

Verification of Injected Germline Transformant

A transformant fly candidate was tested to confirm its genotype of Antp::CFP. A G0 adult
injected fly was completely y+, indicating the presence of y+ locus in its genome.
Genomic DNA was isolated from the y+ flies.
To test for the presence of Antp::CFP at the Antp locus, PCR amplification of DNA
fragments unique to the Antp::CFP gene was performed. The first product spans within
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Injection

Fly
Genotype

Cas9
Plasmid

yw
200 ng/µl

Frost and
P Element
yw

Cas9
Plasmid

Frost

Frost (w+)

200 ng/µl

200 ng/µl

_

500 ng/µl

Scr, Antp,
or Ubx
500 ng/µl

_

Scr, Antp,
or Ubx
600 ng/µl

_

Scr, Antp,
or Ubx
600 ng/µl

Cas9
Transgenic
Flies
act-Cas9

Repair Vector

_

yw

nos-Cas9

chiRNA
Plasmid

Table 4. Injected Flies and DNA.
The concentrations of the DNAs injected into flies.

_
Scr:gfp/tag,
Antp:cfp/tag,
or Ubx:yfp/tag
120 ng/µl
Scr:gfp/tag,
Antp:cfp/tag,
or Ubx:yfp/tag
500 ng/µl
Scr:gfp/tag,
Antp:cfp/tag,
or Ubx:yfp/tag
500 ng/µl

Other

_
P element (w+)
400 ng/µl
Δ2-3wc helper
200 ng/µl
_

_

_
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5’Antp only as a positive control (659 bp). The second product spans 5’Antp to the
middle of CFP (848 bp). The third product spans 5’Antp to the 3’ end of CFP (1352 bp).
Genomic y w DNA and genomic y w DNA spiked with Antp::CFP repair template DNA,
were compared to the y+ genomic DNA using standard PCR mutagenesis technique
(McPherson & Møller, 2000) with a Platinum® Taq DNA Polymerase High Fidelity
(Invitrogen). The following thermocycling parameters were used: 94ºC for 2 min; 30
cycles of 94ºC for 45 s, 58ºC for 45 s and 72ºC for 20 min; 72ºC for 10 min; and held at
4ºC. Primers used for amplification are included in Appendix B.
The candidate Antp::CFP flies were crossed with fly line 496 (containing balancer
chromosomes) to analyze the segregation pattern of Lobe, Curly, Tubby, and y+ to
determine whether the y+ locus is on the 2nd or the 3rd chromosome, which contains the
Antp locus.

2.6 Crossing Schemes
The goal is to create flies with the genotype for nanobody degradation of HOX::XFP
proteins. This genotype will be homozygous for the Hox::XFP locus/loci and have the
genetic elements for GAL4-dependent expression of the nanobody. Expression of the
nanobody will be regulated in one of two ways: first by using an hsp-GAL4 fusion gene
for heat shock-induced GAL4 expression, and second a ubiquitously expressed GAL4
source, arm-GAL4, that is silenced by expression of a temperature sensitive (ts) GAL80
from a ubiquitously expressed tubP-GAL80ts transgene. GAL80ts activity is inhibited at
30ºC, allowing expression of the nanobody. Each fly line was made homozygous with
standard crosses (Greenspan, 2004).
The following short forms are used in the crossing schemes: GAL4(hs), GAL4-Hsp70;
armGAL4, arm-GAL4; UAS-nano, UAS-Nslmb-vhhGFP4; and GAL80+UAS-nano,
tubP-GAL80[ts], UAS-Nslmb-vhhGFP4.
Below are the four separate crossing schemes to result in two final genotypes:
y w ; P{GAL4-Hsp70.PB}2 / P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y+, referred to as the
homozygous Hox::XFP stock with GAL4(hs) and UAS-nano, and y w ; P{arm-GAL4} /
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P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y+, referred to as the
homozygous Hox::XFP with armGAL4 and GAL80+UAS-nano.

2.6.1

Crossing Scheme 1: GAL80+UAS-nano

Crossing scheme 1 (Figure 18) is the recombination of the GAL80 source onto the same
second chromosome as the UAS-nano source resulting in a stock homozygous for the
GAL80 and UAS-nano and a balanced lethal third chromosome:
y w* ; P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 ; TM6, Tb, P{walLy} / Ki ftz11
This stock is used in crossing scheme 3.

2.6.2

Crossing Scheme 2: GAL4(hs) and UAS-nano

Crossing scheme 2 (Figure 19) creates two balanced stocks. The GAL4(hs) stock is
homozygous for GAL4(hs) on the 2nd chromosome with a balanced 3rd chromosome . The
UAS-nano stock is homozygous for UAS-nano on the 2nd chromosome with a balanced
3rd chromosome. They are, respectively:
y w ; P{GAL4-Hsp70.PB}2 ; TM6B, Tb, P{walLy} / Ki ftz11 and
y w ; P{UAS-Nslmb-vhhGFP4}2 ; TM6B, Tb, P{walLy} / Ki ftz11
Both of these stocks are used in crossing scheme 3.

2.6.3

Crossing Scheme 3: Heterozygous Hox::XFP with either
GAL4(hs), UAS-nano, GAL80+UAS-nano, or armGAL4

Crossing scheme 3 (Figure 20) creates balanced flies with either Scr::GFP, Scr::tag,
Antp::CFP, Antp::tag, Ubx::YFP, or Ubx::tag and one nanobody component, GAL4(hs),
UAS-nano, or GAL80+UAS-nano. The genotypes are:
y w ; P{GAL4-Hsp70.PB}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y+ and
y w ; P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y+ and
y w*; P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} /
Hox::XFP y+ and
y w ; P{arm-GAL4 w+} / L ; TM6B, Tb, P{walLy} / Hox::XFP y+
These flies are used in crossing scheme 4.
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Figure 18. Scheme to Create the GAL80+UAS-nano Genotype:
y w* ; P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 ; TM6, Tb, P{walLy} / Ki ftz11.
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Figure 19. Scheme to Create the GAL4(hs) Genotype and UAS-nano Genotype:
GAL4(hs): y w ; P{GAL4-Hsp70.PB}2 ; TM6B, Tb, P{walLy} / Ki ftz11
UAS-nano: y w ; P{UAS-Nslmb-vhhGFP4}2 ; TM6B, Tb, P{walLy} / Ki ftz11
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Figure 20. Scheme to Create the Heterozygous Hox::XFP with GAL4(hs), UASnano, GAL80+UAS-nano, and armGAL4 (Respectively) Genotypes:
y w ; P{GAL4-Hsp70.PB}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y+
y w ; P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} / Hox::XFP y+
y w*; P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 / L ; TM6B, Tb, P{walLy} /
Hox::XFP y+
y w ; P{arm-GAL4 w+} / L ; TM6B, Tb, P{walLy} / Hox::XFP y+
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2.6.4

Crossing Scheme 4: Homozygous Hox::XFP with GAL4(hs)
and UAS-nano & Homozygous Hox::XFP with armGAL4 and
GAL80+UAS-nano

Crossing scheme 4 (Figure 21) creates the final flies that are homozygous at Hox::XFP
locus/loci and carrying one of the two GAL4 sources and the UAS-nanobody source. The
final genotypes are:
y w ; P{GAL4-Hsp70.PB}2 / P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y+ and
y w ; P{arm-GAL4} / P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y+
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Figure 21. Scheme to Create the Homozygous Hox::XFP with GAL4(hs) and UASnano Genotype as well as the Homozygous Hox::XFP with armGAL4 and
GAL80+UAS-nano Genotype:
Homozygous Hox::XFP with GAL4(hs) and UAS-nano:
y w ; P{GAL4-Hsp70.PB}2 / P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y+
Homozygous Hox::XFP with armGAL4 and GAL80+UAS-nano:
y w ; P{arm-GAL4} / P{tubP-GAL80[ts]}, P{UAS-Nslmb-vhhGFP4}2 ; Hox::XFP y+
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3

Results

Nanobody Degradation of HOX::XFP Tagged Proteins
The goal of this study was to degrade HOX proteins specifically during the larval stage
using the nanobody degradation system. To do this, first the Hox loci have to be
modified using CRISPR-mediated HR to create Hox::XFP loci. Second, these Hox::XFP
transformants must be combined with genetic elements that will allow regulated
expression of the nanobody and degradation of the HOX::XFP proteins.

3.1 chiRNA for CRISPR-mediated HR
The first step in implementing CRISPR-mediated HR is to design chiRNA. chiRNA
specific for Scr, Antp, and Ubx were designed to be as close to the stop codon as possible.
20 nt of sequence within the 3’ end of each Hox was chosen as the target for a DSB by a
chiRNA/Cas9 riboprotein. This target sequence was the closest 20 nt of sequence to the
TAG stop codon with a NGG PAM sequence. Table 5 shows: the sequences of the 3’ end
of each Hox (Scr, Antp, and Ubx), the primers used to create the specific chiRNA, and
confirmation of insertion into the expression plasmid.

3.2 Repair Vectors for CRISPR-mediated HR
I created six repair vectors: 5’Scr::GFP loxP y+loxP 3’Scr, 5’Scr::tag loxP y+loxP 3’Scr,
5’Antp::CFP lox2272 y+lox2272 3’Antp, 5’Antp::tag lox2272 y+lox2272 3’Antp,
5’Ubx::YFP loxP y+loxP 3’Ubx, and 5’Ubx::tag loxP y+loxP 3’Ubx (annotated sequence
in Appendix A.d). The tag consists of the 17 aa epitope of GFP (17aa) and a 3X FLAG
peptide. When integrated, they will create the following six novel HOX fusion proteins:
SCR::GFP, SCR::17aa::3XFLAG, ANTP::CFP, ANTP::17aa::3XFLAG, UBX::YFP, and
UBX::17aa::3XFLAG (Figure 22).
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Hox
Gene

Scr

Sequence
Derived From

Sequence

3' Scr

CCTCGATGAACATCGTACCCTACCACATGGGTC
CATATGGCCACCCGTACCACCAGTTCGATATCCA
TCCGTCGCAGTTCGCGCACCTAAGCGCATAG

Designed
chiRNA
Sequencing
Analysis

TTTATATAGGTATGTTTTCCTCAATACTTCGAACATC
GTACCCTACCACAGTTTTAGAGCTAGAAATAGC
AAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA
AAAAGTGGCACCGAGTCGGTGCTTTTTT

3' Antp

GAAGGGCGAGCCGGGATCCGGAGGCGAAGGCG
ACGAGATAACACCACCCAACAGTCCGCAGTAG

Designed
chiRNA
Antp

Ubx

CTTCGAACATCGTACCCTACCACA
CTTGTAGCATGGGATGGTGTCAAA

CTTCGAGCCGGGATCCGGAGGCGA
CTCGGCCCTAGGCCTCCGCTCAAA

Sequencing
Analysis

TTTATATAGGTATGTTTTCCTCAATACTTCGAGCCGG
GATCCGGAGGCGAGTTTTAGAGCTAGAAATAGC
AAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA
AAAAGTGGCACCGAGTCGGTGCTTTTTT

3' Ubx

CGGCTGCGGCGGCGGCGGTCCAAGGTGGACAC
TTAGATCAGTAG

Designed
chiRNA
Sequencing
Analysis

CTTCGCGGCGGCGGCGGTCCAAGG
CGCCGCCGCCGCCAGGTTCCCAAA
TTTATATAGGTATGTTTTCCTCAATACTTCGCGGCGG
CGGCGGTCCAAGGGTTTTAGAGCTAGAAATAGC
AAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA
AAAAGTGGCACCGAGTCGGTGCTTTTTT

Table 5. The Design Strategy of chiRNAs.
The matching 20 nt guide sequence before a PAM sequence (NGG) is highlighted in each
of the three Hox loci for: 3’ end of the gene, the double-stranded primer oligonucleotide
pair for insertion into the chiRNA expression plasmid, and the sequence analysis of the
ligated chiRNA. Legend: 20 nt guide sequence (bold and underlined), NGG PAM
sequence (bold and italicized), TAG stop codon or terminator (bold), pU6 promoter
(italicized), crRNA repeat and tracrRNA (wavy underline).
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Figure 22. Novel Proteins Produced from HOX Protein Fusions.
Abbreviations: SCR, Sex combs reduced; GFP, green fluorescence protein; ANTP,
Antennapedia; CFP, cyan fluorescence protein; UBX, Ultrabithorax; YFP, yellow
fluorescence protein; 17aa, 17 aa epitope of GFP.
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3.3 Screens of Injection Flies for CRISPR Germline
Transformation
3.3.1

Injection of Flies with P Element or Frost

P element mediated transgenesis requires injection of both a P element plasmid and a
helper plasmid. P elements insert into the genome with an efficiency of between 5 and 20
% (Dr. Anthony Percival-Smith, personal communication). P element and a Δ2-3wc
helper plasmid were injected into embryos and these gave 13 fertile, viable G0 progeny,
of which none produced w+ progeny (Table 6).
Frost (Fst) is a Drosophila cold tolerance gene (Colinet et al., 2010) that has been
targeted for CRISPR-mediated HR previously with an efficiency of 10% (Dr. Anthony
Percival-Smith, personal communication). Three CRISPR components; Cas9 vector, Fst
chiRNA vector, and Fst repair vector, were injected into embryos to test the
recombination efficiency. 63 fertile, viable G0 progeny were recovered, of which none
produced w+ progeny (Table 6).

3.3.2

Injection of Flies with the Cas9 Source Encoded on a
Plasmid

Three CRISPR components; Cas9 vector, one of three chiRNA vectors, and one of six
repair vectors, were injected into embryos and these gave 679 fertile, viable G0 progeny
(Table 7). No germ line transformation was observed at any of the three loci or with any
of the six repair vectors when G1 progeny were screened for the y+ phenotype.

3.3.3

Injection of Flies Expressing Cas9 from a Transgene.

Injecting one of three chiRNA vectors and one of six repair vectors into Cas9 transgenic
flies gave 147 fertile, viable adult flies (G0; Table 8). Two Cas9 transgenic flies were
used: act-Cas9 where Cas9 is expressed from a constitutively expressed actin5C
promoter, and nos-Cas9 where Cas9 is expressed from a germline-specific nanos
promoter. The G1 generation was screened for successful transformants. One y+
candidate transformed fly was identified from the Antp::CFP injected into nos-Cas9 flies
(*Table 8). When the G1 male was crossed to y w females, the phenotypes of the G2
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TOTAL
STERILE
VIABLE

DNA
P Element
Fst
14
82
1
19
13
63

Total
96
20
76

Table 6. Screen for Germ-line Transformation with P Element or Frost.
y w flies were injected with either a P element and a Δ2-3wc helper plasmid or with a Fst
repair vector, Fst chiRNA, and a plasmid encoding Cas9. Values represent the number of
vials of flies (each vial contains 50-100 flies).
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DNA
TOTAL
STERILE
VIABLE

Scr::GFP

Scr::tag

Antp::CFP

Antp::tag

Ubx::YFP

Ubx::tag

226
42
184

106
15
91

160
35
125

97
12
85

100
17
83

149
38
111

Total
838
159
679

Table 7. Screen for Germ-line Transformation with the Cas9 Source Encoded on a
Plasmid.
y w flies were injected with one of six repair vectors, one of three chiRNA plasmids and a
plasmid encoding Cas9. Values represent the number of vials of flies (each vial contains
50-100 flies). Abbreviations: Scr, Sex combs reduced; Antp, Antennapedia; Ubx,
Ultrabithorax; CFP, cyan fluorescence protein; GFP, green fluorescence protein; YFP,
yellow fluorescence protein; tag, a 17 aa epitope of GFP with a 3X FLAG peptide.
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nos total
act total
nos sterile
act sterile
nos viable
act viable
TOTAL
STERILE
VIABLE
y+ observed

Scr::
GFP
12
6
1
0
11
6
18
1
17
0

Scr::
tag
8
1
3
1
5
0
9
4
5
0

DNA
Antp:: Antp::
CFP
tag
22
30
9
5
5
3
0
0
17*
27
9
5
31
35
5
3
26
32
1
0

Ubx::
YFP
16
15
2
2
14
13
31
4
27
0

Ubx::
tag
21
31
6
6
15
25
52
12
40
0

Total
109
67
20
9
72
58
176
29
147
1

Table 8. Screen for Germ-line Transformation with the Cas9 Source Encoded on a
Transgene.
nos-cas9 (nos) or act-Cas9 (act) transgenic flies were injected with one of six repair
vectors and one of three chiRNA plasmids. The set of injections that resulted in a
successful HR event is marked with an Asterix (*). Values represent the number of vials
of flies (each vial contains 50-100 flies). Abbreviations: nos, nos-Cas9 flies; act, act-cas9
flies; Scr, Sex combs reduced; Antp, Antennapedia; Ubx, Ultrabithorax; Fst, Frost; CFP,
cyan fluorescence protein; GFP, green fluorescence protein; YFP, yellow fluorescence
protein; tag, a 17 aa epitope of GFP with a 3X FLAG peptide.
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progeny showed that the w+ phenotype , which is the marker for integration of the P{noscas9 w+} transposon on the X chromosome, exhibited X linkage with all females being
w+ and all males being w-. However, the inheritance of y+ showed no X linkage
indicating that the y+ gene is integrated on an autosome (The endogenous y locus is on
the X chromosome; Table 9). The single w+ male is likely a non-disjunction event of the
X chromosome of a female.

3.4 Verification of Injected Germline Transformant
PCR on genomic DNA extracted from transformed flies was performed to verify the
presence of Antp::CFP. A fragment within Antp was used as a positive control and y w
genomic DNA spiked with repair template DNA was also used as a control. To
specifically detect Antp::CFP, the amplified fragments spanned the 5’Antp to CFP
junction to confirm the 5’Antp::CFP lox2272 y+ lox2272 3’Antp integration (illustrated
in Figure 23.B). All products were observed as expected for genomic y w DNA and
genomic y w DNA spiked with Antp::CFP repair template, however y+ genomic DNA
failed to produce the correct products, indicating the y+ locus is not present at the
expected locus within the genome (Figure 23.A).
Furthermore, analysis of the segregation pattern of Lobe, Curly, Tubby, and y+ in the
progeny from crossing the candidate Antp::CFP flies with fly line 496 (containing
balancer chromosomes) revealed that the y+ locus is on the 2 nd chromosome and not on
the 3rd chromosome, which contains the Antp locus.

3.5 Survival Assay
The efficiency of HR is low and this may be due to a low level of survival to the
injection. To determine the survival index, the number of embryos injected was counted
along with larval, pupal, and adult survivers (Table 10). The survival of injected
embryos was 4.9% to larva and 3.0% to eclosed adults. This is low as generally the goal
is 10-20 % survival.
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Gender
Male
Male
Male
Female
Female

Number
37
33
1
51
64

Body
Eyes
Phenotype Phenotype
y+
wywyw+
y+
w+
yw+

Table 9. Progeny from Cross Between Male Transformant Candidate and Female y
w.
Segregation of w+ and y+ phenotypes are shown for the male transformant crossed with y
w females.
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Figure 23. PCR of Genomic DNA Extracted from Transformants and Illustration of
the Associated Amplified Fragments.
(A) PCR gel image displaying amplified fragments flanked by 1 kb+ DNA Ladder to
indicate sizes in base pairs (bp). Lanes 1-3 used genomic DNA from y w flies as template,
lanes 4-6 used genomic DNA from y w flies that was spiked with Antp::CFP repair
vector DNA as template, and lanes 7-9 used genomic DNA of y+ transformant fly
candidates as template. (B) The amplified fragments and their expected sizes (in bp) are
illustrated compared to the transgene: 5’Antp::CFP lox2272 y+ lox2272 3’Antp. The
arrows indicate the position and orientation of the primers used in the PCR.
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Injected
Fly
Genotype
nos-Cas9
nos-Cas9
nos-Cas9
nos-Cas9
act-Cas9
act-Cas9
act-Cas9
act-Cas9
yw
yw
yw
yw

DNA
Antp::CFP
Antp::CFP
Antp::tag
Antp::tag
Scr::GFP
Scr::tag
Ubx::YFP
Ubx::tag
P element
Fst
Fst
Fst
Average:

Embryos
(#)
210
215
210
210
228
326
264
293
210
191
215
206
232

Larva
(#)

Pupa
(#)

Adult
s (#)

9
12
14
29
3
5
4
2
7
22
11
7
10

4
2
9
12
0
1
1
1
7
25
6
7
6

4
2
9
11
0
1
1
1
8
26
4
7
6

Survivors
Larval Adult
(%)
(%)
4.3
1.9
5.6
0.9
6.7
4.3
13.8
5.2
1.3
0.0
1.5
0.3
1.5
0.4
0.7
0.3
3.3
3.8
11.5
13.6
5.1
1.9
3.4
3.4
4.9
3.0

Table 10. Rate of Survival to Injections.
Abbreviations: Antp, Antennapedia; Scr, Sex combs reduced; Ubx, Ultrabithorax; Fst,
Frost; CFP, cyan fluorescence protein; GFP, green fluorescence protein; YFP, yellow
fluorescence protein; tag, a 17 aa epitope of GFP with a 3X FLAG peptide.
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3.6 Fly Lines with Nanobody Components
Multiple balanced fly lines have been generated.
From crossing scheme 1, two fly lines homozygous on the 2nd chromosome for the
GAL80 and UAS-nano with a balanced lethal third chromosome were created (referred to
as GAL80+UAS-nano 7108 and GAL80+UAS-nano 7019). The two lines differ in the
location and expression activity of the GAL80 insertion in the chromosome.
From crossing scheme 2, two fly lines were created with a balanced 3 rd chromosome. The
2nd chromosome is either homozygous for GAL4(hs), referred to as the GAL4(hs) stock,
or homozygous for UAS-nano, referred to as the UAS-nano stock.

3.7 Summary of Results
A summary of plasmids and flies that were obtained and created as well as experiments
conducted are summarized in Table 11.
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Obtained

Plasmids
Cas9 Plasmid

Created

chiRNA

Repair
Vectors

Scr
Antp
Ubx
Scr::GFP
Scr::tag
Antp::CFP

Flies
Cas9
Transgene
Balanced
Stocks

act-Cas9
nos-Cas9
UAS-nano
GAL4(hs)
GAL80(7108)+UAS-nano
GAL80(7019)+UAS-nano
armGAL4

Antp::tag
Ubx::YFP
Ubx::tag
Injection
Experiments Injection
Control
Cas9
Plasmid
Cas9
Transgene

P element
Frost
Scr
Antp
Ubx
Scr
Antp
Ubx

Other
Survival Assay
Transformant Progeny Assay (y+ segregation)
PCR of y+ Transformant Genomic DNA

Table 11. Summary of Results.
Plasmids and flies that were obtained and created as well as experiments conducted are
summarized using short-forms.
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4

Discussion

4.1 Efficiency and Optimization
CRISPR/Cas9 genome editing in Drosophila and many other organisms has only been
established for two years. Several groups have performed CRISPR/Cas9 genome editing
in Drosophila with differing methods of supplying the Cas9 protein and chiRNA
components (Bassett et al., 2013; Gratz et al., 2013; Kondo & Ueda, 2013; Ren et al.,
2013; Sebo et al., 2014; Yu et al., 2013). In genome editing there are two distinct
approaches employed to repair a DSB: first is NHEJ which creates small deletions, and
HR, which creates precise genome modifications.
The efficiency of NHEJ in Drosophila is well documented. Initial mutagenesis with
CRISPR involved co-injection of two plasmids into syncytial blastoderm Drosophila
embryos; one plasmid expressing Cas9 under the Hsp70 promoter and one driving
chiRNA expression through the U6 gene promoter (Gratz et al., 2013). The efficiency of
mutagenesis was low, at 5.9% of injected flies giving rise to a mutant offspring; however,
they were successful in demonstrating that full deletions of sequence was possible (Gratz
et al., 2013). An alternative means that has been applied in Drosophila involves in vitro
transcription to synthesize Cas9 mRNA and chiRNA that are then co-injected into
syncytial blastoderm embryos. This method achieves higher mutagenesis rates, up to
80%, making it possible to target multiple loci simultaneously throughout the genome
(Bassett et al., 2013; Yu et al., 2013). Differences in efficiency may be explained by
lower expression levels of Cas9 protein and chiRNA from injected plasmids relative to
direct injection of Cas9 and chiRNA mRNA (Bassett & Liu, 2014). Another method
uses transgenic flies to express Cas9 in the germline and express the chiRNA
ubiquitously, leading to higher efficiency of mutagenesis with up to 90% of flies
producing mutant offspring and allowing the creation of longer deletions of up to 1.6 kb
(Kondo & Ueda, 2013). However, producing a new transgenic fly for each chiRNA is
very time consuming, as is the removal of the Cas9 and chiRNA transgenes after
mutagenesis (Bassett & Liu, 2014). An alternative to this method is to inject chiRNA
plasmids into germline-expressed Cas9 transgenic lines, which prevents somatic

65
mutagenesis since Cas9 expression is limited to the germline and can yield efficiencies of
12-75 % (Ren et al., 2013; Sebo et al., 2014). Most of these methods created mutants via
deletions or disruptions to genes; however, HR when a donor template is supplied creates
precise genomic alterations.
HR of a DSB requires either endogenous homologous sequences or exogenously
introduced sequences. When exogenously introduced sequences are used to repair a
DSB, the repaired DSB has the sequence of the exogenous DNA allowing precise
genome editing. The donor template supplying exogenous sequence may come in two
forms. One is in the form of short (around 200 nt in length) single-stranded DNA
(ssDNA) oligonucleotides, which can be used to integrate short transgene sequences. The
second form of donor template, and the one used in this study, is longer double-stranded
DNA (dsDNA) constructs containing hundreds to thousands of nt of homologous
sequence on either side of the DSB site, which is capable of integrating longer sequences
(Beumer & Carroll, 2014). For example, Bassett et al. (2013) used longer homology arms
to insert a 1.8 kb cassette with a 4% efficiency rate. This technique can be used in
conjunction with site-specific recombinase sites (such as loxP) to delete, replace, or
otherwise modify intervening sequence (Bassett & Liu, 2014). The process of using
longer dsDNA constructs as repair vectors has a relatively low efficiency, but it allows
the use of marker genes, which is particularly advantageous simplifying identification of
HR events (Bassett et al., 2013). In addition to positive markers, negative selectable
markers, such as UAS-rpr outside of the homology arm, can also be used to optimize
homologous targeting by enabling selection against non-homologous integrations (BaenaLopez et al., 2013). Evidence has suggested that 1 kb of homology at either side of the
integration site is sufficient to allow efficient HR, simplifying the construction of these
vectors (Bassett et al., 2013). Larger homology arms enable the integration of longer
features, for example tagging with fluorescent proteins such as GFP (Bassett & Liu,
2014). When a protein (such as GFP) is fused to an endogenous gene, expression of the
protein is subject to the same transcriptional and post-transcriptional controls as the
endogenous gene, and therefore the tag is expressed at similar levels of functionality and
expression (Bassett & Liu, 2014). This was demonstrated when a circular double-
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stranded plasmid containing the GFP-coding sequence flanked by 1.4 and 1.7 kb
homology arms from the wingless (wg) locus was injected into double transgenic noscas9, wg-chiRNA fly embryos to produce an in-frame insertion of GFP within the wg
coding region, leading to a secreted Wg::GFP protein (Port et al., 2014). 38% of the
offspring of injected embryos expressed a secreted GFP protein in the Wg expression
pattern (Port et al., 2014). Comparison of the integration efficiency across different
CRISPR methods is difficult because of the use of different chiRNAs, donors, and target
genes in each study. Roughly though, when all three DNA components (Cas9, chiRNA,
and donor) are injected together, 0.3% of offspring integrated the exogenous sequence at
the target site (Gratz et al., 2013). Larger constructs were integrated at a rate of 0-11 %
by injecting the donor and chiRNA plasmids into Cas9 transgenic embryos (Gratz et al.,
2014). Injecting donor plasmids into embryos expressing Cas9 and chiRNA transgenes
produced the highest integration rates of 11-38 % of all offspring (Port et al., 2014). In
one comparison where the same chiRNA and donor repair vector construct were used
across all three major CRISPR methods; 3% of all offspring from G0 flies contained the
integration when a Cas9/chiRNA dual plasmid was co-injected with the donor plasmid,
which was significantly lower than both the 5-15 % when the chiRNA expressed on a
plasmid was injected with the donor into single transgenic (Cas9) embryos, and the 19-25
% when donor plasmid was injected into double transgenic (Cas9 and chiRNA) embryos
(Port et al., 2015).
Additionally, the promoter used for chiRNA expression in the chiRNA vector is an
important element that affects the activity of chiRNA. Port et al. (2014) demonstrated
that the same chiRNA expressed from different U6 snRNA promoters (U6:1, U6:2, and
U6:3) have different activities. The previously untested U6:3 promoter gives the most
potent affect and leads to the highest efficiency of genome editing with the CRISPR
system (Port et al., 2014).
When a target gene is cleaved (DSB), either inaccurate NHEJ, or HR when a repair
template is supplied, are stimulated (Lieber et al., 2003; West, 2003). NHEJ uses the
NHEJ pathway and HR mainly uses the invasion-mediated synthesis-dependent strandannealing pathway (Bozas et al., 2009). Deleterious mutations in genes of the NHEJ
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pathway, such as lig4 (DNA ligase IV), can significantly improve the proportion of HR
events (Bozas et al., 2009).

4.2 Hox::XFP Transformation
I attempted to induce homologous integration of a GFP, or a derivative of GFP tag, into
the endogenous Scr, Antp, and Ubx loci, either by co-injection of Cas9 and chiRNA
plasmids or by injection of a chiRNA plasmid into Cas9 transgenic flies. Both
approaches involved supplying a repair vector containing a yellow marker gene flanked
by loxP sites with 1-2 kb homology arms. Unfortunately, the first method yielded no
edited flies, even after screening through 679 vials of G1 progeny (Table 7). This
suggests that the efficiency of genome editing is below 0.2%. A number of different
transgenic Cas9 strains have been described and are publicly available, but differ in their
capacity to make efficient DSBs (Port et al., 2015). Assessments of comparative
performance revealed substantial differences in their pattern and activity level (Port et al.,
2015). Therefore, two different fly strains, nos-Cas9 and act-Cas9 were used for the
second CRISPR approach. Screens of 147 vials of progeny (Table 8) resulted in one
injected fly showing evidence of being edited by the integration of the new sequence;
however this was off-target. This suggests that the efficiency of genome editing is less
than 1%.
There are many reasons to explain this low efficiency of editing. First, the survival rate
of injected flies may explain the low efficiency rate for homologous integration. Only 3%
of injected embryos eclose (Table 10), which may simply be explained by: poor injection
technique and lack of experience by the experimenter. Laura Garofalo and I (working
50/50 together) injected Fst DNA repair vector along with chiRNA and the Cas9 plasmid
as a control for the injection method. Dr. Anthony Percival-Smith found that the
efficiency of editing was 10%, but screening 63 vials of fertile adult flies (Table 6), we
found no editing when we should have seen in the range of 3-8 events. One potential
explanation is the low 3% survivorship of injected flies. The normal survivorship in good
injections is in the range of 10-20 % (Dr. Anthony Percival-Smith, personal
communication).
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Low efficiency of editing at Scr, Antp, and Ubx, may be due to different editing
frequencies at each locus. To date, it is not known how many genomic target sites can be
effectively edited in CRISPR/Cas experiments because most previous studies do not
report results of non-editing (Bassett et al., 2013; Lee et al., 2014; Ren et al., 2014; Zhang
et al., 2014). To date there has been no systematic study on the range of editing rates at
different loci. Furthermore, most experiments have not attempted to insert large
sequences, such as the ~6 kb in this study.
Fly lines containing components for the GFP-nanobody degrader (NSlmb-vhhGFP4;
“nanobody”) were successfully generated with relevant balanced background genotypes
for use in this study. The nanobody components (the UAS driven nanobody, UAS-nano;
GAL4 under control of a hsp, GAL4(hs); GAL4 under control of the armadillo
promoter, armGAL4; and the UAS-nano expressed alongside a ts GAL80 negative
regulator of GAL4, GAL80+UAS-nano) were crossed to create flies that are balanced on
the chromosome 3 and homozygous for the nanobody component on chromosome 2. In a
few crosses, flies that are homozygous for the desired genotype change (Hox::XFP) and
containing one UAS-nanobody source and one GAL4 source can be created.

4.3 Future / Next Steps
4.3.1

Germline Transformants

Co-injections of relevant chiRNA and repair templates in Cas9 transgenic flies will result
in the generation of the six Hox::XFP (Scr::GFP, Scr::tag, Antp::CFP, Antp::tag,
Ubx::YFP, and Ubx::tag) transformants. Once y+ transformants have been identified,
these heterozygous transformants can be crossed with the generated single nanobody
component balanced stock lines.
To test whether combinations of HOX proteins work together to determine the tarsus, the
use of single, double and triple Hox::XFP transformants is required so that multiple HOX
(SCR, ANTP, or UBX) can be degraded at the same time. To create double and triple
mutants, single mutant Hox::XFP lines must first have the yellow (y+) marker gene
removed. Removal of the y+ gene can be accomplished by crossing with flies that carry a
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Cre recombinase source and site-specific recombination between the loxP sites. For the
Scr and Ubx integration events, the y+ marker has been flanked with loxP sites. For Antp,
the y+ is flanked with lox2272 sites that do not recombine with loxP, which is important
to allow multiple, sequential recombination events, especially of Scr::GFP Antp::CFP
genotypes, which are close together on the chromosome. Co-injection of relevant
chiRNA and Hox::XFP repair vectors would establish transformants with the secondary
and/or tertiary transgene integrations.

4.3.2

Homozygous Hox::XFP with Nanobody Components

The Hox::XFP transformants may then be crossed to generate heterozygous Hox::XFP
with all four single nanobody components (GAL4(hs), UAS-nano, GAL80+UAS-nano,
and armGAL4). A few simple crosses will generate the homozygous Hox::XFP with
GAL4(hs) and UAS-nano as well as the homozygous Hox::XFP with armGAL4 and
GAL80+UAS-nano. These two fly lines can be exposed either to a 37ºC heat shock at
the third larval stage to activate expression of the nanobody using hsp-GAL4, or to 29ºC
to inactivate GAL80. This would cause degradation of the tagged HOX proteins within
the developing larva during the stage that determination of segment identity occurs. The
tarsi of the resulting mature adult can be analyzed to determine whether the tarsus has
been transformed to an arista.

4.3.3

Expected Results

If the requirement of ANTP is conserved in insects, the degradation of ANTP will result
in a tarsus to arista transformation on all legs, as is observed in Tribolium. However, if
this is not the case, the use of the other Hox::XFP transformants is required to test the
alternative hypotheses.
One alternate is that SCR is responsible for tarsus determination or that multiple Hox
genes may be working together to determine tarsus development. Tarsus to arista
transformations in one of these cases would suggest that HOX requirement for tarsus
determination has diverged during insect evolution and is not conserved in insects.
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Another alternate is that none of the three HOX proteins, ANTP, SCR, or UBX, are
required for tarsus determination in Drosophila and the mechanism of determination is
HOX-independent.

4.4 Conclusion
Establishing CRISPR mediated HR was difficult and had a very low efficiency. However,
the initial steps have been completed and the system is ready for further experimentation.
Hox::XFP transformants can be used in conjunction with expression of the nanobody and
subsequent recombination events to test the hypotheses and further define the role of
HOX in tarsus determination. The system is established to determine which HOX protein
is required for tarsus determination in Drosophila melanogaster and whether HOX
requirement for tarsus determination is conserved in insects. This information will
provide insight into the scope of conservation of requirement of genetic mechanisms of
development that exist in all bilaterally symmetric organisms.
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Appendices
Appendix A. Sequences for CRISPR
Annotated sequences of (a) codon‐optimized Cas9 under the control of the Drosophila hsp70 promoter and
3’ UTR (Gratz et al., 2013), (b) chiRNA expression vector for generating site‐specific, U6‐driven chiRNAs
(Gratz et al., 2013), (c) the pFUS_A vector used as the backbone for the repair vectors, and (d) the six
repair vectors used to add a GFP derivative tag to Hox with y+ marker gene flanked by loxP sites.

A.a. pHsp70-Cas9
DmHsp70 promoter and 3’UTR
3X FLAG
NLS
Cas9
ATCCCCCTAGAATCCCAAAACAAACTGGTTATTGTGGTAGGTCATTTGTTTGGCAGAAAGAAA
ACTCGAGAAATTTCTCTGGCCGTTATTCGTTATTCTCTCTTTTCTTTTTGGGTCTCTCCCTCTCT
GCACTAATGCTCTCTCACTCTGTCACACAGTAAACGGCATACTGCTCTCGTTGGTTCGAGAGA
GCGCGCCTCGAATGTTCGCGAAAAGAGCGCCGGAGTATAAATAGAGGCGCTTCGTCTACGGA
GCGACAATTCAATTCAAACAAGCAAAGTGAACACGTCGCTAAGCGAAAGCTAAGCAAATAAA
CAAGCGCAGCTGAACAAGCTAAACAATCTGCAGTAAAGTGCAAGTTAAAGTGAATCAATTAA
AAGTAACCAGCAACCAAGTAAATCAACTGCAACTACTGAAATCTGCCAAGAAGTAATTATTG
AATACAAGAAGAGAACTCTGGGGGATCTGATCGATATGGACTATAAGGACCACGACGGAGAC
TACAAGGATCATGATATTGATTACAAAGACGATGACGATAAGATGGCCCCAAAGAAGAAGCG
GAAGGTCGGTATCCACGGAGTCCCAGCAGCCGACAAGAAGTACAGCATCGGCCTGGACATCG
GCACCAACTCTGTGGGCTGGGCCGTGATCACCGACGAGTACAAGGTGCCCAGCAAGAAATTC
AAGGTGCTGGGCAACACCGACCGGCACAGCATCAAGAAGAACCTGATCGGAGCCCTGCTGTT
CGACAGCGGCGAAACAGCCGAGGCCACCCGGCTGAAGAGAACCGCCAGAAGAAGATACACC
AGACGGAAGAACCGGATCTGCTATCTGCAAGAGATCTTCAGCAACGAGATGGCCAAGGTGGA
CGACAGCTTCTTCCACAGACTGGAAGAGTCCTTCCTGGTGGAAGAGGATAAGAAGCACGAGC
GGCACCCCATCTTCGGCAACATCGTGGACGAGGTGGCCTACCACGAGAAGTACCCCACCATCT
ACCACCTGAGAAAGAAACTGGTGGACAGCACCGACAAGGCCGACCTGCGGCTGATCTATCTG
GCCCTGGCCCACATGATCAAGTTCCGGGGCCACTTCCTGATCGAGGGCGACCTGAACCCCGAC
AACAGCGACGTGGACAAGCTGTTCATCCAGCTGGTGCAGACCTACAACCAGCTGTTCGAGGA
AAACCCCATCAACGCCAGCGGCGTGGACGCCAAGGCCATCCTGTCTGCCAGACTGAGCAAGA
GCAGACGGCTGGAAAATCTGATCGCCCAGCTGCCCGGCGAGAAGAAGAATGGCCTGTTCGGA
AACCTGATTGCCCTGAGCCTGGGCCTGACCCCCAACTTCAAGAGCAACTTCGACCTGGCCGAG
GATGCCAAACTGCAGCTGAGCAAGGACACCTACGACGACGACCTGGACAACCTGCTGGCCCA
GATCGGCGACCAGTACGCCGACCTGTTTCTGGCCGCCAAGAACCTGTCCGACGCCATCCTGCT
GAGCGACATCCTGAGAGTGAACACCGAGATCACCAAGGCCCCCCTGAGCGCCTCTATGATCA
AGAGATACGACGAGCACCACCAGGACCTGACCCTGCTGAAAGCTCTCGTGCGGCAGCAGCTG
CCTGAGAAGTACAAAGAGATTTTCTTCGACCAGAGCAAGAACGGCTACGCCGGCTACATTGA
CGGCGGAGCCAGCCAGGAAGAGTTCTACAAGTTCATCAAGCCCATCCTGGAAAAGATGGACG
GCACCGAGGAACTGCTCGTGAAGCTGAACAGAGAGGACCTGCTGCGGAAGCAGCGGACCTTC
GACAACGGCAGCATCCCCCACCAGATCCACCTGGGAGAGCTGCACGCCATTCTGCGGCGGCA
GGAAGATTTTTACCCATTCCTGAAGGACAACCGGGAAAAGATCGAGAAGATCCTGACCTTCC
GCATCCCCTACTACGTGGGCCCTCTGGCCAGGGGAAACAGCAGATTCGCCTGGATGACCAGA
AAGAGCGAGGAAACCATCACCCCCTGGAACTTCGAGGAAGTGGTGGACAAGGGCGCTTCCGC
CCAGAGCTTCATCGAGCGGATGACCAACTTCGATAAGAACCTGCCCAACGAGAAGGTGCTGC
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CCAAGCACAGCCTGCTGTACGAGTACTTCACCGTGTATAACGAGCTGACCAAAGTGAAATAC
GTGACCGAGGGAATGAGAAAGCCCGCCTTCCTGAGCGGCGAGCAGAAAAAGGCCATCGTGGA
CCTGCTGTTCAAGACCAACCGGAAAGTGACCGTGAAGCAGCTGAAAGAGGACTACTTCAAGA
AAATCGAGTGCTTCGACTCCGTGGAAATCTCCGGCGTGGAAGATCGGTTCAACGCCTCCCTGG
GCACATACCACGATCTGCTGAAAATTATCAAGGACAAGGACTTCCTGGACAATGAGGAAAAC
GAGGACATTCTGGAAGATATCGTGCTGACCCTGACACTGTTTGAGGACAGAGAGATGATCGA
GGAACGGCTGAAAACCTATGCCCACCTGTTCGACGACAAAGTGATGAAGCAGCTGAAGCGGC
GGAGATACACCGGCTGGGGCAGGCTGAGCCGGAAGCTGATCAACGGCATCCGGGACAAGCA
GTCCGGCAAGACAATCCTGGATTTCCTGAAGTCCGACGGCTTCGCCAACAGAAACTTCATGCA
GCTGATCCACGACGACAGCCTGACCTTTAAAGAGGACATCCAGAAAGCCCAGGTGTCCGGCC
AGGGCGATAGCCTGCACGAGCACATTGCCAATCTGGCCGGCAGCCCCGCCATTAAGAAGGGC
ATCCTGCAGACAGTGAAGGTGGTGGACGAGCTCGTGAAAGTGATGGGCCGGCACAAGCCCGA
GAACATCGTGATCGAAATGGCCAGAGAGAACCAGACCACCCAGAAGGGACAGAAGAACAGC
CGCGAGAGAATGAAGCGGATCGAAGAGGGCATCAAAGAGCTGGGCAGCCAGATCCTGAAAG
AACACCCCGTGGAAAACACCCAGCTGCAGAACGAGAAGCTGTACCTGTACTACCTGCAGAAT
GGGCGGGATATGTACGTGGACCAGGAACTGGACATCAACCGGCTGTCCGACTACGATGTGGA
CCATATCGTGCCTCAGAGCTTTCTGAAGGACGACTCCATCGACAACAAGGTGCTGACCAGAAG
CGACAAGAACCGGGGCAAGAGCGACAACGTGCCCTCCGAAGAGGTCGTGAAGAAGATGAAG
AACTACTGGCGGCAGCTGCTGAACGCCAAGCTGATTACCCAGAGAAAGTTCGACAATCTGAC
CAAGGCCGAGAGAGGCGGCCTGAGCGAACTGGATAAGGCCGGCTTCATCAAGAGACAGCTGG
TGGAAACCCGGCAGATCACAAAGCACGTGGCACAGATCCTGGACTCCCGGATGAACACTAAG
TACGACGAGAATGACAAGCTGATCCGGGAAGTGAAAGTGATCACCCTGAAGTCCAAGCTGGT
GTCCGATTTCCGGAAGGATTTCCAGTTTTACAAAGTGCGCGAGATCAACAACTACCACCACGC
CCACGACGCCTACCTGAACGCCGTCGTGGGAACCGCCCTGATCAAAAAGTACCCTAAGCTGG
AAAGCGAGTTCGTGTACGGCGACTACAAGGTGTACGACGTGCGGAAGATGATCGCCAAGAGC
GAGCAGGAAATCGGCAAGGCTACCGCCAAGTACTTCTTCTACAGCAACATCATGAACTTTTTC
AAGACCGAGATTACCCTGGCCAACGGCGAGATCCGGAAGCGGCCTCTGATCGAGACAAACGG
CGAAACCGGGGAGATCGTGTGGGATAAGGGCCGGGATTTTGCCACCGTGCGGAAAGTGCTGA
GCATGCCCCAAGTGAATATCGTGAAAAAGACCGAGGTGCAGACAGGCGGCTTCAGCAAAGAG
TCTATCCTGCCCAAGAGGAACAGCGATAAGCTGATCGCCAGAAAGAAGGACTGGGACCCTAA
GAAGTACGGCGGCTTCGACAGCCCCACCGTGGCCTATTCTGTGCTGGTGGTGGCCAAAGTGGA
AAAGGGCAAGTCCAAGAAACTGAAGAGTGTGAAAGAGCTGCTGGGGATCACCATCATGGAA
AGAAGCAGCTTCGAGAAGAATCCCATCGACTTTCTGGAAGCCAAGGGCTACAAAGAAGTGAA
AAAGGACCTGATCATCAAGCTGCCTAAGTACTCCCTGTTCGAGCTGGAAAACGGCCGGAAGA
GAATGCTGGCCTCTGCCGGCGAACTGCAGAAGGGAAACGAACTGGCCCTGCCCTCCAAATAT
GTGAACTTCCTGTACCTGGCCAGCCACTATGAGAAGCTGAAGGGCTCCCCCGAGGATAATGA
GCAGAAACAGCTGTTTGTGGAACAGCACAAGCACTACCTGGACGAGATCATCGAGCAGATCA
GCGAGTTCTCCAAGAGAGTGATCCTGGCCGACGCTAATCTGGACAAAGTGCTGTCCGCCTACA
ACAAGCACCGGGATAAGCCCATCAGAGAGCAGGCCGAGAATATCATCCACCTGTTTACCCTG
ACCAATCTGGGAGCCCCTGCCGCCTTCAAGTACTTTGACACCACCATCGACCGGAAGAGGTAC
ACCAGCACCAAAGAGGTGCTGGACGCCACCCTGATCCACCAGAGCATCACCGGCCTGTACGA
GACACGGATCGACCTGTCTCAGCTGGGAGGCGACAAAAGGCCGGCGGCCACGAAAAAGGCC
GGCCAGGCAAAAAAGAAAAAGTAATCTAGAGATCTTCCATACCTACCAGTTCTGCGCCTGCA
GCAATGGCAACAACGTTGCCCGGATCGAGGTCGACTAAGGCCAAAGAGTCTAATTTTTGTTCA
TCAATGGGTTATAACATATGGGTTATATTATAAGTTTGTTTTAAGTTTTTGAGACTGATAAGAA
TGTTTCGATCGAATATTCCATAGAACAACAATAGTATTACCTAATTACCAAGTCTTAATTTAGC
AAAAATGTTATTGCTTATAGAAAAAATAAATTATTTATTTGAAATTTAAAGTCAACTTGTCATT
TAATGTCTTGTAGACTTTTGAAAGTCTTACGATACAATTAGTATCTAATATACATGGGTTCATT
CTACATTCTATATTAGTGATGATTTCTTTAGCTAGTAATACATTTTAATTATATTCGGCTTTGAT
GATTTTCTGATTTTTTCCGAACGGATTTTCGTAGACCCTTTCGATCTCATAATGGCTCATTTTAT
TGCGATGGACGGTCAGGAGAGCTCCACTTTTGAATTTCTGTTCGCAGACACCGCATTTGTAGC
ACATAGCCGGGACATCCGGTTTGGGGAGATTTTCCAGTCTCTGTTGCAATTGGTTTTCGGGAA
TGCGTTGCAGGCGCATACGCTCTATATCCTCCGAACGGCGCTGGTTGACCCTAGCATTTACAT
AAGGATCAGCAGCAAAATTTGCCTCTACTTCATTGCCCGGAATCACAGCAATCAGATGTCCCT
TTCGGTTACGATGGATATTCAGGTGCGAACCGCACACAAAGCTCTCGCCGCACACTCCACACT
GATATGGTCGCTCGCCCGTGTGGCGCCGCATATGGATCTTAAGGTCGTTGGACTGCACAAAGC
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TCTTGCTGCACATTTTGCAGGAGTACGGCCTTTGACCCGTGTGCAATCGCATGTGTCGCGCCA
GCTTGTTCTGCGAAATAAACTAACGGGAATTCCTGCAGCCCGGGGGATCCGCGGCCGC

A.b. chiRNA Expression Vector pU6-BbsI-chiRNA
Dm snRNA:U6:96Ab promoter
BbsI sites for inserting guide sequence
crRNA repeat-derived sequence
tracrRNA
U6 terminator
GTTCGACTTGCAGCCTGAAATACGGCACGAGTAGGAAAAGCCGAGTCAAATGCCGAATGCAG
AGTCTCATTACAGCACAATCAACTCAAGAAAAACTCGACACTTTTTTACCATTTGCACTTAAA
TCCTTTTTTATTCGTTATGTATACTTTTTTTGGTCCCTAACCAAAACAAAACCAAACTCTCTTAG
TCGTGCCTCTATATTTAAAACTATCAATTTATTATAGTCAATAAATCGAACTGTGTTTTCAACA
AACGAACAATAGGACACTTTGATTCTAAAGGAAATTTTGAAAATCTTAAGCAGAGGGTTCTTA
AGACCATTTGCCAATTCTTATAATTCTCAACTGCTCTTTCCTGATGTTGATCATTTATATAGGT
ATGTTTTCCTCAATACTTCGGGTCTTCGAGAAGACCTGTTTTAGAGCTAGAAATAGCAAGTTA
AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT

A.c. pFUS_A Vector to Insert Repair Sequence
pFUS_A backbone for repair vector sequences
Bsa1 recognition site
digested out section
TTGATGCCTGGCAGTTCCCTACTCTCGCGTTAACGCTAGCATGGATGTTTTCCCAGTCACGACG
TTGTAAAACGACGGCCAGTCTTAAGCGTCTCCCCCTGAACCTGACCCCGGACCAAGTGGTGGC
TATCGAGACCGGCGCCGCTACAGGGCGCGTCCCATTCGCCATTCAGGCTGCGCAACTGTTGGG
AAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCA
AGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGT
GAGCGCGCGTAATACGACTCACTATAGGGCGAATTGGGTACCGGGCCCCCCCTCGAGGTCCTC
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTT
CCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGT
AAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCT
TTCCACCGGTGGTCTCTGGCGGCAAGCAAGCGCTCGAAACGGTGCAGCGGCTGTTGCCGGTGC
TGTGCCAGGACCATGGCCGAGACGTCTAGACCAGCCAGGACAGAAATGCCTCGACTTCGCTG
CTACCCAAGGTTGCCGGGTGACGCACACCGTGAAACGGATGAAGGCACGAACCCAGTGGACA
TAAGCCTGTTCGGTTCGTAAGCTGTAATGCAAGTAGCGTATGCGCTCACGCAACTGGTCCAGA
ACCTTGACCGAACGCAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGT
TTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGA
TGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTA
AACATTATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGT
CATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGG
CGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAAC
AACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGAT
TCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAGCT
AAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCGAGCCA
GCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCGTTGCCTTG
GTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGATCTATTTGAGGCGCTA
AATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGAGCGAAATGTAGT
GCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGCGCCGAAGGATGTCGC
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TGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCATACTTGAAGCTAGACA
GGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGATCAGTTGGAAGAATTTGT
CCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAACCCTCGAGCCACCCATGAC
CAAAATCCCTTAACGTGAGTTACGCGTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCA
AAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACC
GCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGG
CTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTT
CAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCC
AGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCA
GCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCG
AACTGAGATACCTACAGCGTGAGCATTGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCG
GACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGG
GAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTT
GTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGT
TCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGAT
AACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGC
GAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTG
GCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCA
ACGCAATTAATACGCGTACCGCTAGCCAGGAAGAGTTTGTAGAAACGCAAAAAGGCCATCCG
TCAGGATGGCCTTCTGCTTAGTTTGATGCCTGGCAGTTTATGGCGGGCGTCCTGCCCGCCACCC
TCCGGGCCGTTGCTTCACAACGTTCAAATCCGCTCCCGGCGGATTTGTCCTACTCAGGAGAGC
GTTCACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTCCGACTGAGCCTTTCGTTTTAT

A.d. Repair Vectors
A.d.1 Scr::GFP
5’ and 3’ homology arms
GFP
loxP site
y+ marker
Target sequence for chiRNA + PAM
CTATTTGTGGCCACGGCCACAGCAGTTGTCCAAGTAGAAAGAGTCCCTCTCTGTTGCCGGCTG
ATCCGGATGACTGATGGAGACGATGCCGGTTGTCTGGTTACTGTCTGCTCGCTGTTTACTTGGT
CATTAGTTTAAGCCCGTTCAGAATGGCAGCCAGCCGGGGAAGTGCAGGAGCTTTGATGTCGGC
GCTATCCCTGCGCTTTGGCCACACTCAACACACTGAAACTCGCTTTAATTAAATGAGCGGTAA
TTAATTTCAACTTTAATCAGAAATTCCATTTAGATTTTGGCCGCTGATTGATGTGGCCCGACAT
CTTCCGCCAACGTCACATCGAAGACCACTAAACTGTGACAGCGGCAACAACGGGGGAAAACT
TTTGGAAGTGTGTGGGCGGTTTTCTTTTTTGCGTGTGTGTGTTTTTGTTTTGTTTTTGTTAAAGA
AGCAACAGTTGCAATATGTATCTTTAAGTAGGCAACATGAATAATAAACTAACGTACAACATC
AGTTTTATAGGAGACAAAGCTCTACGAAATAGAATTGCAGAATAGGTCTTTTGAATATCAGTT
GCACAAATATACATAACTATTACATAGAGTCAATTGAAGGGAAAACCATTGACTTAAACTCTT
ATTAAGAATAAACAACCTGTTCTAAGCAGTAAGCCTAACTGCCTTTCATTTAGCATGTATTCC
ATGACCCATATAAACTATGAACCAAGCGAGACAACAATACCCAAAAATCAAAGAGAGACGCA
CTAGCAGCAAGTCAGCGGTTGCCGTCTATCACATTGACTGACTGCCACACATTTTGCAGATAT
AAATACTAGAAATACAGATACAGTGTCTATAGCCGAACTGCCTCTGTCTCAGCTCAACTCTTT
ATTGGAAATCCAAAACAAAGCGGGCGGGCCAATTGAGTTGGCCGTAATAACACGCCACGGTA
AATGGCTTTTAAAAGTCTACTTTGCCACAGCACGCCCCCTCATTACGAACGACGCGCTTCGAA
CGCCCTCCTGCGGTTCGCCTCGAATAAAAGAGGAAAACCCGATACAGATGACAGAATAGTTTT
CGGGGGCGACTTGCAAAGAACGGTAAATTGTCATTATCTACCGACGATTGCAGATACAAGTTT
TCAGCAAGCGACAAACATCTGTCCGGGGTGAGATACCTTCGCTGAACTCCTCGGGCCAAACAC
AATTCCAGGCATGAACTTTTTCGGGTGCCACCAAATGGCAGTTTGGCACGTCATATTTATGAA
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AATGAAATGCGCAACGTTGCAGAAAATCACAATATAAATGAGAAAATTAACTGCCTCGAAGC
GGTGAGAAACATAGGGGAATTTGGGGATATGATGGTGGTGTCCACTTGAACGTTTGACGATTG
CCTAGATACGCCTTAAAATAGTTTGCTGCAGAAACAAATGGCTTACATAAAAGAGTAAGGAA
CGAGTGTTTAAACAAAAATTGTTTTACTTAATATATTCAATTTAATTGATTTTCGTTTATTATGT
ATTGATATTGTACACGTTTGAACTTCCCGTCTAGTCTATAGGTATTCCAAGCACTGTTAAAAAG
AAAACTCCTTTAGAGCGCCAAATACTTGATCGACGCGTTAACTACGTTATTCAGAAACTTCAT
TTCTAATTGTTTCCTTTAAATTATTAATATTAAATAAGCACCTCTATTCCTGTATTGCAACAGC
AACTGACAAAACTATTCCGGTTTTTCCTCCAGGTACTGTGAATGCCAATGGCGAGACGAAACG
ACAACGGACCTCATACACCCGCTACCAGACGCTGGAGCTGGAGAAGGAGTTCCACTTCAACC
GCTACCTGACCCGCCGCCGCAGAATCGAGATCGCGCATGCCCTGTGTCTCACGGAGCGGCAG
ATCAAGATCTGGTTCCAGAACCGGCGCATGAAGTGGAAGAAGGAGCACAAGATGGCCTCGAT
GAACATCGTACCCTACCACATGGGTCCATATGGCCACCCGTACCACCAGTTCGATATCCATCC
GTCGCAGTTCGCGCACCTAAGCGCAGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGC
CCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCC
CGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCC
CGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGC
GCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGC
GACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCT
GGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGA
AGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTC
GCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCA
CTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCC
TGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAACATG
ATAACTTCGTATAGCATACATTATACGAAGTTATGTCGACTATTAAATGATTATCGCCCGATTA
CCACATTGAGTGGTTTAAAATAGCCATAAAATATGCAACTGACGATGGCTTAAGATAAATACG
TCGCAGAGTCACTCATAAATTTCGAACGCAGCCCGCTGATTTACCTACCCCTCTAAACGATTC
ATAGTATATGTACGAGTATATCCACTAAGCTTTTTCGAGCACTGATTTTTTCGCTTGCACGAGA
CAAGTGCACCACCGCAATTGCAGGCAAATTATGTCTGAGGTAATGATTCCGTTTCGTGCAAGA
TTACACAGAAATCAAATTACGACAACCTTTATTCAGTAAGCAAACAAAGCCTTTGTTGGCATC
TAATTATTCCACTTATGGTTGCGATTTCGGGAGCTACAATCGGTTTTGGTTTAGTATATCTAGC
GAGTTCCTTGGCGACATTTAAAATTTACAAATAAAGTTTCTCTATTCAATCGGGACAGTGGAA
ATTGACTATTTTATTTATATTAATGAACTTATTTTTAATTTGGCTTAAGTTACTAAGGGGTACT
AATAGTTTGAGCGCAGTGCATGTCATGGGGACATGTGCAATTGTGTGTAAGCGGGAAGTGATC
GCGGCCTTCCGAATTTGGCCATGCCAAATAATCCCAGCTCGAAAGGAGGGGACCCGGCGGTC
AGGGCCATGGACATTGAACTTGAAAAAAAAAAAACACAAAAATATATAACACAAAACGGAA
AATGCTGTGTACCGCTTATGTTAGAGAAGTTGAGCAACGGGTTTTTCGTTTTGCAGTCACGAT
GGATTTCCAAATTAGTGTAGGAGGGGGGAGGGGAGGGAGGGAGATAATGTCCAGGCTGCCAT
AAGTGGGGAATAAGGAAAATAAAACATGAAACACGGGTCGGGCAATGTCATGCGGTATTCGG
CTTTGCTTTCCGCCCAAGTTGAAGTGATCCTGTGTGTAAATAATGTCGAATGTTGCCGGTCGGT
TGCATAAGCGTTGGTCAATTATGGCCAAAGAGATCTGATTTGTGGAAGCTTTTTTTGACCACTT
AGCGCGCTCCGCTGATGTTGTTTTGTTTTGTGCTGGGGCAGAAAACTTGTTTCAATTATTGGGA
AAAGTGCGTATAAATCATTGCCGCAAGCTCTGAAAAGCGAAAAAGAAAAACAGTAACCAAAC
AGACAAACGCAGCATTCCCCCACACAATTAAGCAAAAACTTGAAACAAGTCAATTCGAAAAA
AATTATAGGTTCAACGGCTGCAGCGATCGCATCATTAGTTGCGTTTTTAGTAAATACACCATTT
CATTACACAACACACACAATTAATTAATAAAACTGTACTGGTTATTTCAAGTGTGTCTTTTAAT
AAGCCTGCCGATCGCAATAAATTCGAGCAGCATTGCCGGTAATTTTGTGCAACATATTTTTCG
ATTGCCACACCGTGTTTGTTTATTTTTTCTGTGGGTGCAATGATTTAGAATGCGGGCAAGGGAT
CAAGTTGAACCACTTCTAAGAAAAAATAGACATTGCATAAATGATATAGAGTCCAAAAACTA
CACCAATTCAATAGCAGTAATGGTTACATTAGCTTTGAAATTGTTTTTAGACATCCGAAGAAA
TAAGATTAAATTTAAACGGCATTCTTTAATTTGTATTTTAATATTTTGAGAGGTTTTCCTTATTT
AAAGTGTAGATTATTGAGGATTAATGCAATACCACTTTACCTGCGGAGGTCGTAAAACGTATT
TTTACCCATTTGCATGTTTATTATGCGTGTCGCTGGTTGTTTACTTTACTTAAGTTTTGCAATTT
TTTCTTTAGCAAGCAGGTGCATTTGGGCCAAGAGATATATGCGATCGCTTTCGGTTCGAATTTT
TAACATTTACTTGCGGCGATGGTCATTAGAGCATTACCCACTTAGGGCACCCCCAACATCCAG
TTGATTTTCAGGGACCACAATATTTTAAATAACAGCTAGTGGAATTACCTAAAAGCGCTTTCG
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TTCCTTTTTGAAATTTTATGTAACACTCAATTATATTTATGTATATGTATGCTCAAAATCACCTG
CCAATAACTAGCGGAAACCAAATATTTGACCCTCAGTGAATTGTGAATCATCGGTGACGCCCA
ATCGAAATCCAATCCTAAGCAATTGAAACGAGCACGAGTTCCAATTTAATAGTATACAAGGA
AACACCTGCTTTAAATACTCTACATAGTACACGTTATAATAACGATTTATTTGATATTTCTGGA
TTTTTGTCTGCATGTATTTCATATAATATTGATTTGATTTTTTTAATGAATTGAACTAAAAAATC
ATATTAGAACATTTTTTGCAGTCGCCGATAAAGATGAACACAGTTCTCAGAACACAACTGTCA
TGTATTAAGCTTTCAGATTTTCAGAAATTTGGAGAGCAATGCATTCTATGCACGAGCCTCCTG
GCCTTACAATTTACTTGTTTGAAATTAGATCGTCAAATAAAGTCCCTAAAATTAAATAAATAG
TAGTCACAACTTTAAAATAGGTCTTAATCTTTTAGGGTACCGAAAGGTATTTCGGCACAAATC
AGCGCAGTTTTAAATGTCGATGAAGGCCAAAAATCATACCAAACCCAGCGAAAGGTGATGTC
TGACTCATTAAATTGGGGGATTCGAGTGTATTTATTAAACATGCGTGAAAATCAATCATGGAA
GACAAAACGCAAAGTTGGCCGATCTATGGGAACAGCATAAGCCACCTGATTACCCGAACACT
GAACCACCCGAATCACTAAAACCACCGAAGTTGGCGCGCGCCTTCGTTTTCATTTTCATTGGC
CTGTCTTCGTCTTCGGAGAAAAAAACCTTCATATAAAACGCGGCCGACATATTATGGCCACCA
GTCGTTACCGCGCCACGGTCCACAGAAGAGGATTAAAAAAATATCACACAGCCGAAGGCTAG
AGAAGAACCCCCTATAGCTGAACATATATAAACAAATATATTTTTTTTTATTGCCAACACACTT
TGGCTTAAGTGTTAAGAGTGATTGTCAGCTTAGAGCTAAGTGCAATGTTCCAGGACAAAGGGT
GGATCCTTGTGACCCTGATCACCTTGGTGACGCCGTCTTGGGCTGCTTACAAACTTCAGGAGC
GATATAGTTGGAGCCAGCTGGACTTTGCTTTCCCGAATACCCGACTAAAGGACCAAGCTCTGG
CTAGTGGAGATTATATTCCGCAAAATGCTCTACCTGTTGGAGTCGAACACTTTGGCAATCGGT
TATTCGTCACTGTTCCCCGCTGGCGTGATGGGATTCCGGCCACTCTGACCTATATAAACATGG
ACCGCAGTTTGACGGGTTCACCGGAGCTAATTCCGTATCCAGATTGGCGCTCAAATACAGCTG
GAGATTGCGCCAACAGTATTACCACTGCCTACCGCATTAAAGTGGATGAGTGTGGTCGGCTGT
GGGTTTTGGACACTGGAACCGTGGGCATCGGCAATACCACCACTAATCCGTGCCCCTATGCGG
TAAATGTCTTTGACTTGACCACGGATACGCGAATTCGGAGATACGAGCTACCTGGCGTGGACA
CAAATCCAAATACTTTCATAGCTAACATTGCCGTGGATATAGGCAAAAATTGCGATGATGCAT
ATGCCTATTTTGCCGATGAATTGGGATACGGCTTGATTGCTTACTCCTGGGAACTGAACAAGT
CCTGGAGATTCTCGGCACATTCGTATTTTTTCCCCGATCCATTGAGGGGCGATTTCAATGTCGC
TGGTATTAACTTCCAATGGGGCGAGGAGGGTATATTTGGTATGTCCCTTTCGCCCATTCGATCG
GATGGTTATCGTACCCTGTACTTTAGTCCGTTAGCAAGTCATCGACAATTTGCCGTATCCACGA
GGATTTTGAGGGATGAAACCAGGACGGAAGATAGCTATCATGACTTTGTTGCCTTAGATGAAC
GGGGTCCAAACTCCCATACCACTTCACGTGTGATGAGCGATGATGGAATTGAGCTGTTCAATT
TAATAGATCAAAATGCAGTGGGTTGCTGGCACTCATCAATGCCGTACTCACCGCAATTTCATG
GCATTGTGGATCGCGATGACGTTGGCTTAGTTTTTCCGGCCGATGTGAAAATTGATGAGAACA
AAAACGTTTGGGTTCTATCCGATAGGATGCCCGTTTTCTTGCTGTCTGACTTGGATTATTCAGA
TACTAATTTCCGAATTTACACGGCTCCCTTGGCCACTTTAATTGAGAATACTGTGTGTGATTTG
AGGAATAACGCCTATGGGCCGCCAAATACCGTTTCAATACCAAAACAAGCCGTTTTGCCAATG
GGTCCACCGTTATATACGAAACAATATCGTCCTGTCTTGCCACAGAAACCTCAGACCAGCTGG
GCTTCCTCGCCGCCTCCTCCAAGTCGCACTTATTTGCCCGCCAATTCAGGCAATGTAGTCTCCA
GTATTAGTGTCTCTACAAATTCTGTGGGTCCTGCAGGAGTGGAGGTGCCAAAGGCCTATATTT
TCAACCAGCACAACGGCATAAATTACGAGACAAGTGGTCCCCATCTATTTCCCACCCATCAAC
CCGCCCAACCGGGTGGCCAGGATGGTGGGTTAAAAACTTATGTGAATGCCCGCCAATCTGGGT
GGTGGCATCATCAGCATCAAGGTTAACATAATCCTACACACGGTACTTGGGTATATTCTCACA
CACTCGATTGATGTAAAGAATATTTAAAGACAACAACATAGGGCAACAGCGGTTAAAAAAAC
CACATGACGTATGAGCAAGTGGCAAATCAATACTTTATCTAGTTATGTTAAGCAAAAAATAAC
AATAAATCAACTTTTTTTTGAAGGTTAAGAGTTTACGCAATTTTCTTGAGCGGAAAAAGCGGA
AAAAATGTAAGTATGCATAAATTCTAAATATATCAACAACTGTACATTTTCTGGAGTACTACT
ACCAGGCAAGAAAGTAGGTTGATAAAGCTATGCACAAGATCTTGTTTGGGTGCAGGGAAAGT
TCAACTTAATCGCTCAATTTGAGATCGCCTGGTCGCTTGAGATTCGACTGTAATTGAAATTTTT
GCTTTTGATCGGAGCCAGACTTCAGACGGGGCAAACAAAAAGACTTTGTTGGTGGTAGGGTA
GGATCCGTTGACCTGCAGGTCGAGGACATAACTTCGTATAGCATACATTATACGAAGTTATGA
CGCGTGGCACTTTTCGGGTACTGGTTAGAGACTCAATCAGTTGTATCAGGAACCATATCAGAC
GGCGGCGGCGGCATCGGCGGCCAGTGGTTATCAGTCGCAGGACGGCGGTCCAATTGGTGGCG
GCTCGGTGGGAGTGGGTGGTGGTGCGGGGGGGCCGGGCTCGCTGGCCAACGGTGGCAGCAAT
GGCAGCGGTCCCAACTCTCTCTTCGCCTCCGCCGCCTCCAGCTCCCAGGCTCCCGACTGCATCA
AGTATCCGCAGGAGTTCTGATCTCAGGTTATCATCAGGCAGCAGCATCAGCAGCAGCAGGAT

87
AACTCCATGGATCGGAATCAGGAGCGGGACCTAAAACTGCTTTTGGAAACGGACTGTGAGCC
CGATCCAGAGCTGCAACTGGAGTTCAAGGCGGACATTGTCGAATGCAACTTGTTCTGCTGCTG
AGCTATGTCCGCCTGCCACGCCCCTGCCGCCTCATGCCTGCCGCCTACCGCCCATCGCCTACCG
CCTGTCGCCGCCCGTCGATCAACCAACATCCATAGATGTTTCTTGTTTGCAACTGATTCGTGTT
AAGCTAAGAAACGAGCCATATCCGCATGGTTCGTTTGGGTTTATGATACTGGAGATGGAACCA
CGAGCAATCGACGTCACTCTTTAAGATATTAATCATCAACCTTTAACTAGAATTTGTGATACG
CTGAGTCTAACATATCATGATCATATTATTCACGTCGATTTGAATCAATGACATTAGTATGTGA
TGTTAGTTTGCTGTTGAATGATATGTATATGATTGATATTACTTGATAATGTCAAAGTTAGGTG
TTATCCCTCACTCACTTTCTAAACCTTTCTATGCGAATGCTCGAGGGTCCTTCCAGTATGATGA
ATCTCTTTCTCTAAGCAGTATTCGAAAAGCCGTTAGTTTGTAAGCCTAGCATAATTTTAGCACG
TAAGCTGCACGATGAGCAGACAAAGCTGTCGAGTTGAACAAATCTAATATCTGCAATAATTTC
AAAGTGATTTCTAATTAACATTAGGTCTTCGTTTGTATCGCCCAATCTCCAACCTTGATCCCAA
CCAAACCCCCAACCAGCACCCTCCAGGGAGTCCTAAAGAGTGTACTTAATTCCTAGCTAGTAG
AGAATATAACTCTAGTTACCCACATAAGGCTTTGTTTAGTTTGTAAATAGCAGAGCGCCCCAG
ATCGGGGATCGCCTTTTTATGTTTGTGTTTCGTCTTGAAGAGAAAATTTGAAAGTATCTGCAAC
TGTTTAATTCAATTTATTTTGAGTGTTTGCGTTTATGTTGTTGAAATTGCTCTAGCAGCTTGGAA
AATGCTTTACTAATTTTATCAAAAATCAATCGTTTTTTATTGCCACTGAAGAACAAATTCGGAA
GATAAACAGGAAGTAAAATAATTCAAAAATAGCATAGACCTTGCTATAGTTAATCAGAGTTTT
CTTTAGAACATCAGCCGATCCTTCCTCTTTATTTATTCAAAGGCCTCTCAACAATGTCTGTAAA
TTTAATTCGGTAGTTAATCGATACAGTGTAAGCCAACGAAATTTGATTAAAGTGTGAATCGTT
AAAGCCTAAAGCTAAAGGAAACCCATAACCGTAATGTAAAGTAATTATTTATGCTGTACTTTT
CGCTAAGCTAAGGTTAGTGCATTCTAGAACTATCGGTAGTATATGTCAACCTAGATCGTAAGC
CTAAATTATGTATATCGAATTAGCAAGACAAATTTTAGAGAAAACAAATCAGATTGAGCAAG
GCAAAGCAAAACGAACAAAACTATGGAAATGAGAGAATCAAAAAAAGTATACCTAGCACAA
ATTAATTAATCGTTTTTTGTTTCCCCATTTTGTATATTTGTTCAATCTTAGTTTGTACATTTTCGA
TTGTGTGTTCAATGCAATTGGTCGGAACCATACTGATTTTCGC

A.d.2 Scr::tag
5’ and 3’ homology arms
17 aa tag
3X FLAG
loxP site
y+ marker
Target sequence for chiRNA + PAM
GAATAGTTTTCGGGGGCGACTTGCAAAGAACGGTAAATTGTCATTATCTACCGACGATTGCAG
ATACAAGTTTTCAGCAAGCGACAAACATCTGTCCGGGGTGAGATACCTTCGCTGAACTCCTCG
GGCCAAACACAATTCCAGGCATGAACTTTTTCGGGTGCCACCAAATGGCAGTTTGGCACGTCA
TATTTATGAAAATGAAATGCGCAACGTTGCAGAAAATCACAATATAAATGAGAAAATTAACT
GCCTCGAAGCGGTGAGAAACATAGGGGAATTTGGGGATATGATGGTGGTGTCCACTTGAACG
TTTGACGATTGCCTAGATACGCCTTAAAATAGTTTGCTGCAGAAACAAATGGCTTACATAAAA
GAGTAAGGAACGAGTGTTTAAACAAAAATTGTTTTACTTAATATATTCAATTTAATTGATTTTC
GTTTATTATGTATTGATATTGTACACGTTTGAACTTCCCGTCTAGTCTATAGGTATTCCAAGCA
CTGTTAAAAAGAAAACTCCTTTAGAGCGCCAAATACTTGATCGACGCGTTAACTACGTTATTC
AGAAACTTCATTTCTAATTGTTTCCTTTAAATTATTAATATTAAATAAGCACCTCTATTCCTGT
ATTGCAACAGCAACTGACAAAACTATTCCGGTTTTTCCTCCAGGTACTGTGAATGCCAATGGC
GAGACGAAACGACAACGGACCTCATACACCCGCTACCAGACGCTGGAGCTGGAGAAGGAGTT
CCACTTCAACCGCTACCTGACCCGCCGCCGCAGAATCGAGATCGCGCATGCCCTGTGTCTCAC
GGAGCGGCAGATCAAGATCTGGTTCCAGAACCGGCGCATGAAGTGGAAGAAGGAGCACAAG
ATGGCCTCGATGAACATCGTACCCTACCACATGGGTCCATATGGCCACCCGTACCACCAGTTC
GATATCCATCCGTCGCAGTTCGCGCACCTAAGCGCAATCCTGGGGCACAAGCTGGAGTACAAC
TACAACAGCCACAACGTCTATATCGACTACAAAGACCATGACGGTGATTATAAAGATCATGA
CATCGACTACAAGGATGACGATGACAAGTAACATGATAACTTCGTATAGCATACATTATACGA
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AGTTATGTCGACTATTAAATGATTATCGCCCGATTACCACATTGAGTGGTTTAAAATAGCCAT
AAAATATGCAACTGACGATGGCTTAAGATAAATACGTCGCAGAGTCACTCATAAATTTCGAAC
GCAGCCCGCTGATTTACCTACCCCTCTAAACGATTCATAGTATATGTACGAGTATATCCACTA
AGCTTTTTCGAGCACTGATTTTTTCGCTTGCACGAGACAAGTGCACCACCGCAATTGCAGGCA
AATTATGTCTGAGGTAATGATTCCGTTTCGTGCAAGATTACACAGAAATCAAATTACGACAAC
CTTTATTCAGTAAGCAAACAAAGCCTTTGTTGGCATCTAATTATTCCACTTATGGTTGCGATTT
CGGGAGCTACAATCGGTTTTGGTTTAGTATATCTAGCGAGTTCCTTGGCGACATTTAAAATTTA
CAAATAAAGTTTCTCTATTCAATCGGGACAGTGGAAATTGACTATTTTATTTATATTAATGAAC
TTATTTTTAATTTGGCTTAAGTTACTAAGGGGTACTAATAGTTTGAGCGCAGTGCATGTCATGG
GGACATGTGCAATTGTGTGTAAGCGGGAAGTGATCGCGGCCTTCCGAATTTGGCCATGCCAAA
TAATCCCAGCTCGAAAGGAGGGGACCCGGCGGTCAGGGCCATGGACATTGAACTTGAAAAAA
AAAAAACACAAAAATATATAACACAAAACGGAAAATGCTGTGTACCGCTTATGTTAGAGAAG
TTGAGCAACGGGTTTTTCGTTTTGCAGTCACGATGGATTTCCAAATTAGTGTAGGAGGGGGGA
GGGGAGGGAGGGAGATAATGTCCAGGCTGCCATAAGTGGGGAATAAGGAAAATAAAACATG
AAACACGGGTCGGGCAATGTCATGCGGTATTCGGCTTTGCTTTCCGCCCAAGTTGAAGTGATC
CTGTGTGTAAATAATGTCGAATGTTGCCGGTCGGTTGCATAAGCGTTGGTCAATTATGGCCAA
AGAGATCTGATTTGTGGAAGCTTTTTTTGACCACTTAGCGCGCTCCGCTGATGTTGTTTTGTTT
TGTGCTGGGGCAGAAAACTTGTTTCAATTATTGGGAAAAGTGCGTATAAATCATTGCCGCAAG
CTCTGAAAAGCGAAAAAGAAAAACAGTAACCAAACAGACAAACGCAGCATTCCCCCACACA
ATTAAGCAAAAACTTGAAACAAGTCAATTCGAAAAAAATTATAGGTTCAACGGCTGCAGCGA
TCGCATCATTAGTTGCGTTTTTAGTAAATACACCATTTCATTACACAACACACACAATTAATTA
ATAAAACTGTACTGGTTATTTCAAGTGTGTCTTTTAATAAGCCTGCCGATCGCAATAAATTCGA
GCAGCATTGCCGGTAATTTTGTGCAACATATTTTTCGATTGCCACACCGTGTTTGTTTATTTTTT
CTGTGGGTGCAATGATTTAGAATGCGGGCAAGGGATCAAGTTGAACCACTTCTAAGAAAAAA
TAGACATTGCATAAATGATATAGAGTCCAAAAACTACACCAATTCAATAGCAGTAATGGTTAC
ATTAGCTTTGAAATTGTTTTTAGACATCCGAAGAAATAAGATTAAATTTAAACGGCATTCTTTA
ATTTGTATTTTAATATTTTGAGAGGTTTTCCTTATTTAAAGTGTAGATTATTGAGGATTAATGC
AATACCACTTTACCTGCGGAGGTCGTAAAACGTATTTTTACCCATTTGCATGTTTATTATGCGT
GTCGCTGGTTGTTTACTTTACTTAAGTTTTGCAATTTTTTCTTTAGCAAGCAGGTGCATTTGGGC
CAAGAGATATATGCGATCGCTTTCGGTTCGAATTTTTAACATTTACTTGCGGCGATGGTCATTA
GAGCATTACCCACTTAGGGCACCCCCAACATCCAGTTGATTTTCAGGGACCACAATATTTTAA
ATAACAGCTAGTGGAATTACCTAAAAGCGCTTTCGTTCCTTTTTGAAATTTTATGTAACACTCA
ATTATATTTATGTATATGTATGCTCAAAATCACCTGCCAATAACTAGCGGAAACCAAATATTT
GACCCTCAGTGAATTGTGAATCATCGGTGACGCCCAATCGAAATCCAATCCTAAGCAATTGAA
ACGAGCACGAGTTCCAATTTAATAGTATACAAGGAAACACCTGCTTTAAATACTCTACATAGT
ACACGTTATAATAACGATTTATTTGATATTTCTGGATTTTTGTCTGCATGTATTTCATATAATAT
TGATTTGATTTTTTTAATGAATTGAACTAAAAAATCATATTAGAACATTTTTTGCAGTCGCCGA
TAAAGATGAACACAGTTCTCAGAACACAACTGTCATGTATTAAGCTTTCAGATTTTCAGAAAT
TTGGAGAGCAATGCATTCTATGCACGAGCCTCCTGGCCTTACAATTTACTTGTTTGAAATTAGA
TCGTCAAATAAAGTCCCTAAAATTAAATAAATAGTAGTCACAACTTTAAAATAGGTCTTAATC
TTTTAGGGTACCGAAAGGTATTTCGGCACAAATCAGCGCAGTTTTAAATGTCGATGAAGGCCA
AAAATCATACCAAACCCAGCGAAAGGTGATGTCTGACTCATTAAATTGGGGGATTCGAGTGT
ATTTATTAAACATGCGTGAAAATCAATCATGGAAGACAAAACGCAAAGTTGGCCGATCTATG
GGAACAGCATAAGCCACCTGATTACCCGAACACTGAACCACCCGAATCACTAAAACCACCGA
AGTTGGCGCGCGCCTTCGTTTTCATTTTCATTGGCCTGTCTTCGTCTTCGGAGAAAAAAACCTT
CATATAAAACGCGGCCGACATATTATGGCCACCAGTCGTTACCGCGCCACGGTCCACAGAAG
AGGATTAAAAAAATATCACACAGCCGAAGGCTAGAGAAGAACCCCCTATAGCTGAACATATA
TAAACAAATATATTTTTTTTTATTGCCAACACACTTTGGCTTAAGTGTTAAGAGTGATTGTCAG
CTTAGAGCTAAGTGCAATGTTCCAGGACAAAGGGTGGATCCTTGTGACCCTGATCACCTTGGT
GACGCCGTCTTGGGCTGCTTACAAACTTCAGGAGCGATATAGTTGGAGCCAGCTGGACTTTGC
TTTCCCGAATACCCGACTAAAGGACCAAGCTCTGGCTAGTGGAGATTATATTCCGCAAAATGC
TCTACCTGTTGGAGTCGAACACTTTGGCAATCGGTTATTCGTCACTGTTCCCCGCTGGCGTGAT
GGGATTCCGGCCACTCTGACCTATATAAACATGGACCGCAGTTTGACGGGTTCACCGGAGCTA
ATTCCGTATCCAGATTGGCGCTCAAATACAGCTGGAGATTGCGCCAACAGTATTACCACTGCC
TACCGCATTAAAGTGGATGAGTGTGGTCGGCTGTGGGTTTTGGACACTGGAACCGTGGGCATC
GGCAATACCACCACTAATCCGTGCCCCTATGCGGTAAATGTCTTTGACTTGACCACGGATACG
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CGAATTCGGAGATACGAGCTACCTGGCGTGGACACAAATCCAAATACTTTCATAGCTAACATT
GCCGTGGATATAGGCAAAAATTGCGATGATGCATATGCCTATTTTGCCGATGAATTGGGATAC
GGCTTGATTGCTTACTCCTGGGAACTGAACAAGTCCTGGAGATTCTCGGCACATTCGTATTTTT
TCCCCGATCCATTGAGGGGCGATTTCAATGTCGCTGGTATTAACTTCCAATGGGGCGAGGAGG
GTATATTTGGTATGTCCCTTTCGCCCATTCGATCGGATGGTTATCGTACCCTGTACTTTAGTCC
GTTAGCAAGTCATCGACAATTTGCCGTATCCACGAGGATTTTGAGGGATGAAACCAGGACGG
AAGATAGCTATCATGACTTTGTTGCCTTAGATGAACGGGGTCCAAACTCCCATACCACTTCAC
GTGTGATGAGCGATGATGGAATTGAGCTGTTCAATTTAATAGATCAAAATGCAGTGGGTTGCT
GGCACTCATCAATGCCGTACTCACCGCAATTTCATGGCATTGTGGATCGCGATGACGTTGGCT
TAGTTTTTCCGGCCGATGTGAAAATTGATGAGAACAAAAACGTTTGGGTTCTATCCGATAGGA
TGCCCGTTTTCTTGCTGTCTGACTTGGATTATTCAGATACTAATTTCCGAATTTACACGGCTCC
CTTGGCCACTTTAATTGAGAATACTGTGTGTGATTTGAGGAATAACGCCTATGGGCCGCCAAA
TACCGTTTCAATACCAAAACAAGCCGTTTTGCCAATGGGTCCACCGTTATATACGAAACAATA
TCGTCCTGTCTTGCCACAGAAACCTCAGACCAGCTGGGCTTCCTCGCCGCCTCCTCCAAGTCGC
ACTTATTTGCCCGCCAATTCAGGCAATGTAGTCTCCAGTATTAGTGTCTCTACAAATTCTGTGG
GTCCTGCAGGAGTGGAGGTGCCAAAGGCCTATATTTTCAACCAGCACAACGGCATAAATTAC
GAGACAAGTGGTCCCCATCTATTTCCCACCCATCAACCCGCCCAACCGGGTGGCCAGGATGGT
GGGTTAAAAACTTATGTGAATGCCCGCCAATCTGGGTGGTGGCATCATCAGCATCAAGGTTAA
CATAATCCTACACACGGTACTTGGGTATATTCTCACACACTCGATTGATGTAAAGAATATTTA
AAGACAACAACATAGGGCAACAGCGGTTAAAAAAACCACATGACGTATGAGCAAGTGGCAA
ATCAATACTTTATCTAGTTATGTTAAGCAAAAAATAACAATAAATCAACTTTTTTTTGAAGGTT
AAGAGTTTACGCAATTTTCTTGAGCGGAAAAAGCGGAAAAAATGTAAGTATGCATAAATTCT
AAATATATCAACAACTGTACATTTTCTGGAGTACTACTACCAGGCAAGAAAGTAGGTTGATAA
AGCTATGCACAAGATCTTGTTTGGGTGCAGGGAAAGTTCAACTTAATCGCTCAATTTGAGATC
GCCTGGTCGCTTGAGATTCGACTGTAATTGAAATTTTTGCTTTTGATCGGAGCCAGACTTCAGA
CGGGGCAAACAAAAAGACTTTGTTGGTGGTAGGGTAGGATCCGTTGACCTGCAGGTCGAGGA
CATAACTTCGTATAGCATACATTATACGAAGTTATGACGCGTGGCACTTTTCGGGTACTGGTT
AGAGACTCAATCAGTTGTATCAGGAACCATATCAGACGGCGGCGGCGGCATCGGCGGCCAGT
GGTTATCAGTCGCAGGACGGCGGTCCAATTGGTGGCGGCTCGGTGGGAGTGGGTGGTGGTGC
GGGGGGGCCGGGCTCGCTGGCCAACGGTGGCAGCAATGGCAGCGGTCCCAACTCTCTCTTCG
CCTCCGCCGCCTCCAGCTCCCAGGCTCCCGACTGCATCAAGTATCCGCAGGAGTTCTGATCTC
AGGTTATCATCAGGCAGCAGCATCAGCAGCAGCAGGATAACTCCATGGATCGGAATCAGGAG
CGGGACCTAAAACTGCTTTTGGAAACGGACTGTGAGCCCGATCCAGAGCTGCAACTGGAGTTC
AAGGCGGACATTGTCGAATGCAACTTGTTCTGCTGCTGAGCTATGTCCGCCTGCCACGCCCCT
GCCGCCTCATGCCTGCCGCCTACCGCCCATCGCCTACCGCCTGTCGCCGCCCGTCGATCAACC
AACATCCATAGATGTTTCTTGTTTGCAACTGATTCGTGTTAAGCTAAGAAACGAGCCATATCC
GCATGGTTCGTTTGGGTTTATGATACTGGAGATGGAACCACGAGCAATCGACGTCACTCTTTA
AGATATTAATCATCAACCTTTAACTAGAATTTGTGATACGCTGAGTCTAACATATCATGATCAT
ATTATTCACGTCGATTTGAATCAATGACATTAGTATGTGATGTTAGTTTGCTGTTGAATGATAT
GTATATGATTGATATTACTTGATAATGTCAAAGTTAGGTGTTATCCCTCACTCACTTTCTAAAC
CTTTCTATGCGAATGCTCGAGGGTCCTTCCAGTATGATGAATCTCTTTCTCTAAGCAGTATTCG
AAAAGCCGTTAGTTTGTAAGCCTAGCATAATTTTAGCACGTAAGCTGCACGATGAGCAGACAA
AGCTGTCGA

A.d.3 Antp::CFP
5’ and 3’ homology arms
CFP
modified aa sites
lox2272 site
y+ marker
Target sequence for chiRNA + PAM
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CTCTTCGGCCTCCTACCCCTCATCTCAGACCTGTTGTAGGCCCTGTTTTTTCTCTTTTTTTTTGA
CAAGTACAAATATCCGAATTCGGTAAGGTTGTCTTTTAATCAGCCTCAGTTTCAGAGACGCAG
CGCCCCGCTTCATGTGGTTTTGAGTTACCCATTCCCTGATCCCTCGTCCGATTCTCCGGGAGAA
AAAGAACAAAAAAAAAAAAAACAAAATACAAGACAACAAGAAATAAATAAGTATATATACA
TTTACTCCAGCTCTGGTTGTTGTATGCACTTTAGTGGACCTGTAGATATAGTAGAATTTGTTGT
CGTTGATTTGGTGGCCGGTCATGCATTGCATTGATTTTAATTGTGAAAATCGTTATTTACTTGG
AACCAACAGAACGCAAACGCGGAAGGCAGACATACACCCGGTACCAGACTCTAGAGCTAGA
GAAGGAGTTTCACTTCAATCGCTACTTGACCCGTCGGCGAAGGATCGAGATCGCCCACGCCCT
GTGCCTCACGGAGCGCCAGATAAAGATTTGGTTCCAGAATCGGCGCATGAAGTGGAAGAAGG
AGAACAAGACGAAGGGCGAGCCGGGATCCGGAGGCGAAGGCGACGAGATAACACCACCCAA
CAGTCCGCAGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGC
TGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACC
TACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACC
CTCGTGACCACCCTGACCTGGGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAG
CACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG
GACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCG
CATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGT
ACAACTACAACAGCCACAACGTCTATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGCA
AACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCA
GAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTC
CGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCG
CCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAACATGATAACTTCGTATAGGATA
CTTTATACGAAGTTATGTCGACTATTAAATGATTATCGCCCGATTACCACATTGAGTGGTTTAA
AATAGCCATAAAATATGCAACTGACGATGGCTTAAGATAAATACGTCGCAGAGTCACTCATA
AATTTCGAACGCAGCCCGCTGATTTACCTACCCCTCTAAACGATTCATAGTATATGTACGAGT
ATATCCACTAAGCTTTTTCGAGCACTGATTTTTTCGCTTGCACGAGACAAGTGCACCACCGCA
ATTGCAGGCAAATTATGTCTGAGGTAATGATTCCGTTTCGTGCAAGATTACACAGAAATCAAA
TTACGACAACCTTTATTCAGTAAGCAAACAAAGCCTTTGTTGGCATCTAATTATTCCACTTATG
GTTGCGATTTCGGGAGCTACAATCGGTTTTGGTTTAGTATATCTAGCGAGTTCCTTGGCGACAT
TTAAAATTTACAAATAAAGTTTCTCTATTCAATCGGGACAGTGGAAATTGACTATTTTATTTAT
ATTAATGAACTTATTTTTAATTTGGCTTAAGTTACTAAGGGGTACTAATAGTTTGAGCGCAGTG
CATGTCATGGGGACATGTGCAATTGTGTGTAAGCGGGAAGTGATCGCGGCCTTCCGAATTTGG
CCATGCCAAATAATCCCAGCTCGAAAGGAGGGGACCCGGCGGTCAGGGCCATGGACATTGAA
CTTGAAAAAAAAAAAACACAAAAATATATAACACAAAACGGAAAATGCTGTGTACCGCTTAT
GTTAGAGAAGTTGAGCAACGGGTTTTTCGTTTTGCAGTCACGATGGATTTCCAAATTAGTGTA
GGAGGGGGGAGGGGAGGGAGGGAGATAATGTCCAGGCTGCCATAAGTGGGGAATAAGGAAA
ATAAAACATGAAACACGGGTCGGGCAATGTCATGCGGTATTCGGCTTTGCTTTCCGCCCAAGT
TGAAGTGATCCTGTGTGTAAATAATGTCGAATGTTGCCGGTCGGTTGCATAAGCGTTGGTCAA
TTATGGCCAAAGAGATCTGATTTGTGGAAGCTTTTTTTGACCACTTAGCGCGCTCCGCTGATGT
TGTTTTGTTTTGTGCTGGGGCAGAAAACTTGTTTCAATTATTGGGAAAAGTGCGTATAAATCAT
TGCCGCAAGCTCTGAAAAGCGAAAAAGAAAAACAGTAACCAAACAGACAAACGCAGCATTC
CCCCACACAATTAAGCAAAAACTTGAAACAAGTCAATTCGAAAAAAATTATAGGTTCAACGG
CTGCAGCGATCGCATCATTAGTTGCGTTTTTAGTAAATACACCATTTCATTACACAACACACAC
AATTAATTAATAAAACTGTACTGGTTATTTCAAGTGTGTCTTTTAATAAGCCTGCCGATCGCAA
TAAATTCGAGCAGCATTGCCGGTAATTTTGTGCAACATATTTTTCGATTGCCACACCGTGTTTG
TTTATTTTTTCTGTGGGTGCAATGATTTAGAATGCGGGCAAGGGATCAAGTTGAACCACTTCTA
AGAAAAAATAGACATTGCATAAATGATATAGAGTCCAAAAACTACACCAATTCAATAGCAGT
AATGGTTACATTAGCTTTGAAATTGTTTTTAGACATCCGAAGAAATAAGATTAAATTTAAACG
GCATTCTTTAATTTGTATTTTAATATTTTGAGAGGTTTTCCTTATTTAAAGTGTAGATTATTGAG
GATTAATGCAATACCACTTTACCTGCGGAGGTCGTAAAACGTATTTTTACCCATTTGCATGTTT
ATTATGCGTGTCGCTGGTTGTTTACTTTACTTAAGTTTTGCAATTTTTTCTTTAGCAAGCAGGTG
CATTTGGGCCAAGAGATATATGCGATCGCTTTCGGTTCGAATTTTTAACATTTACTTGCGGCGA
TGGTCATTAGAGCATTACCCACTTAGGGCACCCCCAACATCCAGTTGATTTTCAGGGACCACA
ATATTTTAAATAACAGCTAGTGGAATTACCTAAAAGCGCTTTCGTTCCTTTTTGAAATTTTATG
TAACACTCAATTATATTTATGTATATGTATGCTCAAAATCACCTGCCAATAACTAGCGGAAAC
CAAATATTTGACCCTCAGTGAATTGTGAATCATCGGTGACGCCCAATCGAAATCCAATCCTAA
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GCAATTGAAACGAGCACGAGTTCCAATTTAATAGTATACAAGGAAACACCTGCTTTAAATACT
CTACATAGTACACGTTATAATAACGATTTATTTGATATTTCTGGATTTTTGTCTGCATGTATTTC
ATATAATATTGATTTGATTTTTTTAATGAATTGAACTAAAAAATCATATTAGAACATTTTTTGC
AGTCGCCGATAAAGATGAACACAGTTCTCAGAACACAACTGTCATGTATTAAGCTTTCAGATT
TTCAGAAATTTGGAGAGCAATGCATTCTATGCACGAGCCTCCTGGCCTTACAATTTACTTGTTT
GAAATTAGATCGTCAAATAAAGTCCCTAAAATTAAATAAATAGTAGTCACAACTTTAAAATAG
GTCTTAATCTTTTAGGGTACCGAAAGGTATTTCGGCACAAATCAGCGCAGTTTTAAATGTCGA
TGAAGGCCAAAAATCATACCAAACCCAGCGAAAGGTGATGTCTGACTCATTAAATTGGGGGA
TTCGAGTGTATTTATTAAACATGCGTGAAAATCAATCATGGAAGACAAAACGCAAAGTTGGCC
GATCTATGGGAACAGCATAAGCCACCTGATTACCCGAACACTGAACCACCCGAATCACTAAA
ACCACCGAAGTTGGCGCGCGCCTTCGTTTTCATTTTCATTGGCCTGTCTTCGTCTTCGGAGAAA
AAAACCTTCATATAAAACGCGGCCGACATATTATGGCCACCAGTCGTTACCGCGCCACGGTCC
ACAGAAGAGGATTAAAAAAATATCACACAGCCGAAGGCTAGAGAAGAACCCCCTATAGCTGA
ACATATATAAACAAATATATTTTTTTTTATTGCCAACACACTTTGGCTTAAGTGTTAAGAGTGA
TTGTCAGCTTAGAGCTAAGTGCAATGTTCCAGGACAAAGGGTGGATCCTTGTGACCCTGATCA
CCTTGGTGACGCCGTCTTGGGCTGCTTACAAACTTCAGGAGCGATATAGTTGGAGCCAGCTGG
ACTTTGCTTTCCCGAATACCCGACTAAAGGACCAAGCTCTGGCTAGTGGAGATTATATTCCGC
AAAATGCTCTACCTGTTGGAGTCGAACACTTTGGCAATCGGTTATTCGTCACTGTTCCCCGCTG
GCGTGATGGGATTCCGGCCACTCTGACCTATATAAACATGGACCGCAGTTTGACGGGTTCACC
GGAGCTAATTCCGTATCCAGATTGGCGCTCAAATACAGCTGGAGATTGCGCCAACAGTATTAC
CACTGCCTACCGCATTAAAGTGGATGAGTGTGGTCGGCTGTGGGTTTTGGACACTGGAACCGT
GGGCATCGGCAATACCACCACTAATCCGTGCCCCTATGCGGTAAATGTCTTTGACTTGACCAC
GGATACGCGAATTCGGAGATACGAGCTACCTGGCGTGGACACAAATCCAAATACTTTCATAG
CTAACATTGCCGTGGATATAGGCAAAAATTGCGATGATGCATATGCCTATTTTGCCGATGAAT
TGGGATACGGCTTGATTGCTTACTCCTGGGAACTGAACAAGTCCTGGAGATTCTCGGCACATT
CGTATTTTTTCCCCGATCCATTGAGGGGCGATTTCAATGTCGCTGGTATTAACTTCCAATGGGG
CGAGGAGGGTATATTTGGTATGTCCCTTTCGCCCATTCGATCGGATGGTTATCGTACCCTGTAC
TTTAGTCCGTTAGCAAGTCATCGACAATTTGCCGTATCCACGAGGATTTTGAGGGATGAAACC
AGGACGGAAGATAGCTATCATGACTTTGTTGCCTTAGATGAACGGGGTCCAAACTCCCATACC
ACTTCACGTGTGATGAGCGATGATGGAATTGAGCTGTTCAATTTAATAGATCAAAATGCAGTG
GGTTGCTGGCACTCATCAATGCCGTACTCACCGCAATTTCATGGCATTGTGGATCGCGATGAC
GTTGGCTTAGTTTTTCCGGCCGATGTGAAAATTGATGAGAACAAAAACGTTTGGGTTCTATCC
GATAGGATGCCCGTTTTCTTGCTGTCTGACTTGGATTATTCAGATACTAATTTCCGAATTTACA
CGGCTCCCTTGGCCACTTTAATTGAGAATACTGTGTGTGATTTGAGGAATAACGCCTATGGGC
CGCCAAATACCGTTTCAATACCAAAACAAGCCGTTTTGCCAATGGGTCCACCGTTATATACGA
AACAATATCGTCCTGTCTTGCCACAGAAACCTCAGACCAGCTGGGCTTCCTCGCCGCCTCCTC
CAAGTCGCACTTATTTGCCCGCCAATTCAGGCAATGTAGTCTCCAGTATTAGTGTCTCTACAAA
TTCTGTGGGTCCTGCAGGAGTGGAGGTGCCAAAGGCCTATATTTTCAACCAGCACAACGGCAT
AAATTACGAGACAAGTGGTCCCCATCTATTTCCCACCCATCAACCCGCCCAACCGGGTGGCCA
GGATGGTGGGTTAAAAACTTATGTGAATGCCCGCCAATCTGGGTGGTGGCATCATCAGCATCA
AGGTTAACATAATCCTACACACGGTACTTGGGTATATTCTCACACACTCGATTGATGTAAAGA
ATATTTAAAGACAACAACATAGGGCAACAGCGGTTAAAAAAACCACATGACGTATGAGCAAG
TGGCAAATCAATACTTTATCTAGTTATGTTAAGCAAAAAATAACAATAAATCAACTTTTTTTTG
AAGGTTAAGAGTTTACGCAATTTTCTTGAGCGGAAAAAGCGGAAAAAATGTAAGTATGCATA
AATTCTAAATATATCAACAACTGTACATTTTCTGGAGTACTACTACCAGGCAAGAAAGTAGGT
TGATAAAGCTATGCACAAGATCTTGTTTGGGTGCAGGGAAAGTTCAACTTAATCGCTCAATTT
GAGATCGCCTGGTCGCTTGAGATTCGACTGTAATTGAAATTTTTGCTTTTGATCGGAGCCAGA
CTTCAGACGGGGCAAACAAAAAGACTTTGTTGGTGGTAGGGTAGGATCCGTTGACCTGCAGG
TCGAGGACATAACTTCGTATAGGATACTTTATACGAAGTTATGATCGACGGAGTCTACCCACT
TAAATGAAATTTCTATCTAAATACAATTTACGTTAGTTCGGAGAGCGCAAATGAATTTACTTC
GATCCCAGAGGACTATCTAATAACTATCCAATCCGTTGAACTTCGCGTGAACAAACCTAAACT
AAACTAAACAAAGAGCAGAGCTGAGAACTCTACCTACAACTTAGTTAATTGTTATTATTTTCT
ACTTATTATTTAATTGTACACGAAAGGCAAGTGGGGAAAGCGAAATAAGATTAACGTAAAGA
TAGCGATTACGATAAAGATACAAGTAAAGCGTAAAACTCAAACAAAACCAACTCATGTGACC
TCAGATCTAAATAAGCTATATTTAACTATAATGCATATATATATACACATAAATATATGGATA
ACTATAAATGATACCAAGTAAAGCTAAAGGCAAGGAGTTATATATAAATAAATATATATGAA
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GCATATATAATGTAACATTAGATCTACGCGTCATAAGTACTATACGATTAACTTATATATACA
CCCCAGCATAAACCCTAAAACTAAACCTAAACATTAAACTAAATCAATGTTTGTAGCAATCCT
AGCGCAAAAATATAAAATAAAATCCAATAAATAAAAATAAAAAACAAATGGCGTCAAAATCC
ATTGCATGTTGGTTCATAAAACCTATACATTTTTCATAACTCTGAACATGATAACAGAAAACTT
TGACCTAAGTGAATGTCGCACTTTTAGACAAAGAAATACCAAAACTACGAAAGAAGCGTTGC
TTAAAGTGAAATTAACGTTTTACACATACAATAAGAGTAAAACCTATAAACTGGCAGATGCTT
AACTATAAATAGAAAGAACTCGCAAGAGATTGGCCAACTTAAAAAAAAATAGATGTATATTT
CTACGACAATTCAACTTTCAAAAACTCGCAAGTGGATATTTATGCTTAACCAATTTGAGAGTT
CCCCTTTTCTTTGGCTTCAATACCCATTATATCTGTATTTTTATTTGTTTGTAATTTCTTGTGCAA
TTTTTAGTTCTTGCAAAAAAACAAAATTCGAATTAGGTCGAAAAGGATATAAAGTATACCGAA
TTACAAAAAAATATGAATTGGCAAGTAAGGAGGAAAAATAAAAATTGTTAACAGAGAATCAT
ATGTATAAATAATGAATTCTAACAAAACCCGTGTAAAGTAGTAAATTGAAATGCATTATTATA
CGAGAATGTAGGGAATCCATTTTGAAAGAGCAACCGAACGATTTAAATATGAATATTTCCCTA
ACAACTATATTAATGTATGTGTACGTAACTTAAAATCATTTTCCACGCCATCTGTGGAAATCCA
TATACCAAAGTCAAAGGAACGAAGGAGAAAGAAAAAGGAGGACGGAATGGCAAACTATAAA
GTATCATATGTTTATATGTAGATATATATATTTAAACAAGCCTAATACAAAACATGTAACTTTA
TAGAGCGTTTCGTTTGTAAATTCCCCAGAAATCCCATTTACCTCCCCAGCCCGAATCCCAATCC
CAGGTGAAAAGACTTGTGATTTGCAATAGAACCGAATAGTCAAGAAAAAAAATCTTTACGAA
GTATTGGCTAAGCAACATTGAGAGCAAAATTCAACTCAATCCAGATACGTAACTTTCGGCCTC
ATTCTGTAAGAAACTAATTATTTAAGTTTCAATTATGAAAATTATTAAAAAAAAAACGAACAA
AAAAAAAAACGTAAATATAAAAAAGTAGAAATTCACAAGAAACAAAATTCGAAAGCGTTGA
TTAAAATATATATATATGTGAAACAAAAACAAAAAACCTTAAACAAACCCAAACATTTGTGC
GAAATTGGAACGAAATGTGGAAGCTAAATAAT

A.d.4 Antp::tag
5’ and 3’ homology arms
17 aa tag
3X FLAG
lox2272 site
y+ marker
Target sequence for chiRNA + PAM
CTCTTCGGCCTCCTACCCCTCATCTCAGACCTGTTGTAGGCCCTGTTTTTTCTCTTTTTTTTTGA
CAAGTACAAATATCCGAATTCGGTAAGGTTGTCTTTTAATCAGCCTCAGTTTCAGAGACGCAG
CGCCCCGCTTCATGTGGTTTTGAGTTACCCATTCCCTGATCCCTCGTCCGATTCTCCGGGAGAA
AAAGAACAAAAAAAAAAAAAACAAAATACAAGACAACAAGAAATAAATAAGTATATATACA
TTTACTCCAGCTCTGGTTGTTGTATGCACTTTAGTGGACCTGTAGATATAGTAGAATTTGTTGT
CGTTGATTTGGTGGCCGGTCATGCATTGCATTGATTTTAATTGTGAAAATCGTTATTTACTTGG
AACCAACAGAACGCAAACGCGGAAGGCAGACATACACCCGGTACCAGACTCTAGAGCTAGA
GAAGGAGTTTCACTTCAATCGCTACTTGACCCGTCGGCGAAGGATCGAGATCGCCCACGCCCT
GTGCCTCACGGAGCGCCAGATAAAGATTTGGTTCCAGAATCGGCGCATGAAGTGGAAGAAGG
AGAACAAGACGAAGGGCGAGCCGGGATCCGGAGGCGAAGGCGACGAGATAACACCACCCAA
CAGTCCGCAGATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCG
ACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGACTACAAGGATGACGATGAC
AAGTAACATGATAACTTCGTATAGGATACTTTATACGAAGTTATGTCGACTATTAAATGATTA
TCGCCCGATTACCACATTGAGTGGTTTAAAATAGCCATAAAATATGCAACTGACGATGGCTTA
AGATAAATACGTCGCAGAGTCACTCATAAATTTCGAACGCAGCCCGCTGATTTACCTACCCCT
CTAAACGATTCATAGTATATGTACGAGTATATCCACTAAGCTTTTTCGAGCACTGATTTTTTCG
CTTGCACGAGACAAGTGCACCACCGCAATTGCAGGCAAATTATGTCTGAGGTAATGATTCCGT
TTCGTGCAAGATTACACAGAAATCAAATTACGACAACCTTTATTCAGTAAGCAAACAAAGCCT
TTGTTGGCATCTAATTATTCCACTTATGGTTGCGATTTCGGGAGCTACAATCGGTTTTGGTTTA
GTATATCTAGCGAGTTCCTTGGCGACATTTAAAATTTACAAATAAAGTTTCTCTATTCAATCGG
GACAGTGGAAATTGACTATTTTATTTATATTAATGAACTTATTTTTAATTTGGCTTAAGTTACT
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AAGGGGTACTAATAGTTTGAGCGCAGTGCATGTCATGGGGACATGTGCAATTGTGTGTAAGCG
GGAAGTGATCGCGGCCTTCCGAATTTGGCCATGCCAAATAATCCCAGCTCGAAAGGAGGGGA
CCCGGCGGTCAGGGCCATGGACATTGAACTTGAAAAAAAAAAAACACAAAAATATATAACAC
AAAACGGAAAATGCTGTGTACCGCTTATGTTAGAGAAGTTGAGCAACGGGTTTTTCGTTTTGC
AGTCACGATGGATTTCCAAATTAGTGTAGGAGGGGGGAGGGGAGGGAGGGAGATAATGTCCA
GGCTGCCATAAGTGGGGAATAAGGAAAATAAAACATGAAACACGGGTCGGGCAATGTCATGC
GGTATTCGGCTTTGCTTTCCGCCCAAGTTGAAGTGATCCTGTGTGTAAATAATGTCGAATGTTG
CCGGTCGGTTGCATAAGCGTTGGTCAATTATGGCCAAAGAGATCTGATTTGTGGAAGCTTTTT
TTGACCACTTAGCGCGCTCCGCTGATGTTGTTTTGTTTTGTGCTGGGGCAGAAAACTTGTTTCA
ATTATTGGGAAAAGTGCGTATAAATCATTGCCGCAAGCTCTGAAAAGCGAAAAAGAAAAACA
GTAACCAAACAGACAAACGCAGCATTCCCCCACACAATTAAGCAAAAACTTGAAACAAGTCA
ATTCGAAAAAAATTATAGGTTCAACGGCTGCAGCGATCGCATCATTAGTTGCGTTTTTAGTAA
ATACACCATTTCATTACACAACACACACAATTAATTAATAAAACTGTACTGGTTATTTCAAGT
GTGTCTTTTAATAAGCCTGCCGATCGCAATAAATTCGAGCAGCATTGCCGGTAATTTTGTGCA
ACATATTTTTCGATTGCCACACCGTGTTTGTTTATTTTTTCTGTGGGTGCAATGATTTAGAATGC
GGGCAAGGGATCAAGTTGAACCACTTCTAAGAAAAAATAGACATTGCATAAATGATATAGAG
TCCAAAAACTACACCAATTCAATAGCAGTAATGGTTACATTAGCTTTGAAATTGTTTTTAGAC
ATCCGAAGAAATAAGATTAAATTTAAACGGCATTCTTTAATTTGTATTTTAATATTTTGAGAGG
TTTTCCTTATTTAAAGTGTAGATTATTGAGGATTAATGCAATACCACTTTACCTGCGGAGGTCG
TAAAACGTATTTTTACCCATTTGCATGTTTATTATGCGTGTCGCTGGTTGTTTACTTTACTTAAG
TTTTGCAATTTTTTCTTTAGCAAGCAGGTGCATTTGGGCCAAGAGATATATGCGATCGCTTTCG
GTTCGAATTTTTAACATTTACTTGCGGCGATGGTCATTAGAGCATTACCCACTTAGGGCACCCC
CAACATCCAGTTGATTTTCAGGGACCACAATATTTTAAATAACAGCTAGTGGAATTACCTAAA
AGCGCTTTCGTTCCTTTTTGAAATTTTATGTAACACTCAATTATATTTATGTATATGTATGCTCA
AAATCACCTGCCAATAACTAGCGGAAACCAAATATTTGACCCTCAGTGAATTGTGAATCATCG
GTGACGCCCAATCGAAATCCAATCCTAAGCAATTGAAACGAGCACGAGTTCCAATTTAATAGT
ATACAAGGAAACACCTGCTTTAAATACTCTACATAGTACACGTTATAATAACGATTTATTTGA
TATTTCTGGATTTTTGTCTGCATGTATTTCATATAATATTGATTTGATTTTTTTAATGAATTGAA
CTAAAAAATCATATTAGAACATTTTTTGCAGTCGCCGATAAAGATGAACACAGTTCTCAGAAC
ACAACTGTCATGTATTAAGCTTTCAGATTTTCAGAAATTTGGAGAGCAATGCATTCTATGCAC
GAGCCTCCTGGCCTTACAATTTACTTGTTTGAAATTAGATCGTCAAATAAAGTCCCTAAAATTA
AATAAATAGTAGTCACAACTTTAAAATAGGTCTTAATCTTTTAGGGTACCGAAAGGTATTTCG
GCACAAATCAGCGCAGTTTTAAATGTCGATGAAGGCCAAAAATCATACCAAACCCAGCGAAA
GGTGATGTCTGACTCATTAAATTGGGGGATTCGAGTGTATTTATTAAACATGCGTGAAAATCA
ATCATGGAAGACAAAACGCAAAGTTGGCCGATCTATGGGAACAGCATAAGCCACCTGATTAC
CCGAACACTGAACCACCCGAATCACTAAAACCACCGAAGTTGGCGCGCGCCTTCGTTTTCATT
TTCATTGGCCTGTCTTCGTCTTCGGAGAAAAAAACCTTCATATAAAACGCGGCCGACATATTA
TGGCCACCAGTCGTTACCGCGCCACGGTCCACAGAAGAGGATTAAAAAAATATCACACAGCC
GAAGGCTAGAGAAGAACCCCCTATAGCTGAACATATATAAACAAATATATTTTTTTTTATTGC
CAACACACTTTGGCTTAAGTGTTAAGAGTGATTGTCAGCTTAGAGCTAAGTGCAATGTTCCAG
GACAAAGGGTGGATCCTTGTGACCCTGATCACCTTGGTGACGCCGTCTTGGGCTGCTTACAAA
CTTCAGGAGCGATATAGTTGGAGCCAGCTGGACTTTGCTTTCCCGAATACCCGACTAAAGGAC
CAAGCTCTGGCTAGTGGAGATTATATTCCGCAAAATGCTCTACCTGTTGGAGTCGAACACTTT
GGCAATCGGTTATTCGTCACTGTTCCCCGCTGGCGTGATGGGATTCCGGCCACTCTGACCTATA
TAAACATGGACCGCAGTTTGACGGGTTCACCGGAGCTAATTCCGTATCCAGATTGGCGCTCAA
ATACAGCTGGAGATTGCGCCAACAGTATTACCACTGCCTACCGCATTAAAGTGGATGAGTGTG
GTCGGCTGTGGGTTTTGGACACTGGAACCGTGGGCATCGGCAATACCACCACTAATCCGTGCC
CCTATGCGGTAAATGTCTTTGACTTGACCACGGATACGCGAATTCGGAGATACGAGCTACCTG
GCGTGGACACAAATCCAAATACTTTCATAGCTAACATTGCCGTGGATATAGGCAAAAATTGCG
ATGATGCATATGCCTATTTTGCCGATGAATTGGGATACGGCTTGATTGCTTACTCCTGGGAACT
GAACAAGTCCTGGAGATTCTCGGCACATTCGTATTTTTTCCCCGATCCATTGAGGGGCGATTTC
AATGTCGCTGGTATTAACTTCCAATGGGGCGAGGAGGGTATATTTGGTATGTCCCTTTCGCCC
ATTCGATCGGATGGTTATCGTACCCTGTACTTTAGTCCGTTAGCAAGTCATCGACAATTTGCCG
TATCCACGAGGATTTTGAGGGATGAAACCAGGACGGAAGATAGCTATCATGACTTTGTTGCCT
TAGATGAACGGGGTCCAAACTCCCATACCACTTCACGTGTGATGAGCGATGATGGAATTGAGC
TGTTCAATTTAATAGATCAAAATGCAGTGGGTTGCTGGCACTCATCAATGCCGTACTCACCGC
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AATTTCATGGCATTGTGGATCGCGATGACGTTGGCTTAGTTTTTCCGGCCGATGTGAAAATTG
ATGAGAACAAAAACGTTTGGGTTCTATCCGATAGGATGCCCGTTTTCTTGCTGTCTGACTTGG
ATTATTCAGATACTAATTTCCGAATTTACACGGCTCCCTTGGCCACTTTAATTGAGAATACTGT
GTGTGATTTGAGGAATAACGCCTATGGGCCGCCAAATACCGTTTCAATACCAAAACAAGCCGT
TTTGCCAATGGGTCCACCGTTATATACGAAACAATATCGTCCTGTCTTGCCACAGAAACCTCA
GACCAGCTGGGCTTCCTCGCCGCCTCCTCCAAGTCGCACTTATTTGCCCGCCAATTCAGGCAAT
GTAGTCTCCAGTATTAGTGTCTCTACAAATTCTGTGGGTCCTGCAGGAGTGGAGGTGCCAAAG
GCCTATATTTTCAACCAGCACAACGGCATAAATTACGAGACAAGTGGTCCCCATCTATTTCCC
ACCCATCAACCCGCCCAACCGGGTGGCCAGGATGGTGGGTTAAAAACTTATGTGAATGCCCG
CCAATCTGGGTGGTGGCATCATCAGCATCAAGGTTAACATAATCCTACACACGGTACTTGGGT
ATATTCTCACACACTCGATTGATGTAAAGAATATTTAAAGACAACAACATAGGGCAACAGCG
GTTAAAAAAACCACATGACGTATGAGCAAGTGGCAAATCAATACTTTATCTAGTTATGTTAAG
CAAAAAATAACAATAAATCAACTTTTTTTTGAAGGTTAAGAGTTTACGCAATTTTCTTGAGCG
GAAAAAGCGGAAAAAATGTAAGTATGCATAAATTCTAAATATATCAACAACTGTACATTTTCT
GGAGTACTACTACCAGGCAAGAAAGTAGGTTGATAAAGCTATGCACAAGATCTTGTTTGGGT
GCAGGGAAAGTTCAACTTAATCGCTCAATTTGAGATCGCCTGGTCGCTTGAGATTCGACTGTA
ATTGAAATTTTTGCTTTTGATCGGAGCCAGACTTCAGACGGGGCAAACAAAAAGACTTTGTTG
GTGGTAGGGTAGGATCCGTTGACCTGCAGGTCGAGGACATAACTTCGTATAGGATACTTTATA
CGAAGTTATGATCGACGGAGTCTACCCACTTAAATGAAATTTCTATCTAAATACAATTTACGT
TAGTTCGGAGAGCGCAAATGAATTTACTTCGATCCCAGAGGACTATCTAATAACTATCCAATC
CGTTGAACTTCGCGTGAACAAACCTAAACTAAACTAAACAAAGAGCAGAGCTGAGAACTCTA
CCTACAACTTAGTTAATTGTTATTATTTTCTACTTATTATTTAATTGTACACGAAAGGCAAGTG
GGGAAAGCGAAATAAGATTAACGTAAAGATAGCGATTACGATAAAGATACAAGTAAAGCGT
AAAACTCAAACAAAACCAACTCATGTGACCTCAGATCTAAATAAGCTATATTTAACTATAATG
CATATATATATACACATAAATATATGGATAACTATAAATGATACCAAGTAAAGCTAAAGGCA
AGGAGTTATATATAAATAAATATATATGAAGCATATATAATGTAACATTAGATCTACGCGTCA
TAAGTACTATACGATTAACTTATATATACACCCCAGCATAAACCCTAAAACTAAACCTAAACA
TTAAACTAAATCAATGTTTGTAGCAATCCTAGCGCAAAAATATAAAATAAAATCCAATAAATA
AAAATAAAAAACAAATGGCGTCAAAATCCATTGCATGTTGGTTCATAAAACCTATACATTTTT
CATAACTCTGAACATGATAACAGAAAACTTTGACCTAAGTGAATGTCGCACTTTTAGACAAAG
AAATACCAAAACTACGAAAGAAGCGTTGCTTAAAGTGAAATTAACGTTTTACACATACAATA
AGAGTAAAACCTATAAACTGGCAGATGCTTAACTATAAATAGAAAGAACTCGCAAGAGATTG
GCCAACTTAAAAAAAAATAGATGTATATTTCTACGACAATTCAACTTTCAAAAACTCGCAAGT
GGATATTTATGCTTAACCAATTTGAGAGTTCCCCTTTTCTTTGGCTTCAATACCCATTATATCTG
TATTTTTATTTGTTTGTAATTTCTTGTGCAATTTTTAGTTCTTGCAAAAAAACAAAATTCGAATT
AGGTCGAAAAGGATATAAAGTATACCGAATTACAAAAAAATATGAATTGGCAAGTAAGGAGG
AAAAATAAAAATTGTTAACAGAGAATCATATGTATAAATAATGAATTCTAACAAAACCCGTG
TAAAGTAGTAAATTGAAATGCATTATTATACGAGAATGTAGGGAATCCATTTTGAAAGAGCA
ACCGAACGATTTAAATATGAATATTTCCCTAACAACTATATTAATGTATGTGTACGTAACTTA
AAATCATTTTCCACGCCATCTGTGGAAATCCATATACCAAAGTCAAAGGAACGAAGGAGAAA
GAAAAAGGAGGACGGAATGGCAAACTATAAAGTATCATATGTTTATATGTAGATATATATATT
TAAACAAGCCTAATACAAAACATGTAACTTTATAGAGCGTTTCGTTTGTAAATTCCCCAGAAA
TCCCATTTACCTCCCCAGCCCGAATCCCAATCCCAGGTGAAAAGACTTGTGATTTGCAATAGA
ACCGAATAGTCAAGAAAAAAAATCTTTACGAAGTATTGGCTAAGCAACATTGAGAGCAAAAT
TCAACTCAATCCAGATACGTAACTTTCGGCCTCATTCTGTAAGAAACTAATTATTTAAGTTTCA
ATTATGAAAATTATTAAAAAAAAAACGAACAAAAAAAAAAACGTAAATATAAAAAAGTAGA
AATTCACAAGAAACAAAATTCGAAAGCGTTGATTAAAATATATATATATGTGAAACAAAAAC
AAAAAACCTTAAACAAACCCAAACATTTGTGCGAAATTGGAACGAAATGTGGAAGCTAAATA
ATTTGTTGTAAATAAAATTTAAACTTTAGTGTAAAGAAGAGAACGGAGAATGCAGTGAAAGG
GCTGCAAAGCGGAAAGC

A.d.5 Ubx::YFP
5’ and 3’ homology arms

95
YFP
loxP site
y+ marker
Target sequence for chiRNA + PAM
CTCCAAAATGCCAAGTTAACATGGTCGAATGGGTGGGTTGGTTGGTTGATATGGTGTGGTATG
ATTTGGTATGGGTTGATTTCGATAATATCAGACATTGTCTGGGCCTCTTCTTCGATGGGAGATG
GGCCAGAGACAGCTGCAGTGCATTTGCACACACACGAAATTGAGTTATTGCACTTGAAGGCA
AATTAAACTTCATAAATATTTAAAATCAGAGATTAAACACGGCATTGTTGCAACATGTTGATG
CGACTTCTGGCTGCCCCGGCTCCCCTGGCTTCCCCCGGATTCCCCTGGATTCCCCTGCTCCTCC
TGCCCCATCTCGTCTCTCAGGTTGCCAATTAAACGGGCATTATCTGGCATAACTGCAATTTAAG
TAGCCACATTCGCCATATCCCCAGTGCAATGCCACAACCGAGTGCTCGCACGTTTCTCCTTTTC
ATTTTAATGTGGCTGCATCTGCGGATCTGTGTATCTTTGTATCTGAGGAACTGTGGAACTGCGA
ATCTGGATGCAATGACAGCACGGCAGCAACATTGGCGGTGCAGCGGCAAACGATCAATTTAA
AGTAACGATCGCGCCGCAGAAACAAAAACCGCAACTGCAAACTGGCAAACTGGCAAATACTC
GGCGATACTCGTAAAGATGAAATGTATTTTTTGCGCTGAGATCCCCTTTCCTTTCGATTTGGGC
CCCTTTGCAGGCAATTGCGGCCTACGTTCGAGCTGCTTGATGATCGCTGGCAAAAAGGAGAAT
TTATATTTACGACTTGGCCAAATAACAACGGCGAACAGCAAACAAATGTTGAGTTGCTCGTTG
CAATTTTTCAATTTAATTTGCCCGATGAAAGGCCAAAATATAAATACCCGAAAACACTCTGTC
ACTGCTGCTCAATATGACTCAAATTTTGATGTCCTCATGTTCTCCTAAACGTTAATATAACCAA
TTAAATCACTTTTGTGGCGATTTATATAAATAATTAGGCCAATAAATCGATAAAGATATATAT
CTACTTAGTCACTTTGTCAATGTTTTCCTAACACATATCTGCATTTTGTAGCTGCTGTTATGAG
ACACATATTTTTGATTGCAAAATGAAATGTATGTATTTCGTCGATGCAGGTCCAAAATGAATA
ATATTAAAAGTTTAATAATCTGGTTACTTACAAATGCTTTCCCATTCCGATCTACAGGTACAAA
TGGTCTGCGAAGACGCGGCCGACAGACATACACCCGCTACCAGACGCTCGAGCTGGAGAAGG
AGTTCCACACGAATCATTATCTGACCCGCAGACGGAGAATCGAGATGGCGCACGCGCTATGC
CTGACGGAGCGGCAGATCAAGATCTGGTTCCAGAACCGGCGAATGAAGCTGAAGAAGGAGAT
CCAGGCGATCAAGGAGCTGAACGAACAGGAGAAGCAGGCGCAGGCCCAGAAGGCGGCGGCG
GCAGCGGCTGCGGCGGCGGCGGTCCAAGGTGGACACTTAGATCAGGTGAGCAAGGGCGAGG
AGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAG
TTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCAT
CTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCTTCGGCTACGGCCT
GCAGTGCTTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCC
CGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCG
CCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTC
AAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTA
TATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCG
AGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCC
GTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTCCGCCCTGAGCAAAGACCCCAACGA
GAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGA
CGAGCTGTACAAGTAACATGATAACTTCGTATAGCATACATTATACGAAGTTATGTCGACTAT
TAAATGATTATCGCCCGATTACCACATTGAGTGGTTTAAAATAGCCATAAAATATGCAACTGA
CGATGGCTTAAGATAAATACGTCGCAGAGTCACTCATAAATTTCGAACGCAGCCCGCTGATTT
ACCTACCCCTCTAAACGATTCATAGTATATGTACGAGTATATCCACTAAGCTTTTTCGAGCACT
GATTTTTTCGCTTGCACGAGACAAGTGCACCACCGCAATTGCAGGCAAATTATGTCTGAGGTA
ATGATTCCGTTTCGTGCAAGATTACACAGAAATCAAATTACGACAACCTTTATTCAGTAAGCA
AACAAAGCCTTTGTTGGCATCTAATTATTCCACTTATGGTTGCGATTTCGGGAGCTACAATCGG
TTTTGGTTTAGTATATCTAGCGAGTTCCTTGGCGACATTTAAAATTTACAAATAAAGTTTCTCT
ATTCAATCGGGACAGTGGAAATTGACTATTTTATTTATATTAATGAACTTATTTTTAATTTGGC
TTAAGTTACTAAGGGGTACTAATAGTTTGAGCGCAGTGCATGTCATGGGGACATGTGCAATTG
TGTGTAAGCGGGAAGTGATCGCGGCCTTCCGAATTTGGCCATGCCAAATAATCCCAGCTCGAA
AGGAGGGGACCCGGCGGTCAGGGCCATGGACATTGAACTTGAAAAAAAAAAAACACAAAAA
TATATAACACAAAACGGAAAATGCTGTGTACCGCTTATGTTAGAGAAGTTGAGCAACGGGTTT
TTCGTTTTGCAGTCACGATGGATTTCCAAATTAGTGTAGGAGGGGGGAGGGGAGGGAGGGAG
ATAATGTCCAGGCTGCCATAAGTGGGGAATAAGGAAAATAAAACATGAAACACGGGTCGGGC
AATGTCATGCGGTATTCGGCTTTGCTTTCCGCCCAAGTTGAAGTGATCCTGTGTGTAAATAATG
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TCGAATGTTGCCGGTCGGTTGCATAAGCGTTGGTCAATTATGGCCAAAGAGATCTGATTTGTG
GAAGCTTTTTTTGACCACTTAGCGCGCTCCGCTGATGTTGTTTTGTTTTGTGCTGGGGCAGAAA
ACTTGTTTCAATTATTGGGAAAAGTGCGTATAAATCATTGCCGCAAGCTCTGAAAAGCGAAAA
AGAAAAACAGTAACCAAACAGACAAACGCAGCATTCCCCCACACAATTAAGCAAAAACTTGA
AACAAGTCAATTCGAAAAAAATTATAGGTTCAACGGCTGCAGCGATCGCATCATTAGTTGCGT
TTTTAGTAAATACACCATTTCATTACACAACACACACAATTAATTAATAAAACTGTACTGGTT
ATTTCAAGTGTGTCTTTTAATAAGCCTGCCGATCGCAATAAATTCGAGCAGCATTGCCGGTAA
TTTTGTGCAACATATTTTTCGATTGCCACACCGTGTTTGTTTATTTTTTCTGTGGGTGCAATGAT
TTAGAATGCGGGCAAGGGATCAAGTTGAACCACTTCTAAGAAAAAATAGACATTGCATAAAT
GATATAGAGTCCAAAAACTACACCAATTCAATAGCAGTAATGGTTACATTAGCTTTGAAATTG
TTTTTAGACATCCGAAGAAATAAGATTAAATTTAAACGGCATTCTTTAATTTGTATTTTAATAT
TTTGAGAGGTTTTCCTTATTTAAAGTGTAGATTATTGAGGATTAATGCAATACCACTTTACCTG
CGGAGGTCGTAAAACGTATTTTTACCCATTTGCATGTTTATTATGCGTGTCGCTGGTTGTTTAC
TTTACTTAAGTTTTGCAATTTTTTCTTTAGCAAGCAGGTGCATTTGGGCCAAGAGATATATGCG
ATCGCTTTCGGTTCGAATTTTTAACATTTACTTGCGGCGATGGTCATTAGAGCATTACCCACTT
AGGGCACCCCCAACATCCAGTTGATTTTCAGGGACCACAATATTTTAAATAACAGCTAGTGGA
ATTACCTAAAAGCGCTTTCGTTCCTTTTTGAAATTTTATGTAACACTCAATTATATTTATGTATA
TGTATGCTCAAAATCACCTGCCAATAACTAGCGGAAACCAAATATTTGACCCTCAGTGAATTG
TGAATCATCGGTGACGCCCAATCGAAATCCAATCCTAAGCAATTGAAACGAGCACGAGTTCC
AATTTAATAGTATACAAGGAAACACCTGCTTTAAATACTCTACATAGTACACGTTATAATAAC
GATTTATTTGATATTTCTGGATTTTTGTCTGCATGTATTTCATATAATATTGATTTGATTTTTTT
AATGAATTGAACTAAAAAATCATATTAGAACATTTTTTGCAGTCGCCGATAAAGATGAACACA
GTTCTCAGAACACAACTGTCATGTATTAAGCTTTCAGATTTTCAGAAATTTGGAGAGCAATGC
ATTCTATGCACGAGCCTCCTGGCCTTACAATTTACTTGTTTGAAATTAGATCGTCAAATAAAGT
CCCTAAAATTAAATAAATAGTAGTCACAACTTTAAAATAGGTCTTAATCTTTTAGGGTACCGA
AAGGTATTTCGGCACAAATCAGCGCAGTTTTAAATGTCGATGAAGGCCAAAAATCATACCAA
ACCCAGCGAAAGGTGATGTCTGACTCATTAAATTGGGGGATTCGAGTGTATTTATTAAACATG
CGTGAAAATCAATCATGGAAGACAAAACGCAAAGTTGGCCGATCTATGGGAACAGCATAAGC
CACCTGATTACCCGAACACTGAACCACCCGAATCACTAAAACCACCGAAGTTGGCGCGCGCCT
TCGTTTTCATTTTCATTGGCCTGTCTTCGTCTTCGGAGAAAAAAACCTTCATATAAAACGCGGC
CGACATATTATGGCCACCAGTCGTTACCGCGCCACGGTCCACAGAAGAGGATTAAAAAAATA
TCACACAGCCGAAGGCTAGAGAAGAACCCCCTATAGCTGAACATATATAAACAAATATATTTT
TTTTTATTGCCAACACACTTTGGCTTAAGTGTTAAGAGTGATTGTCAGCTTAGAGCTAAGTGCA
ATGTTCCAGGACAAAGGGTGGATCCTTGTGACCCTGATCACCTTGGTGACGCCGTCTTGGGCT
GCTTACAAACTTCAGGAGCGATATAGTTGGAGCCAGCTGGACTTTGCTTTCCCGAATACCCGA
CTAAAGGACCAAGCTCTGGCTAGTGGAGATTATATTCCGCAAAATGCTCTACCTGTTGGAGTC
GAACACTTTGGCAATCGGTTATTCGTCACTGTTCCCCGCTGGCGTGATGGGATTCCGGCCACTC
TGACCTATATAAACATGGACCGCAGTTTGACGGGTTCACCGGAGCTAATTCCGTATCCAGATT
GGCGCTCAAATACAGCTGGAGATTGCGCCAACAGTATTACCACTGCCTACCGCATTAAAGTGG
ATGAGTGTGGTCGGCTGTGGGTTTTGGACACTGGAACCGTGGGCATCGGCAATACCACCACTA
ATCCGTGCCCCTATGCGGTAAATGTCTTTGACTTGACCACGGATACGCGAATTCGGAGATACG
AGCTACCTGGCGTGGACACAAATCCAAATACTTTCATAGCTAACATTGCCGTGGATATAGGCA
AAAATTGCGATGATGCATATGCCTATTTTGCCGATGAATTGGGATACGGCTTGATTGCTTACTC
CTGGGAACTGAACAAGTCCTGGAGATTCTCGGCACATTCGTATTTTTTCCCCGATCCATTGAG
GGGCGATTTCAATGTCGCTGGTATTAACTTCCAATGGGGCGAGGAGGGTATATTTGGTATGTC
CCTTTCGCCCATTCGATCGGATGGTTATCGTACCCTGTACTTTAGTCCGTTAGCAAGTCATCGA
CAATTTGCCGTATCCACGAGGATTTTGAGGGATGAAACCAGGACGGAAGATAGCTATCATGA
CTTTGTTGCCTTAGATGAACGGGGTCCAAACTCCCATACCACTTCACGTGTGATGAGCGATGA
TGGAATTGAGCTGTTCAATTTAATAGATCAAAATGCAGTGGGTTGCTGGCACTCATCAATGCC
GTACTCACCGCAATTTCATGGCATTGTGGATCGCGATGACGTTGGCTTAGTTTTTCCGGCCGAT
GTGAAAATTGATGAGAACAAAAACGTTTGGGTTCTATCCGATAGGATGCCCGTTTTCTTGCTG
TCTGACTTGGATTATTCAGATACTAATTTCCGAATTTACACGGCTCCCTTGGCCACTTTAATTG
AGAATACTGTGTGTGATTTGAGGAATAACGCCTATGGGCCGCCAAATACCGTTTCAATACCAA
AACAAGCCGTTTTGCCAATGGGTCCACCGTTATATACGAAACAATATCGTCCTGTCTTGCCAC
AGAAACCTCAGACCAGCTGGGCTTCCTCGCCGCCTCCTCCAAGTCGCACTTATTTGCCCGCCA
ATTCAGGCAATGTAGTCTCCAGTATTAGTGTCTCTACAAATTCTGTGGGTCCTGCAGGAGTGG
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AGGTGCCAAAGGCCTATATTTTCAACCAGCACAACGGCATAAATTACGAGACAAGTGGTCCC
CATCTATTTCCCACCCATCAACCCGCCCAACCGGGTGGCCAGGATGGTGGGTTAAAAACTTAT
GTGAATGCCCGCCAATCTGGGTGGTGGCATCATCAGCATCAAGGTTAACATAATCCTACACAC
GGTACTTGGGTATATTCTCACACACTCGATTGATGTAAAGAATATTTAAAGACAACAACATAG
GGCAACAGCGGTTAAAAAAACCACATGACGTATGAGCAAGTGGCAAATCAATACTTTATCTA
GTTATGTTAAGCAAAAAATAACAATAAATCAACTTTTTTTTGAAGGTTAAGAGTTTACGCAAT
TTTCTTGAGCGGAAAAAGCGGAAAAAATGTAAGTATGCATAAATTCTAAATATATCAACAACT
GTACATTTTCTGGAGTACTACTACCAGGCAAGAAAGTAGGTTGATAAAGCTATGCACAAGATC
TTGTTTGGGTGCAGGGAAAGTTCAACTTAATCGCTCAATTTGAGATCGCCTGGTCGCTTGAGA
TTCGACTGTAATTGAAATTTTTGCTTTTGATCGGAGCCAGACTTCAGACGGGGCAAACAAAAA
GACTTTGTTGGTGGTAGGGTAGGATCCGTTGACCTGCAGGTCGAGGACATAACTTCGTATAGC
ATACATTATACGAAGTTATATCCTTAGATCCTTAGATCCTTAGATCCGTAGGGTGTATGTGGG
ATTGGGCGAAATGACGCGGAGACAGATACAAAGCAACTATATTGTAACAAATGAACTATTTA
CTTAAATGAATAATATTTAAATATTTTGATGGTACTTGTGCGAATACGAAACTTAACCTAAAT
CGAACCTAATGGAATTATTTCAAGCGTTTGAGCAGCAACCGAAAATACGTAAATGAAACAAA
ACTACAAACTAATTAACTAGGCTAAGTAAATAAAAGTAGTGGAAGGAGCGCAGATTATAAAC
CTACTTAGAATTAAATGAGCAAAACAAACAATTTTAATTTAGTTCCAAACGAAAAAAAAATTC
AAGAGGATTCGCTCGAAATGGAAACCTCTGTCCTGCCCCTTTGTTGCTTACTGCTATGTTTAAA
TTAATTTCGCGAAAAATACTCAAAAATTGAAACACAAAGAAAACAAAAAATGAAAGTATACC
ATTATAATGTTGAATGCGAGCAAAATTCTGTTGATATGAATTTTTGGTAAAAACATGTTCTAA
ACCAATTTAAGATACGTAACGAAGGATGCAAAAACAAAATGAAAACTATTAAACTTTAACTT
AAATATAAATAGAATTTGTTAGCCAAGTAAACATATTACGACACGAAGAACAAACGTTTTCG
GGAGTATCGAATATTTGAATGTGTATAGTTTGTGCTTATTAAATAAAATAATGCAATTTTAGTT
AACTCTGTTTATTTGTAAACGAATTTGTTTAGTTCTCGCCCAAACGACTAGAGTGAAGCTGTTT
CTTTAAGTAATGTGTAGTGTGTTTACTTTTTAAATTAAATTAATGCCTAATTTTATTATTATTAT
GTTTAGTTTAATGACAAGCGTTTATGAGATTATCCGACAGAAGCGGCGAGAAGAGGAGTGCG
ACAAACCGTTTG

A.d.6 Ubx::tag
5’ and 3’ homology arms
17 aa tag
3X FLAG
loxP site
y+ marker
Target sequence for chiRNA + PAM
CTCCAAAATGCCAAGTTAACATGGTCGAATGGGTGGGTTGGTTGGTTGATATGGTGTGGTATGATTTGGT
ATGGGTTGATTTCGATAATATCAGACATTGTCTGGGCCTCTTCTTCGATGGGAGATGGGCCAGAGACAGC
TGCAGTGCATTTGCACACACACGAAATTGAGTTATTGCACTTGAAGGCAAATTAAACTTCATAAATATTT
AAAATCAGAGATTAAACACGGCATTGTTGCAACATGTTGATGCGACTTCTGGCTGCCCCGGCTCCCCTGG
CTTCCCCCGGATTCCCCTGGATTCCCCTGCTCCTCCTGCCCCATCTCGTCTCTCAGGTTGCCAATTAAACG
GGCATTATCTGGCATAACTGCAATTTAAGTAGCCACATTCGCCATATCCCCAGTGCAATGCCACAACCGA
GTGCTCGCACGTTTCTCCTTTTCATTTTAATGTGGCTGCATCTGCGGATCTGTGTATCTTTGTATCTGAGGA
ACTGTGGAACTGCGAATCTGGATGCAATGACAGCACGGCAGCAACATTGGCGGTGCAGCGGCAAACGAT
CAATTTAAAGTAACGATCGCGCCGCAGAAACAAAAACCGCAACTGCAAACTGGCAAACTGGCAAATACT
CGGCGATACTCGTAAAGATGAAATGTATTTTTTGCGCTGAGATCCCCTTTCCTTTCGATTTGGGCCCCTTT
GCAGGCAATTGCGGCCTACGTTCGAGCTGCTTGATGATCGCTGGCAAAAAGGAGAATTTATATTTACGAC
TTGGCCAAATAACAACGGCGAACAGCAAACAAATGTTGAGTTGCTCGTTGCAATTTTTCAATTTAATTTG
CCCGATGAAAGGCCAAAATATAAATACCCGAAAACACTCTGTCACTGCTGCTCAATATGACTCAAATTTT
GATGTCCTCATGTTCTCCTAAACGTTAATATAACCAATTAAATCACTTTTGTGGCGATTTATATAAATAAT
TAGGCCAATAAATCGATAAAGATATATATCTACTTAGTCACTTTGTCAATGTTTTCCTAACACATATCTGC
ATTTTGTAGCTGCTGTTATGAGACACATATTTTTGATTGCAAAATGAAATGTATGTATTTCGTCGATGCAG
GTCCAAAATGAATAATATTAAAAGTTTAATAATCTGGTTACTTACAAATGCTTTCCCATTCCGATCTACAG
GTACAAATGGTCTGCGAAGACGCGGCCGACAGACATACACCCGCTACCAGACGCTCGAGCTGGAGAAGG
AGTTCCACACGAATCATTATCTGACCCGCAGACGGAGAATCGAGATGGCGCACGCGCTATGCCTGACGG
AGCGGCAGATCAAGATCTGGTTCCAGAACCGGCGAATGAAGCTGAAGAAGGAGATCCAGGCGATCAAG
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GAGCTGAACGAACAGGAGAAGCAGGCGCAGGCCCAGAAGGCGGCGGCGGCAGCGGCTGCGGCGGCGGC
GGTCCAAGGTGGACACTTAGATCAGATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGT
CTATATCGACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGACTACAAGGATGACGATGA
CAAGTAACATGATAACTTCGTATAGCATACATTATACGAAGTTATGTCGACTATTAAATGATTATCGCCC
GATTACCACATTGAGTGGTTTAAAATAGCCATAAAATATGCAACTGACGATGGCTTAAGATAAATACGTC
GCAGAGTCACTCATAAATTTCGAACGCAGCCCGCTGATTTACCTACCCCTCTAAACGATTCATAGTATAT
GTACGAGTATATCCACTAAGCTTTTTCGAGCACTGATTTTTTCGCTTGCACGAGACAAGTGCACCACCGCA
ATTGCAGGCAAATTATGTCTGAGGTAATGATTCCGTTTCGTGCAAGATTACACAGAAATCAAATTACGAC
AACCTTTATTCAGTAAGCAAACAAAGCCTTTGTTGGCATCTAATTATTCCACTTATGGTTGCGATTTCGGG
AGCTACAATCGGTTTTGGTTTAGTATATCTAGCGAGTTCCTTGGCGACATTTAAAATTTACAAATAAAGTT
TCTCTATTCAATCGGGACAGTGGAAATTGACTATTTTATTTATATTAATGAACTTATTTTTAATTTGGCTTA
AGTTACTAAGGGGTACTAATAGTTTGAGCGCAGTGCATGTCATGGGGACATGTGCAATTGTGTGTAAGCG
GGAAGTGATCGCGGCCTTCCGAATTTGGCCATGCCAAATAATCCCAGCTCGAAAGGAGGGGACCCGGCG
GTCAGGGCCATGGACATTGAACTTGAAAAAAAAAAAACACAAAAATATATAACACAAAACGGAAAATG
CTGTGTACCGCTTATGTTAGAGAAGTTGAGCAACGGGTTTTTCGTTTTGCAGTCACGATGGATTTCCAAAT
TAGTGTAGGAGGGGGGAGGGGAGGGAGGGAGATAATGTCCAGGCTGCCATAAGTGGGGAATAAGGAAA
ATAAAACATGAAACACGGGTCGGGCAATGTCATGCGGTATTCGGCTTTGCTTTCCGCCCAAGTTGAAGTG
ATCCTGTGTGTAAATAATGTCGAATGTTGCCGGTCGGTTGCATAAGCGTTGGTCAATTATGGCCAAAGAG
ATCTGATTTGTGGAAGCTTTTTTTGACCACTTAGCGCGCTCCGCTGATGTTGTTTTGTTTTGTGCTGGGGCA
GAAAACTTGTTTCAATTATTGGGAAAAGTGCGTATAAATCATTGCCGCAAGCTCTGAAAAGCGAAAAAG
AAAAACAGTAACCAAACAGACAAACGCAGCATTCCCCCACACAATTAAGCAAAAACTTGAAACAAGTCA
ATTCGAAAAAAATTATAGGTTCAACGGCTGCAGCGATCGCATCATTAGTTGCGTTTTTAGTAAATACACC
ATTTCATTACACAACACACACAATTAATTAATAAAACTGTACTGGTTATTTCAAGTGTGTCTTTTAATAAG
CCTGCCGATCGCAATAAATTCGAGCAGCATTGCCGGTAATTTTGTGCAACATATTTTTCGATTGCCACACC
GTGTTTGTTTATTTTTTCTGTGGGTGCAATGATTTAGAATGCGGGCAAGGGATCAAGTTGAACCACTTCTA
AGAAAAAATAGACATTGCATAAATGATATAGAGTCCAAAAACTACACCAATTCAATAGCAGTAATGGTT
ACATTAGCTTTGAAATTGTTTTTAGACATCCGAAGAAATAAGATTAAATTTAAACGGCATTCTTTAATTTG
TATTTTAATATTTTGAGAGGTTTTCCTTATTTAAAGTGTAGATTATTGAGGATTAATGCAATACCACTTTA
CCTGCGGAGGTCGTAAAACGTATTTTTACCCATTTGCATGTTTATTATGCGTGTCGCTGGTTGTTTACTTTA
CTTAAGTTTTGCAATTTTTTCTTTAGCAAGCAGGTGCATTTGGGCCAAGAGATATATGCGATCGCTTTCGG
TTCGAATTTTTAACATTTACTTGCGGCGATGGTCATTAGAGCATTACCCACTTAGGGCACCCCCAACATCC
AGTTGATTTTCAGGGACCACAATATTTTAAATAACAGCTAGTGGAATTACCTAAAAGCGCTTTCGTTCCTT
TTTGAAATTTTATGTAACACTCAATTATATTTATGTATATGTATGCTCAAAATCACCTGCCAATAACTAGC
GGAAACCAAATATTTGACCCTCAGTGAATTGTGAATCATCGGTGACGCCCAATCGAAATCCAATCCTAAG
CAATTGAAACGAGCACGAGTTCCAATTTAATAGTATACAAGGAAACACCTGCTTTAAATACTCTACATAG
TACACGTTATAATAACGATTTATTTGATATTTCTGGATTTTTGTCTGCATGTATTTCATATAATATTGATTT
GATTTTTTTAATGAATTGAACTAAAAAATCATATTAGAACATTTTTTGCAGTCGCCGATAAAGATGAACA
CAGTTCTCAGAACACAACTGTCATGTATTAAGCTTTCAGATTTTCAGAAATTTGGAGAGCAATGCATTCTA
TGCACGAGCCTCCTGGCCTTACAATTTACTTGTTTGAAATTAGATCGTCAAATAAAGTCCCTAAAATTAAA
TAAATAGTAGTCACAACTTTAAAATAGGTCTTAATCTTTTAGGGTACCGAAAGGTATTTCGGCACAAATC
AGCGCAGTTTTAAATGTCGATGAAGGCCAAAAATCATACCAAACCCAGCGAAAGGTGATGTCTGACTCA
TTAAATTGGGGGATTCGAGTGTATTTATTAAACATGCGTGAAAATCAATCATGGAAGACAAAACGCAAA
GTTGGCCGATCTATGGGAACAGCATAAGCCACCTGATTACCCGAACACTGAACCACCCGAATCACTAAA
ACCACCGAAGTTGGCGCGCGCCTTCGTTTTCATTTTCATTGGCCTGTCTTCGTCTTCGGAGAAAAAAACCT
TCATATAAAACGCGGCCGACATATTATGGCCACCAGTCGTTACCGCGCCACGGTCCACAGAAGAGGATT
AAAAAAATATCACACAGCCGAAGGCTAGAGAAGAACCCCCTATAGCTGAACATATATAAACAAATATAT
TTTTTTTTATTGCCAACACACTTTGGCTTAAGTGTTAAGAGTGATTGTCAGCTTAGAGCTAAGTGCAATGT
TCCAGGACAAAGGGTGGATCCTTGTGACCCTGATCACCTTGGTGACGCCGTCTTGGGCTGCTTACAAACT
TCAGGAGCGATATAGTTGGAGCCAGCTGGACTTTGCTTTCCCGAATACCCGACTAAAGGACCAAGCTCTG
GCTAGTGGAGATTATATTCCGCAAAATGCTCTACCTGTTGGAGTCGAACACTTTGGCAATCGGTTATTCGT
CACTGTTCCCCGCTGGCGTGATGGGATTCCGGCCACTCTGACCTATATAAACATGGACCGCAGTTTGACG
GGTTCACCGGAGCTAATTCCGTATCCAGATTGGCGCTCAAATACAGCTGGAGATTGCGCCAACAGTATTA
CCACTGCCTACCGCATTAAAGTGGATGAGTGTGGTCGGCTGTGGGTTTTGGACACTGGAACCGTGGGCAT
CGGCAATACCACCACTAATCCGTGCCCCTATGCGGTAAATGTCTTTGACTTGACCACGGATACGCGAATT
CGGAGATACGAGCTACCTGGCGTGGACACAAATCCAAATACTTTCATAGCTAACATTGCCGTGGATATAG
GCAAAAATTGCGATGATGCATATGCCTATTTTGCCGATGAATTGGGATACGGCTTGATTGCTTACTCCTGG
GAACTGAACAAGTCCTGGAGATTCTCGGCACATTCGTATTTTTTCCCCGATCCATTGAGGGGCGATTTCAA
TGTCGCTGGTATTAACTTCCAATGGGGCGAGGAGGGTATATTTGGTATGTCCCTTTCGCCCATTCGATCGG
ATGGTTATCGTACCCTGTACTTTAGTCCGTTAGCAAGTCATCGACAATTTGCCGTATCCACGAGGATTTTG
AGGGATGAAACCAGGACGGAAGATAGCTATCATGACTTTGTTGCCTTAGATGAACGGGGTCCAAACTCC
CATACCACTTCACGTGTGATGAGCGATGATGGAATTGAGCTGTTCAATTTAATAGATCAAAATGCAGTGG
GTTGCTGGCACTCATCAATGCCGTACTCACCGCAATTTCATGGCATTGTGGATCGCGATGACGTTGGCTTA
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GTTTTTCCGGCCGATGTGAAAATTGATGAGAACAAAAACGTTTGGGTTCTATCCGATAGGATGCCCGTTT
TCTTGCTGTCTGACTTGGATTATTCAGATACTAATTTCCGAATTTACACGGCTCCCTTGGCCACTTTAATTG
AGAATACTGTGTGTGATTTGAGGAATAACGCCTATGGGCCGCCAAATACCGTTTCAATACCAAAACAAGC
CGTTTTGCCAATGGGTCCACCGTTATATACGAAACAATATCGTCCTGTCTTGCCACAGAAACCTCAGACC
AGCTGGGCTTCCTCGCCGCCTCCTCCAAGTCGCACTTATTTGCCCGCCAATTCAGGCAATGTAGTCTCCAG
TATTAGTGTCTCTACAAATTCTGTGGGTCCTGCAGGAGTGGAGGTGCCAAAGGCCTATATTTTCAACCAG
CACAACGGCATAAATTACGAGACAAGTGGTCCCCATCTATTTCCCACCCATCAACCCGCCCAACCGGGTG
GCCAGGATGGTGGGTTAAAAACTTATGTGAATGCCCGCCAATCTGGGTGGTGGCATCATCAGCATCAAGG
TTAACATAATCCTACACACGGTACTTGGGTATATTCTCACACACTCGATTGATGTAAAGAATATTTAAAG
ACAACAACATAGGGCAACAGCGGTTAAAAAAACCACATGACGTATGAGCAAGTGGCAAATCAATACTTT
ATCTAGTTATGTTAAGCAAAAAATAACAATAAATCAACTTTTTTTTGAAGGTTAAGAGTTTACGCAATTTT
CTTGAGCGGAAAAAGCGGAAAAAATGTAAGTATGCATAAATTCTAAATATATCAACAACTGTACATTTTC
TGGAGTACTACTACCAGGCAAGAAAGTAGGTTGATAAAGCTATGCACAAGATCTTGTTTGGGTGCAGGG
AAAGTTCAACTTAATCGCTCAATTTGAGATCGCCTGGTCGCTTGAGATTCGACTGTAATTGAAATTTTTGC
TTTTGATCGGAGCCAGACTTCAGACGGGGCAAACAAAAAGACTTTGTTGGTGGTAGGGTAGGATCCGTTG
ACCTGCAGGTCGAGGACATAACTTCGTATAGCATACATTATACGAAGTTATATCCTTAGATCCTTAGATC
CTTAGATCCGTAGGGTGTATGTGGGATTGGGCGAAATGACGCGGAGACAGATACAAAGCAACTATATTG
TAACAAATGAACTATTTACTTAAATGAATAATATTTAAATATTTTGATGGTACTTGTGCGAATACGAAACT
TAACCTAAATCGAACCTAATGGAATTATTTCAAGCGTTTGAGCAGCAACCGAAAATACGTAAATGAAAC
AAAACTACAAACTAATTAACTAGGCTAAGTAAATAAAAGTAGTGGAAGGAGCGCAGATTATAAACCTAC
TTAGAATTAAATGAGCAAAACAAACAATTTTAATTTAGTTCCAAACGAAAAAAAAATTCAAGAGGATTC
GCTCGAAATGGAAACCTCTGTCCTGCCCCTTTGTTGCTTACTGCTATGTTTAAATTAATTTCGCGAAAAAT
ACTCAAAAATTGAAACACAAAGAAAACAAAAAATGAAAGTATACCATTATAATGTTGAATGCGAGCAAA
ATTCTGTTGATATGAATTTTTGGTAAAAACATGTTCTAAACCAATTTAAGATACGTAACGAAGGATGCAA
AAACAAAATGAAAACTATTAAACTTTAACTTAAATATAAATAGAATTTGTTAGCCAAGTAAACATATTAC
GACACGAAGAACAAACGTTTTCGGGAGTATCGAATATTTGAATGTGTATAGTTTGTGCTTATTAAATAAA
ATAATGCAATTTTAGTTAACTCTGTTTATTTGTAAACGAATTTGTTTAGTTCTCGCCCAAACGACTAGAGT
GAAGCTGTTTCTTTAAGTAATGTGTAGTGTGTTTACTTTTTAAATTAAATTAATGCCTAATTTTATTATTAT
TATGTTTAGTTTAATGACAAGCGTTTATGAGATTATCCGACAGAAGCGGCGAGAAGAGGAGTGCGACAA
ACCGTTTGCCCCGGCAAACGCAAATAAATTATTGGTTTTGAAAAAATCTAAAGAAAACAAAAAAAAAAA
ACAATGAGAAATCGAATCCGATTGTTGTGTTATTATTTTAGTTCTGCCATTGCGATTTTCCGTTCTCCCAGT
GTAATTAGAGCCTGAGTTGTTTGAGAGAGTCTTCGCGGGCTACCCGCTTGCATGCGAAATTGCTTTTGATC
TCGTTTTGAGCCGTTAATTGATCGTGAGTTGTACGCTCTATAGAGATACCCATACCGATTAGCTATAACGA
TACCATACCGATACCAATACCATATATATAGTTTAGTGGATCCAACGAGCTGTGCTCGACTCAAGCCACA
AGGCGCTCCGTGTGTGTGTCCCGATAATTGATCCTTCAGTTGAGTTTCCATGGTGGTCCCAGTTGGGGCCG
TTCGTAACGAGGTCCTGCAGAAGATGTATACGTACTACCGCCTAAGATTCGATTATAGATATATTATATTT
ATAAATCTTGATATATATTTATGTACTTATGTATGTGGGGATCGAGTCGAAATGGACAAACAATAAGAGA
GTAATTCTGCGGAACGGAACGAAGGCAGATGCAAATACGTAAATAAGAATAAGTTAAATGTTATAGATT
TTAAACGCATATGCGTGGATCGAATGGGATGTCCCCGCCACCGCAAACCAAGAATAGACGCTAAAATAC
AATACATAAATATTTAAACGTGGATTATCGTAGCAACAGATATACGTAAAAGGAAGACGATTCGGTGAG
GTCTTGCATACAGTACTGCATCCGACCACTTACCTACTACTTACTTACCAGTGCATTCGTAGTAAATAGTT
AAATAATCGCTACTTACTTGTACATTTGCTAGTGGCTTTTACTTTAAACTCTCTGACCCTCGGCCGAGCAG
GCCTATCCATAAGAGACTACTACTTTTCCTATATACCTACTTCATCCGATCAGATCAGACCTACAGATACT
TTGCGGTTACATTTTCTACTTGTAATTTCCCCTCCCCGCGATCGAAGATTGGACCCGCAGGCTCCGTTCAT
AC

Appendix B. List of Primers.
(a) List of primers and their sequences used for: integrating 20 nt of target sequences into chiRNA,
generating the six repair vectors, colony PCR screening for candidate repair vectors, and genomic
extraction PCR of Antp::CFP transformant flies. (b) Forward and reverse primer pairs with corresponding
DNA template for: generating the six repair vectors (fragment 1, 2, and 3), colony PCR screening for
candidate repair vectors, and genomic extraction PCR of Antp::CFP transformant flies.
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B.a. List of Primers
Primer Name

Sequence

chiRNA
F.UbxChi

5’CTTCGCGGCGGCGGCGGTCCAAGG 3’

(5’phosphate)

R.UbxChi

5’AAACCCTTGGACCGCCGCCGCCGC 3’

(5’phosphate)

F.AntpChi

5’CTTCGAGCCGGGATCCGGAGGCGA 3’

(5’phosphate)

R.AntpChi

5’AAACTCGCCTCCGGATCCCGGCTC 3’

(5’phosphate)

F.ScrChi

5’CTTCGAACATCGTACCCTACCACA 3’

(5’phosphate)

R.ScrChi

5’AAACTGTGGTAGGGTACGATGTTC 3’

(5’phosphate)

Repair Vectors
F.17FLAG

5’AACGTCTATATCGACTACAAAGACCATGACGGTG 3’

R.17FLAG

5’GTCTTTGTAGTCGATATAGACGTTGTGGCTGTTG 3’

F.UBXXFP

5’CACTTAGATCAGGTGAGCAAGGGCGAGGAGCTG 3’

R.UBXXFP

5’GCCCTTGCTCACCTGATCTAAGTGTCCACCTTG 3’

F.ANTPXFP

5’AACAGTCCGCAGGTGAGCAAGGGCGAGGAGCTG 3’

R.ANTPXFP

5’GCCCTTGCTCACCTGCGGACTGTTGGGTGGTG 3’

F.SCRXFP

5’CACCTAAGCGCAGTGAGCAAGGGCGAGGAGCTG 3’

R.SCRXFP

5’GCCCTTGCTCACTGCGCTTAGGTGCGCGAACTG 3’

F.UBX17

5’CACTTAGATCAGATCCTGGGGCACAAGCTGGAG 3’

R.UBX17

5’GTGCCCCAGGATCTGATCTAAGTGTCCACCTTG 3’

F.ANTP17

5’AACAGTCCGCAGATCCTGGGGCACAAGCTGGAG 3’

R.ANTP17

5’GTGCCCCAGGATCTGCGGACTGTTGGGTGGTG 3’

F.SCR17

5’CACCTAAGCGCAATCCTGGGGCACAAGCTGGAG 3’

R.SCR17
F.5Ubx

5’GTGCCCCAGGATTGCGCTTAGGTGCGCGAACTG 3’
5’CAGCTAGGTCTCGCTATCTCCAAAATGCCAAGTTAACATG 3’

F.x5Antpx

5’CAGCTAGGTCTCGCTATCTCTTCGGCCTCCTACCCCTC 3’

F.5Scr

5’CAGCTAGGTCTCGCTATTTGTGGCCACGGCCACAGCAG 3’

F.x5Scrx

5’CAGCTAGGTCTCGCTATGAATAGTTTTCGGGGGCGAC 3’

R.5XFP

5’CAGCTAGGTCTCCCATGTTACTTGTACAGCTCGTCCATG 3’

R.5FLAG

5’CAGCTAGGTCTCCCATGTTACTTGTCATCGTCATCCTTGTAG 3’

F.loxPy

5’CAGCTAGGTCTCCCATGATAACTTCGTATAGCATACATTATACG
AAGTTATGTCGACTATTAAATGATTATC 3’

F.lox2272y

5’CAGCTAGGTCTCCCATGATAACTTCGTATAGGATACTTTATACG
AAGTTATGTCGACTATTAAATGATTATC 3’

R.loxy

5’CAGCTAGGTCTCGGTCCTCGACCTGCAGGTCAACGGATC 3’

F.loxPUbx

5’CAGCTAGGTCTCGGGACATAACTTCGTATAGCATACATTATACG
AAGTTATATCCTTAGATCCTTAGATCCTTAG 3’
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R.loxPUbx

5’CAGCTAGGTCTCCCGCCGTATGAACGGAGCCTGCGGGTC 3’

R.xloxPUbxx

5’CAGCTAGGTCTCCCGCCCAAACGGTTTGTCGCACTCCTC 3’

F.lox2272Antp

5’CAGCTAGGTCTCGGGACATAACTTCGTATAGGATACTTTATACG
AAGTTATGATCGACGGAGTCTACCCAC 3’

R.lox2272Antp

5’CAGCTAGGTCTCCCGCCGCTTTCCGCTTTGCAGCCCTTTC 3’

F.loxPScr

5'CAGCTAGGTCTCGGGACATAACTTCGTATAGCATACATTATACG
AAGTTATGACGCGTGGCACTTTTCGGGTAC 3’

R.loxPScr

5’CAGCTAGGTCTCCCGCCGCGAAAATCAGTATGGTTCCGAC 3’

R.xloxPScrx

5’CAGCTAGGTCTCCCGCCTCGACAGCTTTGTCTGCTCATC 3’

F.CFP1

5’ACCACCCTGACCTGGGGCGTGCAGTGCTTCAGCCGC 3’

R.CFP1

5’GCACTGCACGCCGGTGGTCAGGGTGGTCACGAGGGTG 3’

F.CFP23

5’GCCGACAAGCAGAAGAACGGCATCAAGGCAAACTTCAAGATCC
GCCACAAC 3’

R.CFP23

5’CTTGATGCCGTTCTTCTGCTTGTCGGCCCAGATATAGACGTTGT
GGCTGTTGTAG 3’

Colony PCR
Screening
F.S2.a

5’ CTGGCAGTTCCCTACTCTCG 3’

R.S2.a

5’ GGTAAATCAGCGGGCTGCGTTCG 3’

F.S1.S2.b

5’ CAGGGAAAGTTCAACTTAATCGC 3’

R.S2.b
Genomic
extraction PCR
F.x5ANTPx

5’ CTGTCCTGGCTGGTCTAGACGTC 3’

R.CFP1

5’GCACTGCACGCCGGTGGTCAGGGTGGTCACGAGGGTG 3’

R.5XFP

5’CAGCTAGGTCTCCCATGTTACTTGTACAGCTCGTCCATG 3’

F.S1.S2.b

5’CAGGGAAAGTTCAACTTAATCGC 3’

R.S1.Antp
R.lox2272Antp

5’GTTTAGGTTTGTTCACGCGAAG 3’
5’CAGCTAGGTCTCCCGCCGCTTTCCGCTTTGCAGCCCTTTC 3’

5’CAGCTAGGTCTCGCTATCTCTTCGGCCTCCTACCCCTC 3’
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B.b. PCR Primers and Templates
DNA template 1

DNA template 2

Forward Primer

Reverse Primer

UBXTT

F.17FLAG

R.5FLAG

eYFP

F.UBXXFP

R.5XFP

pEGFP

F.SCRXFP

R.5XFP

pEGFP

F.ANTPXFP

R.CFP1

pEGFP

F.CFP1

R.CFP23

pEGFP

F.CFP23

R.5XFP

pEGFP

F.UBX17

R.17FLAG

pEGFP

F.SCR17

R.17FLAG

pEGFP

F.ANTP17

R.17FLAG

yw

F.5Ubx

R.UBXXFP

yw

F.5Scr

R.SCRXFP

yw

F.x5Antpx

R.ANTPXFP

yw

F.5Ubx

R.UBX17

yw

F.x5Scrx

R.SCR17

yw

F.x5Antpx

R.ANTP17

Repair Vector Fragment 1

ANTPXFP.CFP1

CFP1.CFP23

F.ANTPXFP

R.CFP23

CFP1.CFP23

CFP23.5XFP

F.CFP1

R.5XFP

ANTPXFP.CFP23

CFP1.5XFP

F.ANTPXFP

R.5XFP
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x5Antpx.ANTPXFP

ANTPXFP.5XFP

F.x5Antpx

R.5XFP

5Scr.SCRXFP

SCRXFP.5XFP

F.5Scr

R.5XFP

5Ubx.UBXXFP

UBXXFP.5XFP

F.5Ubx

R.5XFP

UBX17.17FLAG

17FLAG.5FLAG

F.UBX17

R.5FLAG

SCR17.17FLAG

17FLAG.5FLAG

F.SCR17

R.5FLAG

ANTP17.17FLAG

17FLAG.5FLAG

F.ANTP17

R.5FLAG

5Ubx.UBX17

UBX17.5FLAG

F.5Ubx

R.5FLAG

x5Scrx.SCR17

SCR17.5FLAG

F.x5Scrx

R.5FLAG

x5Antpx.ANTP17

ANTP17.5FLAG

F.x5Antpx

R.5FLAG

y+ (digested miMIC)

F.loxPy

R.loxy

y+ (digested miMIC)

F.lox2272y

R.loxy

yw

F.loxPScr

R.loxPScr

yw

F.loxPScr

R.xloxPScrx

yw

F.loxPUbx

R.loxPUbx

yw

F.loxPUbx

R.xloxPUbxx

yw

F.lox2272Antp

R.lox2272Antp

white bacteria colony

F.S2.a

R.S2.a

white bacteria colony

F.S1.S2.b

R.S2.b

Repair Vector Fragment 2

Repair Vector Fragment 3

Colony PCR Screening
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Genomic Extraction PCR (of y+ transformants)
yw

F.x5ANTPx

R.CFP1

yw

F.x5ANTPx

R.5XFP

yw

F.S1.S2.b

R.S1.Antp

yw

F.S1.S2.b

R.lox2272Antp

y+ transformants

F.x5ANTPx

R.CFP1

y+ transformants

F.x5ANTPx

R.5XFP

y+ transformants

F.S1.S2.b

R.S1.Antp

y+ transformants

F.S1.S2.b

R.lox2272Antp
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Figure 10. Rothbauer et al., 2006.

Permissions:
Free with License:

128

129

130
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